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ABSTRACT 
 
New technologies in green chemistry;  
 Atroposelective synthesis towards korupensamine D 
by 
 
James Carl Fennewald 
 
     Chemists and chemical companies alike are well aware of the large amounts of waste 
they generate, although until recently little attention has been paid to the waste flow in 
terms of cost and environmental consequences.  By most estimates (roughly 85%) of 
organic waste produced comes in the form of organic solvents. Thus, our goal continues 
to be the reduction of waste by focusing on organic solvents, and getting those solvents 
out of reactions via replacement by micellar catalysis, as quantified by E Factors. 
     Fluorinated compounds have blossomed in the pharmaceutical industry due to the 
better bioavailability through an increase in membrane permeability when compared to 
their non-fluorinated analogues. Micellar catalysis has been found to be amenable to 
radical-based trifluoromethylation of various heterocyclic compounds. Nanoreactors 
 x 
composed of the designer surfactant TPGS-750-M enable these substitution reactions to 
be performed in water at room temperature in modest to good yields in combination with 
Langlois’ reagent (NaSO2CF3) and t-BuOOH, negating the need for pre-
functionalization. Trifluoromethylation of several heterocyclic arrays has been 
accomplished, including heteroaromatics.   
     Aromatic halogens have long served as excellent handles for transition metal 
catalysis and directing groups in synthesis, with subsequent need for removal. Current 
protocols for such dehalogenations are cost prohibitive at scale, energy intensive, and 
generally call for harsh reaction conditions. The new surfactant, SPGS-550-M, (‘Nok’) 
in water with Fu’s catalyst and a mild hydride source is used for facile debromination of 
aromatic compounds.  These reactions take place at ambient temperatures. Furthermore, 
the aqueous mediums can be recycled, thus greatly reducing our dependence on organic 
solvents while furthering technologies in green chemistry. 
     Chiral compounds and their syntheses have been an intellectual curiosity of organic 
chemists since the first chiral resolution of tartaric acid in 1848 by Louis Pasteur. We 
have taken on the challenge to induce axial chirality for the natural product 
korupensamine D with use of an internal aromatic auxiliary blocking one face of the 
coupling partner via π-stacking. Korupensamine D has yet to be synthesized in its 
natural form, due to the inherent instability of the cis tetrahydroisoquinoline ring 
presenting an exciting, challenging exercise in stereo control. 
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I. Introduction to green chemistry and its quantification 
1.1 Introduction 
     Academic and industrial chemists alike have been pushing the fields of modern 
medicines and materials to the limits for decades, saving and improving billions of lives 
worldwide.  While this may sound very heartwarming and well intentioned, which it is, this 
continuous drive forward has come at a tremendous cost, affecting many more than we have 
helped.  This cost, is in terms of organic waste production that has been, historically, simply 
poured down the drain, to today’s standard of incineration, sending millions of metric tons 
of toxic pollutants into our atmosphere, oceans, and ultimately our own food sources 
through the trophic pyramid. Thus, the burden is on the backs on the next generation of 
chemists to cease the use of high energy input, high waste generating ‘old’ methodologies, 
and to look for new technologies that are sustainable for the responsible stewardship of our 
world. 
 
     With this insight is has been a pleasure to join the Lipshutz research group with my 
passion for sustainable practices and become an integral player in the green chemistry arena.  
As we have enabled many traditional organic reactions thought to be intolerant to moisture, 
to be ran in … water…yes, water with the aid of designer surfactants PTS-600,1 TPGS-750-
M,
2  
and SPGS-550-M
3 ‘Nok’, as shown in Figure 1. These surfactants spontaneously self-
assemble in water forming micelles with their hydrophobic portions in the interior.  As the 
saying goes ‘like dissolves like’ such that the organic hydrophobic reagents and starting 
materials partition into the hydrophobic pocket or core of these designer surfactants dubbed 
 2 
‘nanoreactors,’ This enables very high localized concentrations within the nanoreactors 
themselves, thus allowing chemistry to proceed at ambient temperatures (rt) with no external 
energy source other than stirring. Because there is little surfactant by weight (2 wt. %) in 
water, there is a truly minimal resource investment for micellar catalysis, even more so 
when the aqueous medium is recycled.  For the past decade we have been leaders of the 
green chemistry movement, showcasing the sheer number of transformation facilitated by 
these nanoreactors.  Some of these transformations include,  but are not limited to the 
following; Pd catalyzed cross couplings (Suzuki, Heck, Negishi, Stille, Sonagashira), 
aminations, borylations, cross metathesis, Cu catalyzed 1,2- and 1,4-asymmetric additions, 
nitro reductions, hydroformylations, and allylic alcohol oxidations to name a few.  Our 
recent review in Green Chemistry
4
 provides an excellent encompassing historical 
perspective and current uses of our groups’ surfactants technology. 
 
 
 
 
 
 
 
 
 
 
 
 3 
Figure 1. Lipshutz Group surfactants for enabling green chemistry 
 
 
     Up until the past few decades little attention has been paid to the waste flow in terms of 
cost and environmental consequences.
5
 Even with Anastas’ and Warners development of the 
“12 Principles of Green Chemistry” in the late 1990’s,6 the specific aims of which call for; 
waste prevention, atom economy, non-hazardous synthesis, design of safer chemicals, use of 
renewable solvents and feedstocks, and catalytic or recyclable systems.  Since the inception 
of the green chemistry movement several metrics have been developed as a way to gauge its 
‘greeness’ using comparative analyses7,8 (vide infra). 
 
     These metrics include, effective mass yield (EMY), as it defines yield in the terms of 
what proportion of the final product mass was produced from non-toxic, benign, and 
 4 
renewable materials. As the EMY reaches ‘1’ the process can be assumed sustainable.9 
Atom economy (AE), one of the original metrics developed by Trost, is measured as the 
mass of desired product divided by the mass of all reagents used, an AE of 1 signifies that 
all atoms used in the synthesis appear in the final product.
10  
While more recently many 
pharmaceutical and fine chemical companies have used process mass intensity (PMI) as a 
measuring stick, as this metric takes into account reagent stoichiometry, reaction media, 
work-up, and purification conditions thus painting a more accurate picture of the mass of 
waste generated for given amount of product, although it does not  include water.
11
 One of 
the most encompassing metrics is the life cycle assessment (LCA), a method commonly 
dubbed ‘cradle to grave’ which takes into account all materials and energy from the 
processes from inception to disposal.
12
 Although it is an extremely time consuming costly 
metric that is commonly discarded by smaller outfits that opt to use either the PMI metric or 
the far more appropriate environmental factor (E Factor) both are reliable comparing various 
processes solely from the waste generated in the form of solvents used for the reaction 
medium and associated work-up.  
 
      E Factors were developed as one of the most effective metrics to quantify the 
‘greenness’ of any given process and its relative waste generated.  The E Factor metric was 
orginated by Sheldon.
13
 By most estimates  (ca 85%) of chemical waste produced comes in 
the form of organic solvents.
14 
Thus, E Factors provide a simple metric for all chemists to 
measure reactions based solely on solvent usage. While E Factors tend to focus only on the 
first use of any medium, all subsequent reactions involving recycled solvent lead to a large 
reduction in E Factors. Secondly the E Factor is often reported with and without its aqueous 
 5 
components to allow for a more uniform metric independent of work up and purification 
procedures. 
 
 
Scheme 1. Definition of an E Factor 
 
     The E factor metric is quantified as the amount of waste generated (kg) divided by the 
amount of pure product obtained (kg), as shown in Scheme 1. A smaller E Factor translates 
into less waste production. It should be noted that while the E Factor is inclusive of the 
major waste component of organic synthesis (solvents) the calculation ignores some 
parameters such as; catalyst systems, recyclable solvents, atom economy, and energy input. 
A breakdown of E Factors by industry,
15
 shown in Table 1, shows that the pharmaceutical 
companies are by far the largest waste generators with typical E Factors ranging from 25 to 
100 due their complexity, while the petroleum industry is the least waste producing by its 
nature of converting crude oils directly to commodity chemicals and fuels with an E Factor 
of generally as low as ~0.1.  
 
 
 
 
 
 
 6 
Table 1. Breakdown of E Factors by industry 
 
 
     Thus, our recent goal has been to reduce E Factors by focusing on organic solvents and 
getting those solvents out of reactions. To showcase our micellar catalysis several current 
large scale Pd catalyzed cross coupling E Factors were calculated both with and without 
their aqueous work ups.  Then, the same reactions using PTS or TPGS-750-M were run to 
replace the organic solvent, which allowed us to access the ‘greenness’ or  E Factors of the 
given process. 
 
     As the cross coupling examples in Scheme 2 illustrate, involving Heck,
16
 Suzuki,
17
 and 
Sonagashira
18
 reactions, E Factors associated with each type can be reduced dramatically, in 
many cases by greater than an order of magnitude.  Since these were run in water on a far 
smaller, academic scale relative to those in the published studies, the corresponding drop in 
E Factor would likely be even more pronounced at larger scales where small loses are of 
little consequence.  Moreover, in most cases, the hydrophobic effect
19 
characteristic of 
aqueous micellar catalysis allows for cross-coupling to take place at room temperature,
 
while in traditional organic media heating might well be needed to initiate and/or drive 
reactions to completion. 
 
Industry E-factor
Petroleum 0.1
Bulk Chemicals <1-5
Fine Chemicals 5-50
Pharmaceuticals 25-100
 7 
 
Scheme 2. Comparison of three of the ‘named’ coupling reactions of E Factors from 
industry verse our micellar catalysis 
 
     The key to lowering E Factors in these reactions is the application of environmentally 
benign surfactants that spontaneously self-assemble in water into nanomicelles of a 
particularly engineered shape and size. Cross-coupling and related reactions run within their 
lipophilic cores, especially at ambient temperatures, are typically clean and thus, can 
 8 
oftentimes be more efficient than those run in organic media and once complete, product can 
be extracted with the minimal amount of organic solvent.  Opportunities for recycling of 
these aqueous reaction mixtures serve to further reduce dependence on organic solvents. 
New industrial processes, therefore, that begin green are very likely to remain green for the 
lifetime of a given process; i.e., years, translating into a potential economic and 
environmental windfall for each green step in a synthesis. For an in depth review of E 
Factors, please see our recent mini review.
20 
 
      In conclusion, micellar catalysis has been found to be amenable to a plethora of various 
couplings, oxidations, reductions, etc.  Nanoreactors composed of the designer surfactants 
enable these reactions to be performed in water at room temperature in good yields.  The 
aqueous reaction mixtures are readily recycled, and given the limited amounts of organic 
solvent needed for product isolation, the associated E Factors imply that a considerably 
enhanced level of greenness is characteristic of these reactions. 
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II. Aqueous trifluoromethylation of heterocycles at room 
temperature 
2.1 Introduction 
Recent research methods for introduction of the trifluoromethyl group onto aromatic and 
especially heteroaromatic ring systems has blossomed, as this moiety imparts several 
physiological advantages. But is also plagued by its problematic and harsh conditions, with 
little to no regard for waste production. 
 
 
Figure 1. Top selling drug examples containing F or CF3 
 
From the latest statistics thirty percent of the top ten selling drugs in 2011 (Figure 1) 
contained fluorine atoms, as do 7 of the 35 newly approved pharmaceutics.
1
 For these 
physiologically active compounds the most common fluorine source is a CF3 group on arene 
units.
2,3
 Fluorinated compounds display better bioavailability through an increase in 
membrane permeability when compared to their non-fluorinated analogues; due to the 
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change in their enhanced solubility and lipophillicity. They are also more difficult to oxidize 
leading to an increase in metabolic stability.
1
  Fluorinated compounds are used heavily 
throughout the pesticide and agrochemical industries.
4
 This large amount of fluorinated 
chemicals necessitates the need for a new, greener, and higher yielding methodology for C-
CF3 bond formation. 
 
Although in the medicinal chemistry and fine chemicals arenas there is a rich history of 
using super stoichiometric CF3Br or more commonly CF3I as precursors to CF3 radicals for 
synthetic targets.
5
 opportunities remain not only for improvements in existing technologies 
and development of new reagents, but also for new processes that are more environmentally 
benign. Most recent methods leading to insertion of this valued appendage rely on transition 
metal-mediated C-CF3 bond constructions, and while these typically offer good yields, they 
tend to require tedious pre-functionalization. 
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2.2 Previous Work in Trifluoromethylation 
The present day industrial process for trifluoromethylated homo and hetero aromatics 
involves exhaustive chlorination of the methyl group appended to an aryl ring
6
 followed by 
the Swarts reaction of the resulting ArCCl3 with hydrofluoric acid.
7
    This current process is 
substantially limited in its functional group tolerance and thus must be performed early in 
the synthesis. It is also environmentally offensive, requiring large amounts of Cl2 and HF 
while generating excessive quantities of acid (HCl) waste.
8 
 
 
Figure 2. Current industrial process for trifluoromethyaltions 
 
Over the past few years, reports on installation of the trifluoromethyl group have 
skyrocketed, with over 100 detailed reviews and books published over the last two years 
alone, and seemingly more reports published daily. Some of the more relevant detailed 
historical reviews of aliphatic
9
 and aromatic
8
 trifluoromethylations are worth noting by Ma 
and Grushin, respectively. While we wish to provide a thorough examination of prior art, the 
sheer number of growing publications makes it impossible. Thus we have listed the more 
commonly employed cases utilizing more traditional CF3 sources, such as Cu/Unemotos 
reagent (S-(trifluoromethyl)thiophenium salts),
10-12
 Re/Togni’s reagent (3,3-dimethyl-1-
(trifluoromethyl)-1,2-benziodoxole),
13,14
 Pd/TESCF3,
15,16
   Cu/Rupperts reagent 
(TMSCF3),
17-18
 Ru/CF3SO2Cl,
19,20
 Ag/NaSO2CF3
21
 and Ag/CF3I.
22
 Some of the more recent 
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methods developed in fluorine chemistry such as from the labs of Buchwald, Grushin, and 
Sanford are shown in Schemes 1-3, respectively.  
 
The Buchwald group has pursued directed trifluoromethylation via Pd catalyzed 
couplings, with use of TESCF3, (Scheme 1, top) using aryl chlorides in refluxing dioxane. 
Aryl bromides and triflates are also amenable to these reaction conditions, although with 
depressed yields compared to the chlorides.
23
 A year later Buchwald et al. followed up their 
earlier work, again with the CF3 source TESCF3, except this time they utilized boronic acids, 
copper, a phenanthroline ligand, and ran the reactions at room temperature instead of 
refluxing conditions. They had obtained modest yields, with lower yields being that of 
theses hindered ortho-substituted aryl rings making the copper mediated coupling difficult.
24 
(Scheme 1, bottom) 
 
 
Scheme 1. Highlighted works by Buchwald et al. in trifluoromethylations 
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Scheme 2. Highlighted works by Grushin et al. in trifluoromethylations 
 
     An effort toward minimization of the use of additional reagents (i.e., base, ligand, atom 
inefficient CF3 sources, etc.) was enabled by the preparation of an inexpensive ‘bottled’ 
CuCF3 species (Scheme 2, top) by Grushin et al. The ready to use CuCF3 reagent in DMF 
was found to be stable at room temperature for up to three days.
25
 Whereas the same 
workers shortly followed up with application of their cheap fluoroform prepared CuCF3 
reagent in DMF, with the substrate (boronic acid) dissolved in PhMe to which was added 
two equivalents of CuCF3 at room temperature while open to air thus avoiding additional 
costly and dangerous O2 or Ag
I
 oxidants.
6
 The mild conditions enable yields up to 99%, with 
excellent functional group compatibilities (Scheme 2, bottom). 
 
 
Scheme 3. Highlighted work by Sandford et al. in trifluoromethylations 
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     Boronic acids were used again for installation of the CF3 group by Sandford et al., by in-
situ formation of CuCF3 from Langlois’ reagent
26
 (NaSO2CF3), ‘Cu’, and radical initiator t-
butyl peroxide.
27 
They observed that for electron deficient boronic acids, CuCl gave very 
low yields (~20%), and later found the copper
I
 salt (MeCN)4CuPF6
 
 to furnish modest yields 
in the 55-70% range, determined via NMR. 
 
     While these prior methods mentioned above offer good opportunities for synthesis of 
trifluoromethylated medicinal and agrochemical compounds for discovery research, their 
costs deem their use at scale unlikely. The key problem with scaling up a majority of the 
reported trifluoromethylation reactions is the prohibitive cost of the CF3 source.
27 
Another 
drawback of many current methodologies is the reliance on transition metals or more often 
times (super)stoichiometric quantities of transition metal complexes which may present 
limitations in terms of both waste disposal and cost.
6
  
 
Most, if not all, methods for trifluoromethylation reported thus far have been optimized 
without consideration of their environmental impact. Likewise, no efforts have been made 
towards consideration of the twelve guiding principles of green chemistry.
28
 There are 
currently no known methods for trifluoromethylation in green solvents.   As well, virtually 
zero procedures have reduced organic and/or aqueous waste being generated, as quantified 
via E Factors.  
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Hence, we have set out to develop a procedure that addresses three main elements of 
green chemistry (a) in a green medium (i.e., water); (b) recyclability, and (c) minimization 
of waste being generated (organic and aqueous). 
 
2.3 Results and Discussion 
We had decided to target  substitution at the C-H bond rather than the C-X bond of 
heterocycles for trifluoromethylation. This will enhance atom economy and help reduce 
waste by avoiding pre-functionalization.  From this perpective, the impressive method 
reported by Baran
29
 involving CF3 radicals seemed especially attractive, utilizing 
commercially available Langlois’ reagent (NaSO2CF3) as the source of these radicals, where 
no transition metal is needed.  
 
 
Scheme 4. Initial GC conversion results for trifluoromethylation in water 
 
As a test case using aqueous micellar conditions based on our designer surfactant TPGS-
750-M
30
, three substituted pyridine systems were treated with NaSO2CF3 and then t-
butylhydroperoxide (TBHP), leading to good levels of conversion to the anticipated 
trifluoromethylated products 1, 2, and 3 of 84, 46, and 72%, respectively, after 24 hours 
(Scheme 4). These initial results were encouraging due to the fact that we obtained a much 
higher rate of conversion than previously cited reports for the same substrates,
 29
 while 
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achieving a greener process due to use of an aqueous medium, no metals, no energy input, 
and high concentrations enabling shortened reaction times.  It was observed that reaction 
preparation was key to a high yield; solid substrates must be ground to a fine powder via 
mortar and pestle and form a uniform suspension in the surfactant before subsequent 
reagents are added. Failure to do so causes clumping, and/or rapid release of sulfur dioxide 
and quenching of the CF3 radical to fluoroform (CF3H). 
 
A screening of alternative surfactants that we have used for previous micellar catalysis 
chemistry was performed at the commercially available concentrations of two weight 
percent (2 wt. %) as shown in Table 1 for the conversion of t-butylpyridine to 1 in the same 
manner as our initial results at a global concentration of 0.5 M.  The top performing 
surfactants, TPGS-750-M (entry 1) and PTS-600
31
 (entry 2) led to 84% and 54% conversion 
to 1, respectively.  Both commercial amphiphillic surfactants were developed by our 
research group for cross coupling reactions, although have now been shown to have a wide 
variety of synthetic applications. The excellent performance by TPGS-750-M (entry 1), can 
be attributed to its larger particles that provide greater amounts of lipophilic material within 
their inner cores, thus, increasing organic solubility and leading to enhanced levels of 
conversion. This is further substantiated by Scheme 1 as 1 had the best levels of conversion 
and being the most lipophilic. The corresponding water reactions (i.e., on water) gave the 
lowest level of conversion (entry 8).  
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Table 1. Screening of surfactants for the production of 1 
                                
 
 
 
 
With the determined optimal surfactant, TPGS-750-M, we varied its concentration from 
zero (only water) to five weight percent as shown in Table 2 for the conversion towards 1 
and 4.  For the example of  1, three weight percent (entry 4) performed slightly better than 
two weight percent (entry 3), although two weight percent was chosen to be used for the 
remainder of the study because of the fact that it is commercially available, thus making our 
process more user friendly. We had also further confirmed that the surfactant was indeed 
playing a pivotal role for these trifluoromethylations as compound 4 was converted from its 
starting indole in 46% conversion using TPGS-750-M (entry 3) versus the water control of 
only 7% (entry 1). 
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Table 2. Screening of TPGS-750-M concentration for the production of 1 and 4 
 
 
 
     Various peroxide sources were screened as radical initiators for the reaction shown in 
Table 3.  We first investigated cumene hypdroperoxide (CHP) as its clogP of 2.44 is much 
higher than that of TBHP of 1.05; from our previous work with micellar catalysis and 
surfactants a significant hydrophobic effect was observed, meaning that as the lipophillicity 
of compound and/or reagent(s) increased the yields tend to follow.
32
 Ultimately, due to the 
high viscosity of CHP, we observed difficulties in maintaining a homogeneous reaction 
medium without significant clumping.  Benzoyl peroxide gave no reaction as it failed to give 
1, presumably due to it gelling providing poor dissolution of the reagent.  Our proposed 
hydrophobic effect theory was further supported by the fact that hydrogen peroxide was not 
incorporated into the micelles for a reaction to occur. The preferred peroxide was 
determined to be TBHP providing 1 in 88% isolated yield.  
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Table 3. Screening of peroxide radical initiators for the production of 1 
 
 
From previous analysis of Langlois’ reagent, various amounts of trace metals were 
discovered.
29
 From these known metal contaminants we chose to screen for those in the 
highest concentrations such as zinc, copper, and nickel, all of which are also known to 
facilitate single electron transfer from the CF3 source as shown for products 5 and 6 (Table 
4).  Zinc(II), copper(I), and nickel(II) salts bearing various counterions appeared in all cases 
to decrease the yields (entries 2-9) obtained in both examples, with annulated pyridine 5 and  
substituted  indole 6, when compared to reactions without added metal (entry 1). From 
previous work using zinc with surfactants, TMEDA or 1,1- phenalthroline (1,10-Phen) is 
needed to coordinate zinc, thus making it more lipophilic and shuttle it into the micelle.
30
 
Although, interestingly, 1,10-Phen completely inhibited the reactions (entry 3). Initially we 
presumed that the ligand itself had been trifluoromethylated but  GC-MS analysis did not 
support this and it is still difficult to explain. 
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Table 4. Screening for metal enhancement for the trifluoromethylations 5 and 6 
 
 
In efforts to further enhance the yield of our aqueous trifluoromethylation we 
investigated the effects of portion-wise versus single addition, and an increase of Langlois’s 
reagent and TBHP for the production of 1.  Our attempt at employing portion-wise addition, 
by adding one third of the reagents every hour to overcome possible slow reaction kinetics 
led to the same conversion as a single addition within experimental error.  Increasing the 
equivalents of Langlois and TBHP reagents to 5 and 8.5  from 3 and 5 respectively caused a 
large reduction in converted substrate due to the unproductive formation of fluoroform. 
Heating the reaction had the same effect. 
 
With our results from these optimization studies completed, the procedure that emerged 
involved use of Langlois’ reagent (3 equiv) in combination with TBHP (5 equiv), in 2 
weight percent TPGS-750-M at room temperature.  Several heterocyclic and heteroaromatic 
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substrates were tested in an effort to establish the scope and utility of this new process.  
Also, many of the examples were directly compared to previously reported syntheses, and to 
our overwhelming pleasure, our aqueous trifluoromethylations furnished products in higher 
yields than prior methodology for all substrates (Table 5).  
 
Table 5. Initial substrate scope for aqueous trifluoromethylations with literature       
comparisons 
 
 
a
 conditions: substrate (1 mmol), NaSO2CF3 (3 equiv), TBHP (5 equiv), 2 wt. % TPGS-750-M (0.5 M),  
    
b 
NMR yield, 
c
 see ref. 33, 
d
 see ref. 29, 
e
 required double addition of reagents, 
f
 see ref. 24 
    
  The compound 3-phenone-pyridine used in early stages of testing was subjected to the 
optimized conditions forming 3 in 66% yield (entry 1).  Makosza et al. had previously 
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reported the formation of 3 over three steps in 40%
33
 via production of a pyridyl protected 
PMB bromide azinium salt, followed by trifluoromethylation with triphenyltin fluoride, KF, 
and TMSCF3 in DCM forming a dihydroazine intermediate, then oxidized with CAN. 
Additionally  Makosza et al. used this same strategy producing 7 in 59% overall yield
33
 
verse our yield of 71% of 7 (entry 3). Buchwald et al. also produced 7 in 38% yield 
24 
using 
Cu (II) salts with TESCF3 in DCE under an oxygen atmosphere as described above in 
Scheme 1. Examples from Baran and co-workers
29
 were also directly compared as his 
method is most similar in respects to the reagents utilized, as demonstrated in Table 5 for 
compounds 5, 6, and 8-13 (entries 2,3,5-10); again all yields had been improved.  It is worth 
noting that for compounds 5, and 10-12 Baran required additional NaSO2CF3  and TBHP 
reagents (3-6 equiv; 5-10 equiv, respectively) to achieve modest yields. In no case did we 
find it necessary to use more than our optimized amounts of NaSO2CF3  and TBHP. 
 
    Two additional compounds 4 and 14 were also subjected to the reaction conditions and 
provided isolated yields of 42 and 68%, respectively.  The yield of compound 4 is 
presumably low and not an accurate representation of the quality of bond formation, caused 
by aldehyde oxidation to the water soluble carboxylic acid by the peroxide.   
 
Figure 3. Additional examples of aqueous trifluoromethylation 
a
 conditions: substrate (1 mmol), NaSO2CF3 (3 equiv), TBHP (5 equiv), 2 wt. % TPGS-750-M (0.5 M) 
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Workup of these trifluoromethylations is quite simple; a minimum amount of EtOAc is 
added directly to the reaction vessel, slowly stirred and extracted.  This technique allows the 
isolation of crude product generally in >85% purity, while the remaining aqueous mixture 
retains the TPGS-750-M and hence, can be recycled several times. The reuse of the aqueous 
media and no need for additional water during the work up, drastically reduced our waste 
output. Results from a recycling study for the synthesis of 1 are shown in Table 6. The drop 
in isolated yields associated with 4
th
 and 5
th
 recycle is likely due to continuous buildup of t-
butanol in the reaction mixture, which would help solubilize the product in the aqueous 
layer. Although the yields tended to decrease over time, the TLC analysis of each recycle 
suggests that the extent of conversion is also dropping, and the reactions are not any less 
clean than those done earlier in the sequence.  
 
Table 6. Surfactant recycling study for the of 1 
 
 
a
 conditions: substrate (1 mmol), NaSO2CF3 (3 equiv), TBHP (5 equiv), 2wt% TPGS-750-M (0.5 M),                 
b
 extracted with EtOAc and subjected the aqueous medium to the next reaction 
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Table 7. Calculated E Factors for production of 1 
 
 
 
One of the ways to measure the environmental impact or “greenness” of any specific 
reaction is by means of an E Factor.
34
 While as the rules from Sheldon
35
 state only the first 
use of any medium need be calculated in the E Factor, all subsequent reactions may ignore 
the recycled solvent thus causing a large reduction in E Factor.   As shown in Table 7, 
trifluoromethylation reactions carried out in nanomicelles led to an E Factor of only 5-6, 
given the complete absence of any organic solvent in the reaction medium. An E Factor 
calculated on inclusion of water raises this value to only 18.2, but with a single recycle this 
value is cut in half, in line with our previous observations relating to cross-coupling 
reactions performed within these recyclable nanoreactors. 
 
In conclusion, micellar catalysis has been found to be amenable to radical-based 
trifluoromethylation of various hetercyclic and heteroaromatic compounds.  Nanoreactors 
composed of the designer surfactant TPGS-750-M enable these substitution reactions to be 
performed in water at room temperature in modest to good yields.  The aqueous reaction 
mixtures are readily recycled, and given the limited amounts of organic solvent needed for 
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product isolation, the associated E Factors imply that a considerably enhanced level of 
greenness is characteristic of these reactions. Thus completing our goals of (1) eliminated 
use of a mixed aqueous solvent system that included a chlorinated solvent (DCM); (2) 
reducing the amounts of reagents involved; (3) improve yields; (4) be amenable to recycling 
of the purely aqueous reaction medium, and (5) reduce the level of organic waste being 
created.  
 
2.4 Experimental and compound data 
General information 
The water for this study was HPLC grade and was degassed prior to use by bubbling a 
flow of argon through the mixture for several hours. All commercially available reagents 
were used without further purification unless otherwise stated. The surfactant TPGS-750-M 
is commercially available from Sigma-Aldrich but can be synthesized through a previously 
published procedure.
30 
Analytical thin layer chromatography (TLC) was performed using 
Silica Gel 60 F254 plates (Merck, 0.25 mm thick). The developed chromatogram was 
analyzed by UV lamp (254 nm) and/or aqueous potassium permanganate (KMnO4), and 
developed by applying heat with a heat gun. Flash chromatography was performed in glass 
columns using Silica Flash® P60 (SiliCycle, 40-63 μm). 1H and 13C spectra were recorded at 
23 °C on a Varian UNITY INOVA 500 MHz. Chemical shifts in 
1
H NMR spectra are 
reported in parts per million (ppm) on the δ scale from an internal standard of residual 
chloroform (7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, brs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling 
constant in hertz (Hz), and integration. Chemical shifts of 
13
C NMR spectra are reported in 
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ppm from the central peak of CDCl3 (77.23 ppm) on the δ scale. GC/MS data was recorded 
on a 5975C Mass Selective Detector, coupled with a 7890A Gas Chromatograph (Agilent 
Technologies). As capillary column a HP-5MS cross-linked 5% phenylmethyl- 
polysiloxanediphenyl column (30 m x 0.250 mm, 0.25 micron, Agilent Technologies) was 
employed. Helium was used as carrier gas at a constant flow of 1 mL/min.  
 
Standard Procedures 
Surfactant screening 
To a 5 mL microwave vial equipped with a PTFE stir bar (1x5mm) with septum.  Added 
2 wt% surfactant ([0.5], 0.2 mL, Table 1), 4-tert butyl pyridine (0.10 mmol, 15uL), sodium 
trifluoromethanesulfinate (0.30 mmol, 47 mg) then cooled to ~ 5 °C.  Then via syringe 
added 70wt% TBHP (0.50 mmol, 68uL).  Allowed to stir at room temperature (~ 23°C) for 
24 hours, quenched with saturated NaHCO3 (1 mL), extracted with EtOAc (1 mL) and 
percent conversion determined by GC. 
Surfactant strength screening 
To a 5 mL microwave vial equipped with a PTFE stir bar (1x5mm) with septum.  Added 
TPGS-750-M ([0.5], 0.2 mL, Table 2), 4-tert butyl pyridine (0.10 mmol, 15uL), sodium 
trifluoromethanesulfinate (0.30 mmol, 47 mg) then cooled to ~ 5 °C.  Then via syringe 
added 70wt% TBHP (0.50 mmol, 68uL).  Allowed to stir at room temperature (~ 23°C) for 
24 hours, quenched with saturated NaHCO3 (1 mL), extracted with EtOAc (1 mL) and 
percent conversion determined by GC. 
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Peroxide screening 
    To a 5 mL microwave vial equipped with a PTFE stir bar (1x5mm) with septum.  Added 
2wt% TPGS-750-M ([0.5], 0.2 mL),  4-tert butyl pyridine (0.10 mmol, 15uL), sodium 
trifluoromethanesulfinate (0.30 mmol, 47 mg) then cooled to ~ 5 °C.  Then added the 
peroxide (Table 3) drop wise for liquid reagents and slow addition for solids,  70 wt% TBHP 
(0.50 mmol, 68uL), 80% CHP (0.5mmol, 94uL), benzoyl peroxide (0.5 mmol, 121 mg), and 
30% hydrogen peroxide (0.5 mmol, 40 uL).  Allowed to stir at room temperature (~ 23°C) 
for 24 hours then quenched with saturated NaHCO3 (2 mL) ), extracted with EtOAc (3 mL), 
concentrated under reduced pressure. Isolated via column chromotagraphy eluting with 
EtOAc:Hex. 
Metal additive screening 
To a 5 mL microwave vial equipped with a PTFE stir bar (1x5mm) with septum.  Added 
2wt% TPGS-750-M ([0.5], 0.3 mL), substrate (0.15 mmol), sodium 
trifluoromethanesulfinate (0.45 mmol, 70 mg), various metal salts at 10 mol% and 
associated ligands at 1 equiv (Table 4)  then cooled to ~ 5 °C.  Then added 70 wt% TBHP 
(0.75 mmol, 103uL) drop wise.  Allowed to stir at room temperature (~ 23°C) for 24 hours, 
then quenched with saturated NaHCO3 (2 mL) ), extracted with EtOAc (3 mL), concentrated 
under reduced pressure. Isolated via column chromotagraphy eluting with EtOAc:Hex. 
Portion wise addition 
To a 5 mL microwave vial equipped with a PTFE stir bar (1x5mm) with septum.  Added 
2wt% TPGS-750-M ([0.5], 0.5 mL), caffeine (0.25 mmol). The sodium 
trifluoromethanesulfinate and TBHP were then added in one third portions per hour over 
three hours. Sodium trifluoromethanesulfinate (0.75 mmol, 117 mg), 70 wt% TBHP (1.25 
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mmol, 171uL) drop wise.  Allowed to stir at room temperature (~ 23°C) for 48 hours, then 
quenched with saturated NaHCO3 (2 mL) ), extracted with EtOAc (3 mL), concentrated 
under reduced pressure.  Isolated via column chromotagraphy eluting with EtOAc:Hex to 
provide the trifluoromethylated caffeine analog 6 in 81% yield as a white crystalline solid. 
Representative procedure 
To a 5 mL round bottom flask with a PTFE stir bar (1x5mm) with septum.  Added 2wt% 
TPGS-750-M ([0.5], 2.0 mL), heterocycle (1.00 mmol) sodium trifluoromethanesulfinate 
(3.0 mmol, 468 mg) then cooled to ~ 5 °C.  Then added 70 wt% TBHP (5.00 mmol, 690uL) 
drop wise .  Allowed to stir at room temperature (~ 23°C) until complete by TLC, then 
quenched with saturated NaHCO3 (2 mL) ), extracted with EtOAc (3 mL), concentrated 
under reduced pressure.    Passed through a bed a silica gel with EtOAc to provide the 
trifluoromethylated heterocycle analog. 
Note: highly crystalline solids must be ground to a fine powder (mortar and pestle) 
thereby forming a uniform suspension in the aqueous medium prior to introduction of 
reagents. As well as slow addition of the TBHP is necessary.  Failure to do so causes 
clumping, and/or rapid release of sulfur dioxide and ultimately quenching of the CF3 radical 
to form fluoroform (CHF3).
29 
Recycling study 
To a 5 mL round bottom flask with a PTFE stir bar (1x5mm) with septum.  Added 2wt% 
TPGS-750-M ([0.5], 2.0 mL), 4-tert butyl pyridine (1.0 mmol, 148uL), sodium 
trifluoromethanesulfinate (3.0 mmol, 468 mg) then cooled to ~ 5 °C.  Then added 70 wt% 
TBHP (5.00 mmol, 690uL) drop wise (~100uL/min)  Allowed to stir at room temperature (~ 
23°Cfor 24 hours then extracted with EtOAc (1 mL), concentrated under reduced pressure.  
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Isolated via column chromotagraphy eluting with EtOAc:Hex.to provide the 
trifluoromethylated 4-tert butyl pyridine analog 1.  The aqueous reaction media was then 
subjected to a subsequent reaction and repeated four more times as shown in Table 5. 
 
Surfactant solution preparation 
The water for this study was HPLC grade and was degassed prior to use by bubbling a flow 
of argon through the mixture for several hours. Then each solution prepared weight by 
weight for the desired concentration with the previously degassed HPLC grade water and 
subjected to an addition sparging with argon for an hour.  All surfactants were stored under 
an argon atmosphere prior to use. Surfactants PTS and TPGS-750-M are both commercially 
available from Sigma-Aldrich
 
but can be synthesized through a previously published 
procedures.
30,31 
Compound data 
 
4-t-Butyl-2-trifluoromethylpyridine (1, JF-004-205). The representative procedure 
was followed using 4-t butylpyridine (1.0 mmol, 148 uL), sodium trifluoromethanesulfinate 
(3.0 mmol, 468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL).  Reaction was complete after 
15 h by TLC.  Crude product was purified by passage through a bed a silica gel with 20% 
EtOAc:hex. (Rf = 0.55, 20% EtOAc:hex) to yield 1 161 mg, 79% of faint yellow liquid; 
1
H 
NMR (500 MHz, CDCl3) δ 8.63 (d, J = 5.19 Hz, 1H), 7.66 (s, 1H), 7.47 (d, J = 5.19 Hz, 
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1H), 1.35 (s, 9H). GC/MS m/z: 203.09.  Compound data matches that of previously 
reported. 
29 
 
  
phenyl(6-(trifluoromethyl)pyridin-3-yl)methanone (3, JF-003-117). The 
representative procedure was followed using phenyl(pyridin-3-yl)methanone (1.0 mmol, 183 
mg), sodium trifluoromethanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP (5.00 
mmol, 690 uL).  The crude product was isolated by passage through a bed a silica gel with 
15% EtOAc:hex (Rf = 0.35, 20% EtOAc:hex) to yield 3, 166 mg, 66%, of a clear solid; 
1
H 
NMR (500 MHz, CDCl3) δ  8.73 (d, J = 1.97 Hz, 1H), 8.19 (d, J = 8.22 Hz, 2H), 8.13 (dd, J 
= 0.96, 7.85 Hz, 1H), 7.94 (m, 1H), 7.75 (d, J = 8.15 Hz, 2H), 7.53 (m, 1H). GC/MS m/z: 
251.23. Compound data matches that of previously reported.
24
  
 
 
1-Methyl-3-(trifluoromethyl)-1H-indole-2-carbaldehyde (4, JF-003-116). The 
representative procedure was followed using 1-methyl-1H-indole-2-carbaldehyde (1.0 
mmol, 159 mg), sodium trifluoromethanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP 
(5.00 mmol, 690 uL).  The crude product was isolated by passage through a bed a silica gel 
with 20% EtOAc:hex (Rf = 0.55, 10% EtOAc:hex) to yield 4, 96 mg, 42%, of an off white 
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solid; 
1
H NMR (500 MHz, CDCl3) δ 10.30 (s, 1H), 7.91 (d, J = 8.32 Hz, 1H), 7.53 – 7.44 
(m, 2H), 7.32 (ddd, J = 1.22, 6.66, 8.08 Hz, 1H), 4.15 (s, 3H). 
13
C NMR (500 MHz, CDCl3) 
δ 182.62, 154.30, 131.87, 130.72, 127.49, 122.96, 121.88, 110.78, 96.12, 92.77, 32.49. 
HREIMS calcd for C11H8F3NO: 227.0558. Found: 227.0560  
 
 
2-(Trifluoromethyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine (5-C2, JF-002-
182) and 3-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine (5-C3, JF-
002-182). The representative procedure was followed using 6,7,8,9-tetrahydro-5H-
cyclohepta[b]pyridine (1.0 mmol, 156 uL),  sodium trifluoromethanesulfinate (3.0 mmol, 
468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL).  The reaction was complete after 43 h by 
TLC. Crude product by purified by passage through a bed a silica gel with 20% EtOAc:hex 
to yield 394 mg, 73%, (1:3.8 5-C2:5-C3)  of faint yellow liquid. Data for (5-C2) (105 mg), 
(Rf = 0.60, 20% EtOAc:hex). 
1
H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 7.68 Hz, 1H) 7.38 
(d, J = 7.70 Hz, 1H), 3.14 – 3.08 (m, 2H), 2.88 – 2.81 (m, 2H), 1.95 – 1.86 (m, 2H), 1.79 – 
1.64 (m, 4H), GC/MS m/z: 215.1.  Data for (5-C3) (289 mg),  (Rf = 0.55, 20% 
EtOAc:hex).
1
H NMR (500 MHz, CDCl3) δ 8.41 (d, J  =  5.20 Hz, 1H), 7.33 (d, J = 5.19 Hz, 
1H), 3.21 – 3.11 (m, 2H), 2.98 – 2.90 (m, 2H), 1.92 – 1.83 (m, 2H), 1.74 – 1.62 (m, 4H). 
GC/MS m/z: 215.09. Compound data matches that of previously reported.
29
 Note: Minor 
region-isomer impurities observed in 
1
H NMR. 
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2-Trifluoromethyl melatonin (6, JF-002-189).
 
The representative procedure was 
followed using melatonin (1.0 mmol, 232 mg), sodium trifluoromethanesulfinate (3.0 mmol, 
468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL).  Reaction was complete as judged by 
TLC in 44 h. Crude product was purified by passage through a bed a silica gel with EtOAc 
(Rf = 0.70, 100% EtOAc) to yield 6, 192 mg, 64% of off white solid; 
1
H NMR (500 MHz, 
CDCl3) δ 9.97 (s, 1H), 7.54 (d, J = 9.04 Hz, 1H), 7.06 (d, J = 9.06 Hz, 1H), 5.72 (t, J = 5.36 
Hz, 1H), 3.89 (s, 3H), 3.47 (m,  2H), 3.10 (t, J = 6.93 Hz, 2H), 1.95 (s, 3H). GC/MS m/z: 
300.11. Compound data matches that of previously reported.
29 
 
 
3-(Trifluoromethyl)quinolone (7, JF-002-210). The representative procedure was 
followed using quinoline (1.0 mmol, 129 uL),  sodium trifluoromethanesulfinate (3.0 mmol, 
468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL). The reaction was stopped after 36 h (no 
additional conversion passed this point). The crude product was purified by passage through 
a bed a silica gel with 20% EtOAc:hex (Rf = 0.25, 20% EtOAc:hex) to yield 7, 140 mg of 
product and starting material. The yield was determined by NMR to be 71%. 
1
H NMR (500 
MHz, CDCl3) δ 9.09 (d, J = 4.15 Hz, 1H), 8.24 (d, J = 8.30 Hz, 1H), 8.10 (d, J = 7.27 Hz, 
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1H), 8.04 (d, J = 8.28 Hz, 1H), 7.61 (t, J = 7.32 Hz, 1H), 7.52 (m, 1H). GC/MS m/z: 197.16. 
Compound data matches that of previously reported.
29
 
 
 
1-(5-(Trifluoromethyl)-1H-pyrrol-2-yl)ethan-1-one (8, JF-004-185). The 
representative procedure was followed using 1-(1H-pyrrol-2-yl)ethan-1-one (1.0 mmol, 109 
mg), sodium trifluoro-methanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP (5.00 
mmol, 690 uL).  The reaction was complete as judged by TLC in 28 h. Crude product was 
purified by passage through a bed a silica gel with 20% EtOAc:hex (Rf = 0.45, 20% 
EtOAc:hex) to yield 8, 110 mg, 62% of an off white solid; 
1
H NMR (500 MHz, CDCl3) δ 
9.79 (brs, 1H), 6.87 (s, 1H), 6.61 (s, 1H), 2.48, (s, 3H). GC/MS m/z: 177.04. Compound data 
matches that of previously reported.
29
 Note: Minor regio-isomer impurities observed in 
1
H 
NMR. 
 
 
Trifluoromethylated caffeine (9, JF-002-134). The representative procedure was 
followed using caffeine (1.0 mmol, 194 mg), sodium trifluoromethanesulfinate (3.0 mmol, 
468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL).  The reaction was complete as judged by 
TLC in 23 h. The crude product was purified by passed through a bed a silica gel with 20% 
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EtOAc:hex (Rf = 0.25, 20% EtOAc:hex) to yield 9, 222 mg, 84% of white crystalline solid; 
1
H NMR (500 MHz, CDCl3) δ 4.16 (s, 3H), 3.58 (s, 3H), 3.40 (s, 3H). GC/MS m/z: 264.08. 
Compound data matches that of previously reported.
29 
 
 
 
2-Trifluoromethyl-4-cyano-pyridine (10-C2, JF-002-187) and 3-trifluoromethyl-4-
cyano-pyridine (7-C3, JF-004-187).   The representative procedure was followed using 4-
cyano-pyridine (1.0 mmol, 104 mg),  sodium trifluoromethanesulfinate (3.0 mmol, 468 mg), 
and 70 wt % TBHP (5.00 mmol, 690 uL).  The reaction was complete as judged by TLC in 
44 h. The crude product was purified by passage through a bed a silica gel with 20% 
EtOAc:hex to yield 97 mg, 55% (1.6:1 10-C2:10-C3) of a colorless oil. Data for 10-C2 (61 
mg), (Rf = 0.50, 20% EtOAc:Hex); 
1
H NMR (500 MHz, CDCl3) δ 8.95 (d, J = 4.93 Hz, 1H), 
7.92 (s, 1H), 7.76 (d, J = 4.92 Hz, 1H). GC/MS m/z: 172.02; Data for (10-C3) (35 mg), (Rf 
= 0.30, 20% EtOAc:hex); 
1
H NMR (500 MHz, CDCl3) δ 9.11 (s, 1H), 9.03 (d, J = 4.93 Hz, 
1H), 7.74 (d, J = 4.94 Hz, 1H). GC/MS m/z: 172.02. Compound data matches that of 
previously reported.
29
 Note: Minor regio-isomer impurities observed in 
1
H NMR. 
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Methyl 5-(trifluoromethyl)pyrazine-2-carboxylate (11, JF-002-193). The 
representative procedure was followed using methyl pyrazine-2-carboxylate (1.0 mmol, 138 
uL), sodium trifluoro-methanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP (5.00 
mmol, 690 uL).  The reaction was complete by TLC in 51 h. The crude product by passed 
through a bed a silica gel with 20% EtOAc:hex (Rf = 0.35, 20% EtOAc:hex) to yield 11, 112 
mg, 54%, as an off white solid; 
1
H NMR (500 MHz, CDCl3) δ 9.40 (s, 1H), 9.07 (s, 1H), 
4.10 (s, 3H). GC/MS m/z: 206.03. Compound data matches that of previously reported.
29 
 
 
5-(trifluoromethyl)-1,3,4-thiadiazol-2-amine (12, JF-004-110). The representative 
procedure was followed using 1,3,4-thiadiazol-2-amine (1.0 mmol, 101.mg), sodium 
trifluoro-methanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL).  
The reaction was complete by TLC in 38 h. The crude product by passed through a bed a 
silica gel with 50% EtOAc:hex (Rf = 0.73, 75% EtOAc:hex) to yield 12, 73 mg, 43%, as an 
off white solid; 
1H NMR (500 MHz, MeOD) δ 4.88 (s, 2H), GC/MS m/z: 169.12. 
Compound data matches that of previously reported.
29 
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4-chloro-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine (13, JF-003-116). The 
representative procedure was followed using 4-chloro-7H-pyrrolo[2,3-d]pyrimidine (1.0 
mmol, 154.mg), sodium trifluoro-methanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP 
(5.00 mmol, 690 uL).  The reaction was complete by TLC in 52 h. The crude product by 
passed through a bed a silica gel with 40% EtOAc:hex (Rf = 0.70, 50% EtOAc:hex) to yield 
13, 73 mg, 47%, as an off white solid; 
1
H NMR (500 MHz, CDCl3) δ 12.67 (br s, 1H), 8.81 
(s, 1H), 7.09 (s, 1H). GC/MS m/z: 221.54. Compound data matches that of previously 
reported.
29 
 
 
2-(p-Tolyl)-6-(trifluoromethyl)pyridine (14, JF-002-214). The representative 
procedure was followed using 2-(p-tolyl)pyridine (1.0 mmol, 169 uL),  sodium 
trifluoromethanesulfinate (3.0 mmol, 468 mg), and 70 wt % TBHP (5.00 mmol, 690 uL). 
The reaction was complete as judged by TLC in 18 h. The crude product was purified by 
passage through a bed a silica gel with 20% EtOAc:hex (Rf = 0.35, 10% EtOAc:hex) to 
yield 14, 161 mg, 68%, as a clear oil. 
1
H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 8.13 Hz, 
2H), 7.89 (d, J = 4.61 Hz, 2H), 7.57 (t, J = 3.89 Hz, 1H), 7.30 (d, J = 8.05 Hz, 2H), 2.42 (s, 
3H). GC/MS m/z: 237.08. Compound data matches that of previously reported.
36
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2.5 Spectral Data 
4-tert butyl-2-trifluoromethyl pyridine 1; Proton NMR (CDCl3) 
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phenyl(6-(trifluoromethyl)pyridin-3-yl)methanone 3; Proton NMR (CDCl3) 
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1-methyl-3-(trifluoromethyl)-1H-indole-2-carbaldehyde 4; Proton NMR (CDCl3) 
 
 
 
  42 
1-methyl-3-(trifluoromethyl)-1H-indole-2-carbaldehyde 4; Carbon NMR (CDCl3) 
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1-methyl-3-(trifluoromethyl)-1H-indole-2-carbaldehyde 4; LREIMS 
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1-methyl-3-(trifluoromethyl)-1H-indole-2-carbaldehyde 4; HREIMS 
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2-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine 5-C2; Proton NMR   
(CDCl3) 
 
 
  46 
3-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine 5-C3; Proton NMR 
(CDCl3) 
 
 
  47 
2-trifluoromethyl melatonin 6; Proton NMR (CDCl3) 
 
 
 
  48 
3-(trifluoromethyl)quinolone 7; Proton NMR (CDCl3) 
 
 
 
  49 
1-(5-(trifluoromethyl)-1H-pyrrol-2-yl)ethan-1-one 8; Proton NMR (CDCl3) 
 
 
 
  50 
Trifluoromethylated caffeine 9; Proton NMR (CDCl3) 
 
 
 
  51 
2-trifluoromethyl-4-cyano-pyridine 10-C2; Proton NMR (CDCl3) 
 
 
 
  52 
3-trifluoromethyl-4-cyano-pyridine 10-C3; Proton NMR (CDCl3) 
 
 
 
  53 
methyl 5-(trifluoromethyl)pyrazine-2-carboxylate 11; Proton NMR (CDCl3) 
 
 
 
  54 
5-(trifluoromethyl)-1,3,4-thiadiazol-2-amine 12; Proton NMR (MeOD) 
 
 
 
 
  55 
4-chloro-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine 13; Proton NMR (CDCl3) 
 
 
 
  56 
2-(p-tolyl)-6-(trifluoromethyl)pyridine 14; Proton NMR (CDCl3) 
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 III. Aqueous aromatic dehalogenation at room temperature 
3.1 Introduction 
From a synthetic chemist’s point of view, aromatic halogen substituents are often 
valuable handles enabling facile access towards transition metal catalysis, for the production 
of pharmaceuticals, agrichemicals, perfumes, and materials.
1
 Historically, aromatic halogens 
were precursors for the construction of aryl-aryl bonds via SEAr reactions long before the 
discovery of modern cross couplings,
2
 and as directing or protecting groups in the 
construction of aromatic systems.
3
 Examples of halides serving as blocking or directing 
groups have been explored,
4
 which oftentimes necessitates their subsequent removal, as 
shown in Scheme 1. Lam et al. used this method for the synthesis of chiral spiro-biindane 
ligands
5 
(Scheme 1, top) and Dobbs for his directed Bartoli indole 2 synthesis.
6 
(bottom) 
 
 
Scheme 1. Examples of bromides used as a directing group and subsequent removal 
      
The high demand placed upon aryl halides en route to modern medicines, agrichemicals, 
and materials, has come at a cost. Their disposal has historically been an afterthought, 
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resulting in improper disposal. Due to the high toxicity of many halogenated aromatics and 
their long term stability there continues to be a need for new dehalogenation protocols, aside 
from their applications in synthetic research. Ideally, dehalogenation would proceed in a 
recyclable aqueous medium rather than in organic solvent, involves a recyclable catalyst, 
mild hydride source, be highly functional group tolerant, and occur under mild conditions 
such that little-to-no investment of energy is required beyond that provided at ambient 
temperatures. Such a process would then adhere to many of the ‘12 Principles of Green 
Chemistry’ and thus, might be viewed not only as synthetically useful, but also as 
environmentally attractive.
7 
 
3.2 Initial discovery 
   The discovery of our method for aromatic dehalogenation in aqueous media was found 
serendipitously during prior work with comparisons between literature examples of Pd-
catalyzed cross couplings performed by pharmaceutical companies. Typically, such 
reactions are run in refluxing organic solvents rather than the identical couplings done in the 
hydrophobic core of aqueous nanoreactors composed of our designer surfactants.
8
   
 
 
 
Scheme 2. Discovery conditions for aromatic dehalogenation 
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The intent was to originally perform a tandem cross coupling sequence, Suzuki followed 
by Heck; the second coupling (Heck) with allyl alcohol was unsuccessful and led solely to 
dehalogenated intermediate. (Scheme 2)  
 
 
Figure 1. Proposed catalytic cycle for aromatic dehalogenation using alcohols 
 
This dehalogenation process was originally discovered by Heck almost 40 years earlier 
from works attributed to his cross-couplings
9
 with allylic and aromatic hydrocarbons as by-
products. His work was later confirmed by Helquist et al. as a viable route for the reduction 
of aryl halides with methanol as the reductant;
10
 while the  proposed mechanism is displayed 
above (Figure 1). 
 
3.3 Prior Work on Aromatic Dehalogenation 
Due to our wide use of various halogenated aromatic compounds, we have seen a surge 
in protocols for the dehalogenation of these toxic substrates to their more benign 
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hydrocarbon analogs. Even more useful for synthesis is the need for their removal when 
used as directing or protecting groups. As the methods for dehalogenation and hydride 
sources are numerous and ever expanding, we have chosen a small subset that has received 
the most attention recently, mainly from the dehalogenation of environmental toxins. Silyl 
hydrides have enjoyed use as a mild hydride source for utilization of radical initiated silyl 
hydride dehalogenation methodology.  
 
 
Scheme 3. Methods for radical initiated silyl hydride dehalogenations 
 
While one method includes the unattractive use of stoichiometric indium chloride with 
two equivalents of Et3SiH (Scheme 3, top right) from Baba et al., this wasteful process gave 
dehalogenated product in mediocre yields along with large amounts of homocoupled side 
products were detected.
11
 They had previously employed similar conditions for their studies 
with NaBH4/InCl3 systems for simple non-substituted aromatic dehalogenations and enyne 
cyclizations.
12
 In 2007, dehalogenation via catalytic use of indium was reported, a large 
improvement over the work of Baba, Miura et. al., (Scheme 3, top left), lowering the 
precious metal use fivefold to 20 mol %. Their use of indium acetate and triphenylsilane in 
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refluxing THF, noting that esters were compatible with the reaction conditions but ketones 
are generally reduced.
13 
Methodology developed by Chatgilialoglu et al. for the 
dehalogenation of heterocycles is easily appreciable as an example of clean, 
environmentally friendly chemistry. Their method utilizes water as the reaction medium 
with the radical initiator azobiscyclohexylcarbononitrile (ACCN) and TMS3SiH, albeit at 
elevated reaction temperatures. A broad diverse range of functionalized substrates was also 
noted
14
 (Scheme 3, bottom). 
 
 
Scheme 4. Grignard reagents as a hydride source 
 
 Others hydride sources include alkyl magnesium reagents (Grignards) capable of β-
hydride elimination in the presence of transition metals. Takahashi had reported very high 
yields of unwanted dehalogenated starting material from his original work with Zr-Negeshi 
like reagents to be used for cross-coupling.
15
 This led to their reinvestigation of the reaction 
conditions and through screening of various  Grignard reagents had helped prove the hydride 
hypothesis,  it was concluded that the reduction was, in fact, due to β-hydride elimination as 
simple methylmagnesium bromide gave no reaction while detection of n-butene was 
observed when researchers used n-BuLi.
16
 While they had readily achieved yields in excess 
of 90% (Scheme 4, right) little can be said in regards to functional group compatibility but 
one could assume that the typical groups known to be incompatible with Grignards would 
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apply here as well. Replacing expensive, precious zirconocene with cheap abundant iron and 
therefore reducing the environmental footprint was performed by Wangelin et al. in 
conjunction with mechanistic studies. They formed deuterated Grignard (Etd6MgBr) that 
when the halogen was replaced by deuterium forming ethane (Etd4), this further reinforced 
beta-hydride delivery mechanism
2
 (Scheme 4, left). With impressive yields even including 
heteroaromatics, they stated that these dehalogenations are functional group tolerant; 
although the only labile example is that of a t-butylester, a group that would normally 
survive reaction conditions with the bulky t-BuMgBr Grignard utilized. 
 
 
Scheme 5. Formaldehyde hydride source 
 
Lee and workers utilized formaldehyde as the hydride source. After attack by the base 
(Cs2CO3) there is a β-hydride ready for delivery, ultimately producing the dehalogenated 
product.  The assumed notion that formaldehyde was oxidized in-situ to formate following 
hydride delivery by release if CO2 in the typical fashion, was disproven as benzaldehyde 
also provided dehalogenated product. Lee et. al. had also employed a novel detection 
technique of paper based colorimetric sensors (PBCS) developed for the pharmaceutical 
industry to aide in the facile detection of aryl halides and metals from industrial cross 
couplings. This enabled them to rapidly screen hundreds of reaction conditions, saving 
countless hours of GC or LC time.
17 
The final reaction conditions are shown in Scheme 5. 
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With very low levels of Pd (<0.1 mol%) they were able to achieve modest yields, although 
the examples are all fairly simple. They did perform a dehalogenation of an aryl methyl ester 
where only the aryl halide bond was reduced and the ester remained intact. 
 
 
Scheme 6. Dehalogenation via traditional hydrogenation 
.. 
The use of traditional hydrogenation conditions (i.e., H2, Pd/C, and alcoholic solvent) 
were employed by Jimenez et al.
4
 Using bromide as a para blocking group as shown in 
Scheme 6, removal of the halogen would be required with sensitive functional groups 
present.  High yields were obtained when electron-withdrawing groups were appended to the 
ring, but the opposite is true for electron-rich systems. One of their most significant draw 
backs is the need for stoichiometric Pd but, in principle, it could be recovered and reused. 
 
Even with all the recent advances in methodology for aromatic dehalogenation, they 
appear to be cost prohibitive at scale, energy intensive, make use of H2 gas, toxic reagents, 
harsh conditions, and in general, have limited substrate scope with little functional group 
tolerance. These limitations have placed further pressure on green chemists to develop 
benign processes, with little-to-no production of waste other than dehalogenated product. 
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   3.4 Results and Discussion 
     Excited from our initial findings (Scheme 2) by the prospects of developing an aqueous 
aromatic dehalogenation protocol, we set out to further explore and optimize the reaction 
conditions. Using similar conditions illustrated in Scheme 2, we began to screen various 
catalysts known for their facile oxidative addition into aryl halide bonds. Our initial hit led 
us to Fu’s catalyst, Pd(P[tBu]3)2 (entry 1, Table 1).  
 
Table 1. Catalyst screening for the dehalogenation of 3 using allyl alcohol 
 
 
     Next, we turned our efforts towards determining the number of equivalents of allyl 
alcohol necessary for complete conversion of 4-bromobiphenyl 3 as a model substrate. As 
shown in Table 2, only require 1.5 equivalents are needed (entry 2). 
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Table 2. Screen for equivalents needed of allyl alcohol for dehalogenation of 3 
 
     With our results beginning to turn towards a promising method for a mild and green 
protocol, we had overlooked our waste production. We soon realized that throughout the 
course of the reaction, acrolein is produced in stoichiometric amounts, a compound 
associated with high toxicity for humans with respiratory difficulties.
18
 Thus, we performed 
a thorough screening of mild hydride sources that have been previously employed for 
dehalogenation on a range of substrates. (Table 3) The plan was to reduce the reductant to a 
1:1 ratio (hydride:substrate) over previous experiments, using the original allyl alcohol 
reduction as a metric. 
 
 
 
 
 
 
  69 
Table 3. Screening of hydride sources for the dehalogenation of 3-6 
 
 
     Substrates 4-bromobiphenyl 3, 5-bromoindole 4, p-chlorobenzonitrile 5, and 3-bromo 
nitrobenzene 6 were used as model substrates for hydride screening (Table 3). Although our 
goal was focused on bromide reductions we included 5 as the increased strength of the aryl 
chloride bond might lead to a more robust method. Sodium borohydride (entry 1) clearly 
afforded the best results, while allyl alcohol (entry 2) was superior for the reduction of 5 and 
comparable to us of NaBH4 on educt 6. In the case of cinnamyl alcohol (entry 3) a lower 
conversion was observed than with allyl alcohol, but was tested to determine if 
cinnamaldehyde was produced in order to confirm that the hydride was being supplied from 
the alcohol precursor. This would be in agreement with prior observations by Yoshida.
19
 As 
expected, cinnamaldehyde was produced, as detected by GCMS to the same extent of 
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conversion from cinnamyl alcohol as the substrate to product. Triphenylsilyl hydride was 
tested (entry 4) although gave mediocre levels of conversion were observed, and thus, it was 
not tested on the remaining substrates as it would be considered  poor atom economy if 
taken forward.  Reductants H2, formic acid, NH4 formate, and i-PrOH (entries 5-8) did not 
lead to any appreciable amounts of product. 
 
     Focusing on NaBH4, as the stoichiometric reductant, we chose to optimize the required 
stoichiometry of Et3N and NaBH4, shown in Tables 4 and 5, respectively. The base (Et3N), 
was reduced from two to one and a half equivalents without impacting conversion, and 
adjustments in the amount of hydride included lowering from one to a half equivalent; 
although in reality it is still 4 equivalents of hydride. 
Table 4. Effect of the equivalents of trimethylamine for the conversion of 3 
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Table 5. Effect of the equivalents of NaBH4 on the conversion of 3 to biphenyl 
 
 
     From efforts to reduce the loading of Pd catalyst, we found that one could go from 3 to 2 
mol % Pd,, although mild heating of the reaction mixture to 30 °C was required. 
Nonetheless we decided to remain at the 3 mol % to minimize reaction times (Table 6). 
 
Table 6. Effect of the catalyst loading for the conversion of 3 
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From our groups’ previous work utilizing micellar catalysis we have found that inclusion 
of salt (NaCl) can greatly affect the size of the micelle, thus enhancing rates of reactions.
20
 
Using the optimal amounts of reductant and base, the effect of NaCl was screened, again for 
the dehalogenation of 3, with the results shown in Table 7. The optimized concentration of 
NaCl in the aqueous medium was found to 3 M. (entry 4) 
Table 7. Effect of the salt concentration for the conversion of 3 
.  
 
     Screening of alternative surfactants that might facilitate micellar catalysis at the standard 
two weight percent showed that SPGS-550-M (‘Nok’)21 (entry 1) our latest (3rd) generation 
surfactant enabled the highest levels of conversion for all substrates 3, 5, 7,  and 8 (Table 8). 
Curiously the reactions run in the absence of surfactant (i.e., on water), (entry 5) was very 
competitive with Nok and PTS-600 for substrates 3, 5, and 7. Fortunately, substrate 8 
displayed a moderate discrepancy between Nok and the ‘on water’ control with 98 and 72% 
conversion, respectively. Although the ‘on water’ reaction performed almost as well for 
three of the substrates, we had chosen to use the surfactant Nok due to the anticipated 
recycling of the aqueous medium. 
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Table 8.  Impact of the surfactant on dehalogenation of 3, 5, 7, and 8
 
 
 
     It has been shown during earlier cross coupling studies by our research group that the 
weight percent of surfactant can play a pivotal role in the success or failure of certain 
reactions under micellar catalysis.
20
 As we varied the concentration of Nok from one up to 
five weight percent for substrates 3, 5, 7, and 9, (Table 9), substrates 3, 7, and 9 all 
performed essentially the same regardless of surfactant strength. Compound 5 seemed to 
suggest that as the level of surfactant increased, so did the extent of conversion.  Given this 
information two weight percent was chosen for all remaining screenings and determination 
of substrate scope, for reasons mentioned vide infra. In addition, this concentration also 
corresponds to material that is commercially available.   
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Table 9.  Impact of the surfactant strength (Nok) for dehalogenation of 3, 5, 7, and 9
 
 
 
     With the optimal choices of reducing agent, surfactant, and its strength made, we next re-
visited various sources of palladium (Table 10). The bisphosphino-ferrocenyl ligated Pd
II
 
(entry 5) performed equally as well as Fu’s catalyst (entry 1) for 1 and 7, and provided even 
better conversion in the case of 5.  The catalyst Pd[P(Cy3)]2 (entry 4) had also displayed 
somewhat useful levels of conversion.  It was tempting for us to change the catalyst at this 
point with this data but in hand; however, we chose to move forward with Fu’s catalyst as 
we have already observed excellent conversion with other substrates described above. We 
opted to keep the possibility of using Pd[P(Cy3)]2  and Pd(dtbpf)Cl2 in the future in case of 
any un foreseen complications. 
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Table 10. Catalyst screening for dehalogenation of 3, 5, and 7 
 
 
   Additional reaction parameters, such as temperature and global substrate concentration, 
were investigated (Table 11). Results obtained appear to be independent of both temperature 
(22-30 °C) and concentration (0.5 to 1.0 M). We had determined that conditions C (rt, 1.0 
M) (Table 11), provided the greenest method since no additional nvestment of energy as 
well no organic solvent is needed. Further increasing the global concentration past 1.0 M led 
to difficulty in stirring the reaction due to substantial clumping of the reagents and substrate, 
and thus, was abandoned. 
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Table 11. Concentration and temperature dependence for the debromination of 3 
 
 
 
Figure 2. Optimized reaction conditions reduction of aryl bromides in water  
 
     With our newly optimized conditions for the reduction of aryl bromides in water (Figure 
2), we set out to determine the substrate scope and feasibility of the methodology. When the 
steric bulk of the ortho positions relative to the bromide was increased, for substrates 2,5-
bromoxylene 10 and 2,4,6-bromoisoproylmesityl 11 (Figure 3), the conversion was 
drastically reduced to 67% and 36%, respectively. Groups sensitive to hydrogenation 
conditions were examined next, as we had observed evolution of hydrogen gas during the 
process.  Compounds 12, 13, and 14 all achieved high rates of conversion. The highly 
activating nitro groups of 12 were not reduced to the respective amines. Likewise, the 
benzyl protecting group in 13 was not cleaved by the dehalogenation conditions.  
Brominated diphenyl acetylene 14 was tested as, our group recently studied selective alkyne 
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hydrogenation from in-situ formed Pd nanoparticles, H2 from NaBH4 and Pd(OAc)2 in 
water,
22
 we obtained 97% conversion to desired debrominated product from 14 with only 
2% of reduced alkyne.   
 
 
Figure 3. Initial substrate scope and feasablity screening  
a
 percent conversions determined by GC-MS 
 
Additional substrates were examined, with isolated yields found to be high, and with 
equal levels of functional group tolerance (Figure 4), as suggested by ketone 19, that could 
be debrominated without carbonyl group reduction. This was a pleasant surprise assuming 
the ketone functionality would be lost due the NaBH4 used in the reaction. The pseudo-
halide, tosylate 15, was debrominated in 91% yield. The benzyl protecting group of 20, 
again remained intact, as previously demonstrated. The polyhalogenated amide 17 led solely 
to debromination allowing one to selectively remove bromine in the presence of aryl 
chlorides. The product from indole 21 was obtained in 89%, a result that compliments 
previous work in indole syntheses by Dobbs
6
 (Scheme 1). Dibromide 22 gave the 
corresponding  doubly reduced aromatic product in a modest 66% yield, although the yield 
may likely increase if repeated with stoichiometric NaBH4. Since naphthol derivative 23 
afforded the expected product in 91% yield, this result displays the robustness of the method 
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given the acidic nature of this substrate. The phenyl acetamide 9 also smoothly furnished its 
debrominated product in 89% yield 
 
 
Figure 4. Representative examples of our debrominations with isolated yields 
 
 In further validation of our green methodology, we performed a comparison study of 
several substrates in the literature, as shown in Table 12. The model compound 3 used for all 
optimizations was previously dehalogenated by MacArthur
23
 et al. in 77% isolated yield 
using CuI (20 mol %), NaI (2 equiv), and racemic N,N’-dimethylcyclohexane-1,2-diamine 
(1.5 equiv) in CH3CN under microwave irradiation. The compound p-bromoacetophenone 
24 was previously dehalogenated in the ionic liquid 1-butyl-3-methyl-imidazolium bromide 
(bmim Br), and stoichiometric nanoindium. Only a 20% isolated yield was achieved
24
 
compared to our 92% yield, also noting that the ketone remained intact, as shown above. In 
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work reported by Birman et al., spirocyclic ligand precursor 25, where bromine was used as 
a directing group (Scheme 1) and required its subsequent removal by n-BuLi in THF at – 78 
°C giving a 93% yield.
5
 While their method was efficient, there is no functional group 
compatibility in contrast to our method that provides a 91% yield for the same compound. 
Impressively brominated piperonal 26 was successfully debrominated in 87% yield, with 
<5% of the corresponding reduced aldehyde being observed.  Previously, 26 was 
dehalogentated by Chen and co-workers using Pd(OAc)2 with triphenylphosphine in n-
butanol at 100 °C.
25
  
 
Table 12. Direct comparisons with literature methodology. 
 
 
We also endeavored to recycle our reaction medium leading to a ‘greener’ process; 
hence, we conducted the study outlined in Table 13. The workup of these dehalogenation 
reactions consists of the addition of a small amount of organic solvent (EtOAc) (~1 mL / g 
product), directly to the reaction vessel with slow stirring, then extraction and the product is 
then subjected to further purification. The total amount of water invested in the entire 
process is truly minimal, as reactions are run at 1.0 M and no additional water is used for the 
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workup. Because the aqueous layer retains the surfactant, the reaction mixture can be 
recycled. Results from a recycling study for the dehalogenation of 3 are shown in Table 8. 
For recycles 2-5 it was necessary to add 1.5 mol % of catalyst in order to reach full 
conversion, most likely due to the labile catalyst being oxidized during handling. In 
hindsight, we may have been able to circumvent the need for excess catalyst if we had 
chosen one of the more stable alternatives discovered to work equally as well (Table 10) 
such as Pd(dtbpf)Cl2. 
 
Table 13. Recycling the aqueous medium for the debromination of 3
 
 
a
 extracted with EtOAc; aqueous medium used for next reaction. 
b
 for cycle 2-5 1.5 mol % catalyst was used. 
 
 
   To further assess the “greenness” of this process, E Factors were calculated based on 
organic solvent usage, since most organic waste from organic reactions is attributable to this 
reaction variable,
26 
as previously described (Chapter 1). As shown in Figure 5, these 
dehalogenation reactions lead to E Factors that are quite low given the absence of any 
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organic solvent in the reaction medium. An E Factor calculated inclusive of water raises this 
value to only 8.9, but upon recycling this value drops dramatically to 3.7.  
 
 
 
Figure 5. E Factors associated with debromination of 3 
 
     In an effort to gain insight as to the source of the hydrogen in the product, a series of 
experiments were performed, as outlined in Figure 6. As expected, NaBH4 promotes 
formation of a hydrido-palladium species that delivers hydrogen to the aromatic ring, rather 
than involvement by water. This was supported by the use of NaBD4 in H2O leading to 
100% deuterium incorporation, while NaBH4 in D2O gave no deuterium incorporation. 
 
 
Figure 6. Source of hydrogen for the debromination of 3 
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   In conclusion, we have developed a mild, and environmentally friendly aromatic 
debromination prcedure. Because reagent formation takes place in-situ, the method is 
functional group tolerant. This methodology relies on the use of a designer surfactant that 
forms nanoreactors in water within which the reductions take place.  As for observed 
limitations of this methodology, attempts to remove bromine from either an aromatic ring 
bearing a thioether residue or in a brominated pyridine led to no reaction. By contrast, yields 
in all cases utilizing this nanomicellar technology afforded each product in high isolated 
yield.  
 
3.5 Experimental and Compound Data 
General Information 
     The water used in this study was HPLC grade and was degassed prior to use by bubbling 
a flow of argon through the mixture for several hours. All commercially available reagents 
were used without further purification unless otherwise stated. The surfactants SPGS-550-M 
(Nok) and TPGS-750-M are commercially available from Sigma-Aldrich. ( Catalog #’s 
776033 and 733857)
 
Analytical thin layer chromatography (TLC) was performed using 
Silica Gel 60 F254 plates (Merck, 0.25 mm thick). The developed chromatogram was 
analyzed by UV lamp (254 nm) and/or aqueous potassium permanganate (KMnO4), and 
developed by applying heat with a heat gun. Flash chromatography was performed in glass 
columns using Silica Flash® P60 (SiliCycle, 40-63 μm). 1H and 13C spectra were recorded at 
23 °C on a Varian UNITY INOVA 500 MHz. Chemical shifts in 
1
H NMR spectra are 
reported in parts per million (ppm) on the δ scale from an internal standard of residual 
chloroform (7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
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singlet, brs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling 
constant in hertz (Hz), and integration. Chemical shifts of 
13
C NMR spectra are reported in 
ppm from the central peak of CDCl3 (77.23 ppm) on the δ scale. GC/MS data was recorded 
on a 5975C Mass Selective Detector, coupled with a 7890A Gas Chromatograph (Agilent 
Technologies). As capillary column a HP-5MS cross-linked 5% phenylmethyl- 
polysiloxanediphenyl column (30 m x 0.250 mm, 0.25 micron, Agilent Technologies) was 
employed. Helium was used as carrier gas at a constant flow of 1 mL/min. 
 
Standard Procedures 
Hydride screening 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under argon 
with septum was added substrate (0.25 mmol), Pd[P(t-Bu)3]2 (0.008 mmol, 3.8 mg, 3 mol 
%), reductant (0.25 mmol, 1.0 equiv), triethylamine (0.375 mmol, 52 uL, 1.5 equiv.), then 5 
wt. % PTS with 3M NaCl ([0.5], 0.5 mL).  The mixture was allowed to stir in an oil bath at 
40 °C for 18 h then extracted with EtOAc (1 mL). The percent conversion was determined 
by GC. 
 
Triethylamine screening 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
a septum was added 3 (0.2 mmol, 47 mg), Pd[P(t-Bu)3]2 (0.006 mmol, 3.1 mg, 3 mol %), 
NaBH4 (0.2 mmol, 7.6 mg, 1.0 equiv), triethylamine (see above), then 5 wt. % PTS with 3 M 
NaCl ([0.5], 0.4 mL).  The mixture was allowed to stir in an oil bath at 40 °C for 20 h and 
then extracted with EtOAc (1 mL). The percent conversion was determined by GC. 
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Sodium borohydride screening 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
a septum was added 3 (0.2 mmol, 47 mg), Pd[P(t-Bu)3]2 (0.006 mmol, 3.1 mg, 3 mol %), 
NaBH4 (see above), triethylamine (0.3 mmol, 42 uL, 1.5 equiv), then 5 wt. % PTS with 3 M 
NaCl ([0.5], 0.4 mL).  The mixture was allowed to stir in an oil bath at 40 °C for 20 h then 
extracted with EtOAc (1 mL). The percent conversion was determined by GC. 
 
Salt effect on dehalogenations 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
septum was added 3 (0.25 mmol, 58 mg), Pd[P(t-Bu)3]2 (0.008 mmol, 3.8 mg, 3 mol %), 
NaBH4 (0.125 mmol, 4.7 mg, 0.5 equiv), triethylamine (0.38 mmol, 52 uL, 1.5 equiv), then 
5 wt. % PTS with  NaCl ([0.5], 0.5 mL). The mixture was allowed to stir in an oil bath at 40 
°C for 18 h and then extracted with EtOAc (1 mL). The percent conversion was determined 
by GC. 
 
Surfactant screening 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
a septum was added substrate (0.25 mmol, see above), Pd[P(t-Bu)3]2 (0.008 mmol, 3.8 mg, 3 
mol %), NaBH4 (0.125 mmol, 4.7 mg, 0.5 equiv), triethylamine (0.38 mmol, 52 uL, 1.5 
equiv), then 2 wt. % surfactant with 3 M NaCl ([0.5], 0.5 mL, see above). The mixture was 
allowed to stir in an oil bath at 30 °C for 18 h then extracted with EtOAc (1 mL). The 
percent conversion was determined by GC. 
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Screening of surfactant strength  
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5mm) under Ar with a 
septum was added substrate (0.25 mmol, see above), Pd[P(t-Bu)3]2 (0.008 mmol, 3.8 mg, 3 
mol %), NaBH4 (0.125 mmol, 4.7 mg, 0.5 equiv), triethylamine (0.38 mmol, 52 uL, 1.5 
equiv), then X wt. % surfactant with 3 M NaCl ([0.5], 0.5 mL, see above). The mixture was 
allowed to stir in an oil bath at 30 °C for 18 h then extracted with EtOAc (1 mL). The 
percent conversion was determined by GC. 
 
Catalyst screening 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
a septum was added substrate (0.25 mmol, see above), catalyst (0.008 mmol, 3.8 mg, 3 mol 
%), NaBH4 (0.125 mmol, 4.7 mg, 0.5 equiv), triethylamine (0.38 mmol, 52 uL, 1.5 equiv), 
and then 2 wt. % Nok with 3 M NaCl ([0.5], 0.5 mL, see above). The mixture was allowed to 
stir in an oil bath at 30 °C for 18 h then extracted with EtOAc (1 mL). The percent 
conversion was determined by GC. 
 
Temperature and concentration dependence 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5mm) under Ar with a 
septum was added 3 (1.00 mmol, 233 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), 
NaBH4 (0.50 mmol, 18.9  mg, 0.5 equiv), triethylamine (01.50 mmol, 209 uL, 1.5 equiv),  
then 2 wt. % Nok with 3 M NaCl (see above).  The mixture was allowed to stir (Figure 1) for 
18 h then extracted with EtOAc (1 mL). The percent conversion was determined by GC. 
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Recycling study 
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
a septum was added 3 (1.00 mmol, 233 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), 
NaBH4 (0.50 mmol, 18.9  mg, 0.5 equiv), triethylamine (01.50 mmol, 209 uL, 1.5 equiv), 
then 2 wt. % Nok with 3 M NaCl ([1.0], 1.0 mL,). The mixture was allowed to stir at RT for 
24 h then extracted with EtOAc (2 x 0.2 mL) and then concentrated under reduced pressure. 
Passage through a bed a silica gel with 5% EtOAc:hexanes provided dehalogenated 3. The 
aqueous reaction medium was then subjected to a subsequent identical reaction, and the 
cycle repeated four more times, as summarized above. 
 
Representative procedure  
To a dry 5 mL microwave vial equipped with a PTFE stir bar (1 x 5 mm) under Ar with 
a septum was added Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaCl (3 mmol, 175 mg, 
[3.0]), NaBH4 (0.50 mmol, 18.9 mg, 0.5 equiv), substrate (1.00 mmol), triethylamine (1.50 
mmol, 209 uL, 1.5 equiv), then 2 wt. % Nok  ([1.0], 1.0 mL). The mixture allowed to stir at 
rt (~ 23 °C) until complete as judged by TLC or GC-MS. It was, extracted with EtOAc (2 x 
2 mL), and concentrated under reduced pressure. Passage through a bed a silica gel with 
EtOAc:hexanes provided the desired dehalogenated analog. 
Note:  Highly crystalline solids must be ground to a fine powder (mortar and pestle) 
thereby forming a uniform suspension in the aqueous medium. 
 
Surfactant solution preparation 
The water used in this study was HPLC grade and was degassed prior to use by bubbling 
Ar through for several hours.Then each solution was prepared by weight percent for the 
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desired surfactant concentration with degassed HPLC grade water and subjected to an 
additional sparging with Ar for 1 h. All aqueous solutions containing surfactants were stored 
under an Ar atmosphere prior to use. Surfactants PTS and TPGS-750-M are both 
commercially available from Sigma-Aldrich
 
but can be synthesized through previously 
published procedures. 
 
Compound Data 
 
Reduction product from 4-bromobiphenyl (3, JF-003-012). The representative 
procedure was followed using 4-bromobiphenyl (1.00 mmol, 233.3 mg), Pd[P(t-Bu)3]2 (0.03 
mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 mg, 0.5 equiv) NaCl (3 mmol, 175 mg), 
triethylamine (1.50 mmol, 209 uL, 1.5 equiv), then 2 wt % Nok  ([1.0], 1.0 mL). The 
reaction was complete after 18 h by GC-MS.  Crude product was purified by passage 
through a bed a silica gel with 20% EtOAc:hexanes to yield 149 mg, 97% 3 a white 
crystalline solid; 
1
H NMR (500 MHz, CDCl3) δ 7.81 (dd, J = 8.3, 1.3 Hz, 2H), 7.59 (m, 1H), 
7.48 (t, J = 7.6 Hz, 2H); 
13
C NMR (126 MHz, CDCl3) δ 141.36, 128.88, 127.37, 127.28;  
GC/MS m/z: 154.2.  Compound data matched those previously reported.
23 
 
 
Reduction product from N-(4-bromophenyl)acetamide (9, JF-002-259). The 
representative procedure was followed using N-(4-bromophenyl)acetamide (0.70 mmol, 150 
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mg), Pd[P(t-Bu)3]2 (0.02 mmol, 10.7 mg, 3 mol %), NaCl (2.1 mmol, 123 mg), NaBH4 (0.70 
mmol, 13  mg, 1.0 equiv), triethylamine (1.05 mmol, 146 uL, 1.5 equiv), and then 2 wt % 
Nok with ([1.0], 0.70 mL). The reaction was complete after 24 h by TLC. Crude product 
was purified by passage through a bed a silica gel with EtOAc (Rf = 0.30, 3% 
EtOAc:hexanes) to yield 84.3 mg, 89% 9 a white crystalline solid; 
1
H NMR (600 MHz, 
CDCl3) δ 7.49 (d, J = 7.9 Hz, 2H), 7.32 (t, J = 7.7 Hz, 2H), 7.15 (s, 1H), 7.11 (t, J = 7.4 Hz, 
1H), 2.18 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 169.01, 138.07, 128.88, 124.26, 120.17, 
24.39; GC/MS m/z: 135.1. Compound data matched those previously reported.
27 
 
 
Reduction product from 1-bromonaphthalen-2-tosylate (15, JF-004-096). The 
representative procedure was followed using 1-bromonaphthalen-2-tosylate (1.00 mmol, 
377.3 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 mg, 0.5 
equiv), NaCl (3 mmol, 175 mg, [3.0]),  triethylamine (1.50 mmol, 209 uL, 1.5 equiv), then 2 
wt % Nok ([1.0], 1.0 mL). The reaction was complete after 8 h by GC-MS. Crude product 
was purified by passage through a bed a silica gel with 20% EtOAc:hexanes to yield 272 
mg, 91% 15 a white crystalline solid; 
1
H NMR (500 MHz, CDCl3) δ 7.84 – 7.78 (m, 1H), 
7.74 (dd, J = 9.9, 9.0 Hz, 4H), 7.50 – 7.45 (m, 3H), 7.30 (d, J = 8.5 Hz, 2H), 7.10 (dd, J = 
8.9, 2.4 Hz, 1H), and 2.44 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 147.19, 145.35, 133.43, 
132.45, 131.87, 129.76, 129.72, 128.55, 127.87, 127.73, 126.82, 126.35, 121.17, 119.94, and 
21.71. GC/MS m/z: 298.4. HREIMS calcd for C17H14O3S: 298.0664, found = 298.0670 
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Reduction product from 4-methoxybenzyl 4-bromobenzoate (16, JF-002-254). The 
representative procedure was followed using 4-methoxybenzyl-4-bromo benzoate (1.00 
mmol, 321.2 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 
mg, 0.5 equiv), NaCl (3 mmol, 175 mg, [3.0]), triethylamine (1.50 mmol, 209 uL, 1.5 
equiv), then 2 wt % Nok  ([1.0], 1.0 mL). The reaction was complete after 16 h by GC-MS. 
Crude product was purified by passage through a bed a silica gel with 20% EtOAc:hexanes 
to yield 228 mg, 94% of a clear waxy solid; 
1
H NMR (500 MHz, CDCl3) δ 8.07 (dd, J = 8.2, 
1.1 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (dd, J = 17.0, 8.3 Hz, 4H), 6.92 (d, J = 8.7 Hz, 
2H), 5.31 (s, 2H), and 3.81 (s, 3H); 
1
H NMR (126 MHz, CDCl3) δ 166.49, 159.66, 132.94, 
130.07, 129.66, 128.33, 128.17, 127.21, 113.97, 66.54, and 55.29; GC-MS m/z: 242.3. 
Compound data matched those previously reported.
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Reduction product from N-(3-bromophenyl)-2,4-dichlorobenzamide (17, JF-004-
008). The representative procedure was followed using N-(3-bromophenyl)-2,4-
dichlorobenzamide (1.00 mmol, 345.1 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), 
NaBH4 (0.50 mmol, 18.9 mg, 0.5 equiv), NaCl (3 mmol, 175 mg, [3.0]),  triethylamine (1.50 
mmol, 209 uL, 1.5 equiv), then 2 wt % Nok ([1.0], 1.0 mL). The reaction was complete after 
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18 h by TLC. Crude product was purified by passage through a bed a silica gel with 10% 
EtOAc:hexanes (Rf = 0.45, 20% EtOAc:hexanes) to yield 249 mg, 94% 17 as a white 
crystalline solid 
1
H NMR (500 MHz, CDCl3) δ 8.05 (s, 1H), 7.65 (d, J = 8.3 Hz, 1H), 7.62 
(d, J = 7.9 Hz, 2H), 7.44 (s, 1H), 7.37 (t, J = 7.9 Hz, 2H), 7.32 (dd, J = 8.3, 1.6 Hz, 1H), and 
7.18 (t, J = 7.4 Hz, 1H). 
13
C NMR (126 MHz, CDCl3) δ 163.54, 137.35, 137.15, 133.56, 
131.48, 131.29, 130.14, 129.13, 127.65, 125.05, and 120.22; HREIMS calcd for 
C13H9Cl2NO:  265.0061, found 265.0063.  
 
 
Reduction product from 4-bromo-N-phenylbenzamide (18, JF-004-010). The 
representative procedure was followed using 4-bromo-N-phenylbenzamide (1.00 mmol, 
276.1 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 mg, 0.5 
equiv), NaCl (3 mmol, 175 mg, [3.0]), triethylamine (1.50 mmol, 209 uL, 1.5 equiv), then 2 
wt % Nok ([1.0], 1.0 mL). Added The second portion of NaBH4 was added after 18 h. The 
reaction was complete after 37 h by TLC. Crude product was purified by passage through a 
bed a silica gel with 0% EtOAc:hexanes (Rf = 0.15, 10% EtOAc:hexanes) to yield 189 mg, 
96% 18 as a white crystalline solid; 
1
H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 7.1 Hz, 2H), 
7.85 (s, 1H),7.65 (d, J = 8.2 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.48 (t, J = 7.4 Hz, 2H), 7.37 
(t, J = 7.9 Hz, 2H), 7.16 (t, J = 7.4 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 165.71, 137.91, 
135.01, 131.83, 129.09, 128.79, 127.00, 124.57, and 120.19. HREIMS calcd for C13H11NO:  
197.0841, found 197.0842.  
  91 
  
Reduction product from 2-bromo-4-methylacetophenone (19, JF-004-014). The 
representative procedure was followed using 2-bromo-4-methylacetophenone (1.00 mmol, 
213.4 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 mg, 0.5 
equiv), NaCl (3 mmol, 175 mg, [3.0]), triethylamine (1.50 mmol, 209 uL, 1.5 equiv), then 2 
wt % Nok ([1.0], 1.0 mL). The reaction was complete after 14 h by TLC. Crude product was 
purified by passage through a bed a silica gel with 5% EtOAc:hexanes (Rf = 0.22, 5% 
EtOAc:hexanes) to yield 126 mg, 94% of waxy white solid; 
1
H NMR (500 MHz, CDCl3) δ 
7.85 (d, J = 8.2 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 2.57 (s, 3H), and 2.40 (s, 3H); 
13
C NMR 
(126 MHz, CDCl3) δ 197.81 143.84, 134.71, 129.21, 128.41, 26.49, and 21.60; HREIMS 
calcd for C9H10O:  134.0732, found 134.0731. 
 
  
Reduction product from ((7-(benzyloxy)-6-bromonaphthalen-2-yl)oxy) (t-
butyl)dimethyl-silane (20, JF-004-015). The representative procedure was followed using 
((7-(benzyloxy)-6-bromo-naphthalen-2-yl)oxy) (t-butyl)dimethylsilane (1.00 mmol, 443.4 
mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 mg, 0.5 
equiv), NaCl (3 mmol, 175 mg, [3.0]),  triethylamine (1.50 mmol, 209 uL, 1.5 equiv), and 
then 2 wt % Nok ([1.0], 1.0 mL). The reaction was complete after 15 h by TLC. Crude 
product was purified by passage through a bed a silica gel with 3% EtOAc:hexanes (Rf = 
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0.40, 3% EtOAc:hexanes) to yield 351 mg, 96% 20 as a faint yellow liquid;  
1
H NMR (500 
MHz, CDCl3) δ 7.67 (dd, J = 14.0, 8.7 Hz, 2H), 7.51 (d, J = 7.2 Hz, 2H), 7.43 (t, J = 7.4 Hz, 
2H), 7.37 (d, J = 7.2 Hz, 1H), 7.12 (s, 2H), 7.09 (d, J = 2.5 Hz, 1H), 6.95 (dd, J = 8.7, 2.3 
Hz, 1H), 5.18 (s, 2H), 1.05 (s, 9H), and 0.27 (s, 6H); 
13
C NMR (126 MHz, CDCl3) δ 158.18, 
155.11, 137.96, 136.89, 130.16, 130.02, 129.58, 128.96, 128.55, 127.97, 120.64, 117.78, 
115.22, 107.18, 70.96, 26.73, 19.26, and -3.31; HREIMS calcd for C23H28O2Si: 364.1859, 
found 364.1866. 
 
 
Reduction product from ethyl 6-bromo-1H-indole-2-carboxylate (21, JF-004-034). 
The representative procedure was followed using ethyl 6-bromo-1H-indole-2-carboxylate 
(1.00 mmol, 268.1 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 
18.9 mg, 0.5 equiv), NaCl (3 mmol, 175 mg, [3.0]), triethylamine (1.50 mmol, 209 uL, 1.5 
equiv), then 2 wt % Nok ([1.0], 1.0 mL).  The reaction was complete after 20 h by TLC. 
Crude product was purified by passage through a bed a silica gel with 10% EtOAc:hexanes 
(Rf = 0.22,  10% EtOAc:hexanes) to yield 168 mg, 89% of 21 a white crystalline solid; 
1
H 
NMR (500 MHz, CDCl3) δ 8.92 (s, 1H), 7.69 (d, J = 8.1 Hz, 1H), 7.43 (d, J = 8.3 Hz, 1H), 
7.33 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 2.0 Hz, 1H), 7.16 (dd, J = 7.8, 7.2 Hz, 1H), 4.42 (q, J = 
7.1 Hz, 2H), and 1.42 (t, J = 7.1 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 161.96, 136.76, 
127.51, 125.33, 123.56, 122.58, 120.78, 111.81, 108.62, 61.00, and 14.39; GC/MS m/z: 
189.2.  Compound data matched those previously reported.
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Reduction product from 2,2'-(oxybis(methylene))bis(1-bromonaphthalene) (22, EL-
lnb).
 
 The representative procedure was followed using 2,2'-(oxybis(methylene))-bis-(1-
bromonaphthalene) (0.70 mmol, 319 mg), Pd[P(t-Bu)3]2 (0.02 mmol, 10.7 mg, 3 mol %), 
NaCl (2.1 mmol, 123 mg [3.0]), NaBH4 (0.70 mmol, 13  mg, 1.0 equiv), triethylamine (1.05 
mmol, 146 uL, 1.5 equiv), then 2 wt % Nok with ([1.0], 0.70 mL). The reaction was 
complete after 24 h by TLC. Crude product was purified by passage through a bed a silica 
gel with EtOAc (Rf = 0.30, 3% EtOAc:hexanes) to yield 138 mg, 66% of 22 a white 
crystalline solid; 
1
H NMR (400 MHz, CDCl3) δ 7.88 – 7.82 (m, 4H), 7.55 – 7.51 (m, 1H), 
7.48 (p, J = 5.8 Hz, 2H), 4.77 (s, 2H); 
13
C NMR (126 MHz, CDCl3) δ 135.87, 133.43, 
133.14, 128.33, 128.00, 127.83, 126.65, 126.21, 125.97, 125.94, 72.32. Compound data 
matched those previously reported.
30 
 
 
Reduction product from 5-bromo-8-methoxy-3-methylnaphthalen-1-ol (23, EL-
lnb). The representative procedure was followed using 5-bromo-8-methoxy-3-
methylnaphthalen-1-ol (0.5mmol, 133 mg), Pd[P(t-Bu)3]2 (0.015 mmol, 7.7 mg, 3 mol %), 
NaCl (1.5 mmol, 88 mg, [3.0]), NaBH4 (0.55 mmol, 20.8  mg, 1.1 equiv), triethylamine 
(0.75 mmol, 76 uL, 1.5 equiv), then 2 wt % Nok with ([1.0], 0.50 mL). The reaction was 
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complete after 20 h by GC. The reaction was treated with HCl (1.5 ml, [2.0]) and the crude 
was passed through a bed of silica gel with 10% EtOAc:hexanes (Rf  0.27, 10% 
EtOAc:hexanes). The product was dissolved in Et2O (2 mL) and washed twice with HCl 
([1.0], 1.5mL). The product was  purified by passing through through a bed of silica gel with 
10% EtOAc:hexanes (Rf  0.27, 10% EtOAc:hexanes) to yield 85.5 mg, 91% of 23 a white 
crystalline solid.  
1
H NMR (500 MHz, CDCl3) δ 9.23 (s, 1H), 7.32 (d, J = 8.3 Hz, 1H), 7.26 
(t, J = 7.9 Hz, 1H), 7.09 (s, 1H), 6.74 (s, 1H), 6.70 (d, J = 7.6 Hz, 1H), 4.04 (s, 3H), 2.42 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 156.29, 154.30, 137.99, 137.03, 125.80, 121.39, 
118.40, 113.40, 112.39, 103.23, 56.14, 21.75. GC/MS mz: 188.1. Compound data matched 
those previously reported.
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Reduction product from 4-bromoacetophenone (24, JF-003-012). The representative 
procedure was followed using 4-bromoacetophenone (1.00 mmol, 199.1 mg), Pd[P(t-Bu)3]2 
(0.03 mmol, 15.3 mg, 3 mol %), NaBH4 (0.50 mmol, 18.9 mg, 0.5 equiv), NaCl (3 mmol, 
175 mg, [3.0]),  triethylamine (1.50 mmol, 209 uL, 1.5 equiv), then 2 wt % Nok ([1.0], 1.0 
mL). The reaction was complete after 16 h by TLC. Crude product was purified by passage 
through a bed a silica gel with 20% EtOAc:hexanes (Rf = 0.70, 30% EtOAc:hexanes) to 
yield 111 mg, 92% of 24 a clear liquid; 
1
H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 8.1 Hz, 
2H), 7.55 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.7 Hz, 2H), 2.59 (s, 3H). 
13
C NMR (126 MHz, 
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CDCl3) δ 198.11, 137.12, 133.07, 128.54, 128.28, 26.58; GC/MS m/z: 120.1.  Compound 
data matched those previously reported.
24 
 
 
Reduction product from bis-bromospirobiindane (25, ).
 
 The representative procedure 
was followed using bis-bromospirobiindane (0.35 mmol, 153 mg), Pd[P(t-Bu)3]2 (0.01 
mmol, 5.4 mg, 3 mol %), NaBH4 (0.35 mmol, 13 mg, 1.0 equiv), NaCl (0.53 mmol, 61 mg, 
[3.0]), triethylamine (0.53 mmol, 73 uL, 1.5 equiv), then 2 wt % Nok  ([1.0], 0.35 mL). The 
reaction was complete after 20 h by TLC. Crude product was purified by passage through a 
bed a silica gel with 5% EtOAc:hexanes (Rf = 0.30, 5% EtOAc:hexanes) to yield 89 mg, 
91% 25 as a white crystalline solid; 
1
H NMR (500 MHz, CDCl3) δ 7.13 (t, J = 7.7 Hz, 2H), 
6.85 (d, J = 7.4 Hz, 2H), 6.62 (d, J = 8.0 Hz, 2H), 3.53 (s, 3H), 3.06 (m, 2H), 3.00 (m, 2H), 
2.33 (m, 2H), and 2.16 (m, 2H); 
13
C NMR (126 MHz, CDCl3) δ 156.53, 145.35, 136.64, 
127.52, 116.79, 108.64, 59.22, 55.18, 38.81, and 31.61; GC/MS m/z: 280.4.  Compound 
data matched those previously reported.
5 
 
 
Reduction product from 6-bromobenzo[1,3]dioxole-5-carbaldehyde (26, JF-004-
031). The representative procedure was followed using 6-bromobenzo[1,3]dioxole-5-
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carbaldehyde (1.00 mmol, 229.1 mg), Pd[P(t-Bu)3]2 (0.03 mmol, 15.3 mg, 3 mol %), NaBH4 
(0.50 mmol, 18.9 mg, 0.5 equiv), NaCl (3 mmol, 175 mg, [3.0]), triethylamine (1.50 mmol, 
209 uL, 1.5 equiv), then 2 wt % Nok ([1.0], 1.0 mL).  The reaction was complete after 22 h 
by TLC. Crude product was purified by passage through a bed a silica gel with 10% 
EtOAc:hexanes (Rf = 0.60, 10% EtOAc:hexanes) to yield 131 mg, 87% of 26 a clear oil; 
1
H 
NMR (500 MHz, CDCl3) δ 9.81 (s, 1H), 7.41 (dd, J = 7.9, 1.6 Hz, 1H), 7.33 (d, J = 1.6 Hz, 
1H), 6.93 (d, J = 7.9 Hz, 1H), and 6.07 (s, 2H); 13C NMR (126 MHz, CDCl3) δ 190.23, 
153.08, 148.70, 131.89, 128.61, 108.34, 106.92, and 102.08; GC/MS m/z: 150.1. Compound 
data matched those previously reported.
25
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3.6 Spectral Data 
Reduced 4-bromobiphenyl 3 Proton NMR (CDCl3)  
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Reduction product from 4-bromobiphenyl 3; Carbon NMR (CDCl3)  
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Reduction product from N-(4-bromophenyl)acetamide 9; Proton NMR (CDCl3)  
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Reduction product from N-(4-bromophenyl)acetamide 9; Carbon NMR (CDCl3) 
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Reduction product from 1-bromonaphthalen-2-tosylate 15; Proton NMR (CDCl3)  
 
 
  102 
Reduction product from 1-bromonaphthalen-2-tosylate 15; Carbon NMR (CDCl3)  
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Reduction product from 4-methoxybenzyl 4-bromobenzoate 16; Proton NMR (CDCl3)  
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Reduction product from 4-methoxybenzyl 4-bromobenzoate 16; Carbon NMR (CDCl3)  
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Reduction product from N-(3-bromophenyl)-2,4-dichlorobenzamide 17; Proton NMR 
(CDCl3) 
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Reduction product from N-(3-bromophenyl)-2,4-dichlorobenzamide 17; Carbon NMR 
(CDCl3)  
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Reduction product from 4-bromo-N-phenylbenzamide 18; Proton NMR (CDCl3)  
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Reduction product from 4-bromo-N-phenylbenzamide 18; Carbon NMR (CDCl3)  
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Reduced 2-bromo-4-methyl acetophenone 19; Proton NMR (CDCl3)  
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Reduced 2-bromo-4-methyl acetophenone 19; Carbon NMR (CDCl3)  
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Reduction product from ((7-(benzyloxy)-6-bromonaphthalen-2-yl)oxy) (t-
butyl)dimethylsilane 20; Proton NMR (CDCl3) 
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Reduction product from ((7-(benzyloxy)-6-bromonaphthalen-2-yl)oxy) (t-
butyl)dimethylsilane 20; Carbon NMR (CDCl3)  
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Reduction product from ethyl 6-bromo-1H-indole-2-carboxylate 21; Proton NMR (CDCl3)  
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Reduction product from ethyl 6-bromo-1H-indole-2-carboxylate 21; Carbon NMR (CDCl3) 
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Reduction product from 2,2'-(oxybis(methylene)) bis-(1-bromonaphthalene) 22; Proton 
NMR (CDCl3) 
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Reduction product from 2,2'-(oxybis(methylene)) bis-(1-bromonaphthalene) 22; Carbon 
NMR (CDCl3)  
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Reduction product from 1-bromo-2-((1-bromonaphthalen-2-yl)methoxy)naphthalene 23; 
Proton NMR 
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Reduction product from 1-bromo-2-((1-bromonaphthalen-2-yl)methoxy)naphthalene 23; 
Carbon NMR 
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Reduction product from 4-bromoacetophenone 24; Proton NMR (CDCl3)  
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Reduction product from 4-bromoacetophenone 24; Carbon NMR (CDCl3) 
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Reduction product from bis-bromospirobindane 25; Proton NMR (CDCl3)  
 
 
  122 
Reduction product from bis-bromospirobindane 25; Carbon NMR (CDCl3) 
 
 
  123 
Reduction product from 6-bromobenzo[1,3]dioxole-5-carbaldehyde 26; Proton NMR 
(CDCl3)  
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Reduction product from 6-bromobenzo[1,3]dioxole-5-carbaldehyde 26; Carbon NMR 
(CDCl3)  
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IV. Atroposelective Synthesis Towards korupensamine D 
4.1 Introduction 
Chiral compounds and their syntheses have been an intellectual curiosity of organic 
chemists since the first chiral resolution of tartaric acid in 1848 by Louis Pasteur.
1
 This has 
provided a challenge to synthetic chemists, creating chirality like mother nature has 
elegantly done over the millennia.  Although many of us take chirality of sp
3
 centers for 
granted, it has taken almost 60 years since chemists developed an appreciation for the 
importance of axially chiral compounds that possess hindered rotation about an aryl – aryl 
bond thus giving rise to atropisomers. 
 
Optical chirality due to atropisomers were first reported in 1922 by Christie and Kenner
2
 
through crystal formation of P-6,6'-dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid 1. 
Although at first glance 1 seems symmetrical, it is not due to hindered rotation about the 
biaryl bond leads to optical rotation of polarized light (Figure 1). This led to the discovery of 
this unique form of stereoisomerism.  The term ‘atropisomer’ was not coined until almost a 
decade later by Nobel laureate Kuhn, coming from the Greek words of ‘a’ and ‘tropos’ 
meaning not and to turn, respectively.
3
   
 
Figure 1. The first structure 1 to be recognized as having axial chirality 
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This newly found phenomenon of atropisomers via hindered rotation of a seemingly 
symmetric aryl – aryl bond was unfortunately given little industrial attention. Only a small 
number of scientists in the pursuit of academic research were interested until the early 
1980’s with development of the enantiopure biaryls bis-diphenylphosphine binaphthalene 
(BINAP) (Figure 3). These biaryls represent a valuable class of ligands capable of inducing 
stereochemical control for a vast number of synthetic transformations. Secondly, the 
understanding that the configuration of a given biaryl axis is a decisive factor for a 
molecules physiological properties of biological active pharmacophores
1
 and has recently 
helped further the exploration in atroposelective syntheses. 
 
The assignment of stereochemistry for these atropisomers can be made by viewing down 
either biaryl axis. Group priority is given identically to that of central carbon sp
3
 chirality by 
atomic number, while the priority along the ring is ortho > meta.  The chiral descriptors M 
and P are used for the way they each rotate polarized light, minus or plus, respectively, as 
shown in Figure 2.  
 
Figure 2. Assignment of atropisomer chirality 
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From one of the axis the viewer assigns priority to each group as 1 or 2, then the ring out 
of plane is assigned in the same fashion but using 1’ and 2’ instead. Once the assignment has 
been made, if 1’ is counter clockwise (left) with respect to 1, then the compound is labeled 
the M atropisomer, while the opposite is true for the P atropisomer. (Figure 2)  
 
As well for atropisomers the nomenclature of R and S become M (minus) and P (plus), 
respectively, as shown with 2 and 3 in Figure 3 with the commonly used ligand BINAP.   
 
 
Figure 3. Nomenclature relationship between R/S and M/P of the BINAP 2 and 3 
 
Atropisomers can be subdivided into two low level groups; non-bridged and bridged 
(Figure 4). They can be further classified into isocyclic, fused heterocycles, and hetero 
biaryls for non-bridged cases (Figure 5) Bridged atropisomers contain lactones, peptides, 
lignans, and all carbon biaryl
4 
 (Figure 6). 
 
 
Figure 4. Classification of the two forms of atropisomers 
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Figure 5.  Selected examples of non-bridged biaryls 
 
 
Figure 6. Selected examples of bridged biaryls 
 
While a vast quantity (>1000) of biaryls with configurationally stable axis have been 
isolated and identified from nature, only a few have been prepared atroposelectively via total 
synthesis.  That such a small number have been synthesized in an atroposelective manner 
despite their excellent biological activities for a number of ailments, is due to the high 
complexity and difficulty of controlling the configuration of the biaryl bond.
5 
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4.2 Discovery and Biological Activity 
 In 1991 Boyd et al. discovered a novel atropisomeric pair of compounds that were 
found to exhibit anti HIV activity, michellamines A 4 and B 5 (Figure 7) from Korup, 
Cameroon.
6
 These two michellamines are dimers of two naphthyl-tetrahydroisoquinolines 
linked at the C5 to C8 positions, isolated from the plant source of Ancistrocladus 
abbreviatus collected in 1987.  Their connectivity and relative stereochemistry was 
established through extensive nOe and HMQC NMR studies and found to only differ in their 
biaryl configurations.
6
 Later, the absolute configurations at C1 and C3 were determined by 
Bringmann et al.
7
 via ruthenium catalyzed degradation of the tetrahydroisoquinoline ring to 
its respective simple amino acids alanine and 3-aminobutaric acid; they had previously 
employed this technique to determine the absolute stereochemistry of an unrelated 
monomeric naphthyl-tetrahydroisoquinoline dioncophylline A.
8
  
 
     Shortly after, the same researchers discovered a third compound, michellamine C 6.
9
 
Soon thereafter michellamines D-F 7-9
10 
(Figure 7) were isolated, completing the known 
michellamine series, along with a new monomer korupensamine E 14
10 
(Figure 8), the 
structure for which was determined using the same techniques as previously employed.
9
 
While the michellamine series displayed biological activity against HIV, michellamine B 
was more effective against HIV-1 and 2 and thus selected as a preclinical drug candidate, 
although later it was abandoned due to its high toxicity in the liver.
10 
 
     Upon reinvestigation of the original plant source Ancistrocladus abbreviates from 
additional locations in Cameroon, it became apparent that there were subtle differences in 
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the taxonomy from the first reported herbaceous isolation of michellamines,
11
 this was later 
confirmed when the newly collected specimens all disappointingly lacked the presence of 
michellamines A-F 4-9. This revealed that the first isolation was from an unknown plant 
species and prompted a new investigation for the true source of michellamines. Again, from 
Cameroon the authentic michellamine-containing species was identified and aptly named 
Ancistrocladus kourpensis after the new class of alkaloids discovered from them.  
 
 
 
Figure 7. michellamines A-F 4-9 
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   Once the corrected plant species had been identified by Hallock et al., who had scaled up a 
subsequent isolation for additional michellamines, when several closely related monomeric 
alkaloids were discovered in 1994.
12
 The new alkaloids named kourpensamine A-D (10-13) 
were found to be biosynthetic precursors towards the michellamine series (Figure 8). While 
these newly discovered natural products did not display anti-HIV properties they showed 
promising efficacy against malarial parasites in vitro,
13
 but their low concentrations in the 
plant and extreme difficulty in their atroposelective synthesis caused them to be abandoned 
for other more cost effective drugs. 
 
 
Figure 8. korupensamines A-E 10-14 
 
     The absolute configuration of the korupensamine A-E (10-14), was determined via nOE 
and HMBC NMR correlations with comparisons against the previously isolated 
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michellamines A-F
7,10
 and further confirmed via ruthenium degradation.
7
  Further 
elucidation was performed on korupensamine A (10) as its brosylate derivative (15) via 
single crystal X-ray spectroscopy.
12 
4.3 Prior Work in Atroposelective Syntheses 
     Currently there are three main methodologies commonly employed for the synthesis of 
atropisomers: (1) atroposelective biaryl cross coupling; (2) desymmetrization or resolution 
of atropisomers; and (3) atropisomer via construction of the second aryl ring.  Of these three 
only one efficiently constructs the appropriate atropisomer in the key cross coupling step 
while the other two rely upon further modification and synthetic effort (Scheme 1). 
 
 
Scheme 1. Three strategies commonly employed in atropisomer synthesis 
 
     Atroposelective cross couplings can be subdivided into five categories for bond 
formation: (1) intramolecular chiral bridges; (2) intermolecular chiral directing groups; (3) 
chiral leaving groups; (4) ligand control; and (5) planar chirality (Scheme 2). 
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Scheme 2. Five strategies for atroposelective couplings 
 
     The use of intermolecular chiral bridges was developed in large part by Miyano et. al. in 
the early 1980’s by utilizing ester linkages to M-BINOL. This chiral bridge induced the 
desired atropisomer using a copper-mediated Ullmann coupling and became widely 
established by the end of the decade
14,15 
(Scheme 3).  The advantages of this method are the 
high yields, ability to form both homo- and hetero-coupled products, and the excellent 
distereoselectivity (>99%) that makes this an extremely versatile method for biaryl 
formation, especially considering that the bridge may remain intact or cleaved for the final 
product. A potential drawback is the need for CO2H groups to append the BINOL bridge 
which many natural products lack. 
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Scheme 3. Miyano’s use of chiral bridges  
 
     The use of bridges was greatly advanced by our group in the mid 1990’s with use of a 
tartaric acid derived linkage which bears two stereogenic centers further increasing the 
atroposelectivity (>90%), whereas bridges with only a single stereogenic center typically 
provide selectivity in the range of 66-90%. The tartaric acid derivative was installed via a 
double Mistunobu then coupled via Ullmann coupling. The chiral bridge was cleaved with 
NBS in the presence of hydroxide
16 
(Scheme 4). 
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Scheme 4. Lipshutz’s derivatized tartaric acid chiral bridge 
 
     This tartaric acid derivative method was used for the atroposelective nickel catalyzed 
synthesis of the AB biaryl system of vancomycin
17
 (Scheme 5), possibly one of the most 
well-known of all atropisomers. 
 
Scheme 5. Lipshutz’s atroposelective synthesis of the AB fragment of vancomycin 
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     The employment of intermolecular chiral directing groups has also enjoyed a broad 
substrate scope where only one of the coupling partners needs a chiral auxiliary in order to 
induce high diastereoselectivity of the biaryl coupling reaction. This chiral information can 
be transmitted from the ortho and meta positions. Meyers et. al. may have pushed this 
method further than any other researcher by the development and use of his chiral 
oxazolines to induce axial chirality through a SN2Ar reactions with aryl Grignards and a 
methoxy leaving group (Scheme 6).  
 
 
Scheme 6. Use of Meyer’s chiral oxazoline directing group 
 
     The atroposelectivity of this reaction is strongly dependent upon the electron donating 
character of the R group appended to the aryl Grignard coupling partner.
18
 Meyers et. al. 
noted that for substituents with a greater donating ability than that of methoxy, selectivity of  
> 80% could readily be achieved due to chelation control from the lone pair of electrons of 
oxygen with the incoming aryl Grignard species.
19
 The general requirement of an ortho 
methoxy substituent should not be seen as a limitation considering that many of the biaryl 
natural products contain a methoxy group in this position or an alkoxy group that is readily 
accessible through well-known demethylation and etherification methods. This methodology 
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was applied by Bringmann et al. for the total synthesis of a number of naphthyl 
tetrahydroisoquinoline alkaloids. (vide infra)  
 
     Meyers later expanded this work to the more facile Ullmann coupling (Scheme 7) 
negating the need to protect functional groups known to be sensitive towards Grignard 
reagents. The need for ortho methoxy groups was replaced by increasing the steric bulk of 
the oxazoline rings leading to high distereoselectivity (> 80%).
20
 One of the large draw 
backs of this method is the high price and synthetic effort needed to install the t-butyl 
oxazoline chiral auxiliary. 
 
 
Scheme 7. Meyer’s atroposelective Ullmann coupling with chiral oxazolines 
 
     Our research group has also been active in the development of atroposelective biaryl ring 
formation in the arena of intramolecular chiral induction with work in 
naphthyltetrahydroisoquinoline syntheses.  Most recently we have utilized π-stacking 
(Scheme 8). By taking advantage of the chiral methyl group at C3, a naphthyl unit was 
installed blocking one face of the aryl iodide coupling partner inducing selectivity of 9:1 for 
the synthesis of korupensamine B (11).
21
 This technique allowed for an improvement over 
the previous synthesis of 11 1.5:1 by Bringmann et. al.
22, 23 
  140 
 
Scheme 8. Lipshutz’s atroposelective route of korupensamine B 11 via π-stacking 
 
     We previously employed a similar strategy (Scheme 9) for the synthesis 16 an analogue 
of korupensamine A 10.  A chelating phosphine was appended in the same fashion as the π-
stacking unit for the synthesis of 11.  The effect of the chelating phosphine was confirmed 
via the exchange of a TIPS silyl ether leading to only a 11% de in contrast to the completely 
selective >99% de coupling achieved with the diphenylphosphinyl auxiliary.
24
 Our two 
methods of chiral directing groups (pi stacking and chelation control) should allow one to 
access all of the korupensamines regardless of the axial and C3 chirality. 
 
11 
  141 
 
Scheme 9. Lipshutz’s work in atroposelectivity via chiral chelation control for 
synthesis of a korupensamine A analog 16 
 
 
 
     The third method of accessing atroposelective biaryl coupling is enabled by a chiral 
leaving group used to direct the incoming coupling partner.  The advantage of this technique 
is that in SNAr reactions the chiral auxiliary introduces the atroposelectivity while 
automatically displacing the chiral leaving group negating the need for further manipulation 
in order to remove the auxiliary.  In the early 1980’s Cram and Wilson noted that non-
racemic R-menthol was suitable as a leaving group inducing the desired atroposelectivity for 
direct cross coupling with aryl Grignards.
25
 Less than a decade later Miyano et al. developed 
a complimentary method to that of Cram and Wilson’s by the addition of ortho carboxylate 
groups to the R-menthol (Scheme 10) although steric effects did not play a pivotal role as 
one may have suspected (Scheme 7). As the steric bulk was increased from iso-propyl to 
phenyl ethyl the % ee remained largely unaffected.  It was fascinating that with the addition 
of the ortho methoxy group could completely invert the atroposelectivity from M to P via 
chelation control.
26
 This same observation was noted by Meyers et al. in their work with 
oxazolines.
20 
  142 
 
Scheme 10. Atroposelective biaryls via chiral R-menthol leaving group 
 
     Non ethereal based chiral leaving groups such as sulfoxides were utilized by Baker
27
 and 
Sargent,
28
 again in an aryl Grignard SNAr reaction pathway. (Sheme 11)  
 
 
Scheme 11. Chiral sulfoxide leaving group for atroposelectivity 
 
     Although this method offers stereoselectivity (>90%ee) there are several shortcomings; if 
the steric bulk ortho to the aryl Grignard partner is greater than hydrogen (i.e., any group), 
no cross coupling reaction was observed; if the t-butyl group appended to the sulfoxide 
contains less steric bulk  the atroposelectivity is greatly reduced to <75% ee due to 
racemization at sulfur; lastly, accessing the enantiopure starting material is very labor 
intensive, and it is prone to racemization upon purification.
29, 30
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     Ligand-controlled synthesis of biaryls has some of the largest advantages in comparison 
with the other four methods described herein. These key benefits include: the biaryls can be 
constructed in a single step with all functionalities present, negating the need for further 
modification; generally proceed under mild conditions, and the chiral information of the 
ligand is transferred directly to the product in a catalytic nature leading to high atom 
economy.  Despite these promising features the field is still in its infancy due to the 
complexity and limited generality found among biaryl natural products.  Some of the initial 
attempts by Kumada et. al. in the early 1970’s with aryl Grignards, M-BINAP, and nickel 
catalysis led to low selectivity (10-25% ee) for the cross coupling of ortho substituted 
naphthalene’s.31 The work by the Kumada group led to an academic investigation for 
furthering the selectivity of these ligand controlled atroposelective cross couplings to more 
relevant examples, such as vancomycin.
32 
 
 
Scheme 12. Bringmann’s ligand-controlled atroposelective approach to 17 and 18 
 
     More recently, Bringmann et al. have utilized this technique, with M-BINAP for the 
synthesis of ancistrotanzanine B 17 and ancistroealaine A 18, which differ only in their 
biaryl configuration (Scheme 12) in modest atroposelectivity (3:1).
33
 Although the 
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atroposelectivity is low, it is valuable to note that the cross coupling was the last reaction in 
the total synthesis, allowing access to the natural product without further de-protection or 
modification. 
 
     The work performed by Tang et. al. for the total synthesis of korupensamines A 10 and B 
11, with subsequent dimerization to form michellamine B 5, was performed in an elegant 
series of atroposelective reactions. Their design of the chiral monophosphine ligand 19 
enabled effective atroposelectivity through numerous biaryl substrates, all with % ee greater 
than 90%, via the internal coordinating highly polarized BOP group (Scheme 13). Although 
the THIQ ring was constructed post-Suzuki coupling, an astonishing 93% ee was obtained 
from the simple coupling partners all enabled by the ligand!
34 
 
 
Scheme 13. Tang’s work for atroposelective synthesis of 10, 11, and 5 via chiral ligand 19 
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     Control of atropisomer induction via a fixed but not covalently bound element of planar 
chirality, is the fifth main method. It likens its strategy to that of ligand controlled in regards 
that it is viewed as a traceless stereogenic center capable of inducing atroposelective cross 
couplings, shown in the generic coupling reactions in Scheme 2.  This novel idea was 
pursued by Uemura et. al.
35
 with the use of Cr(CO)3 catalyst for the Pd catalyzed Suzuki 
couplings to generate the syn or anti products relative to the chromium and ortho 
substituents (Scheme 14).  The distribution of syn vs anti products were obtained in 
excellent atroposelectivity (>99%) and interestingly, led more to the syn atropisomer, with 
greater steric congestion.  They noted if the ortho group had a carbonyl present the opposite 
product (anti) could be obtained although at the time researchers were unable to determine a 
trend from the limited screening data.
35
 From their later work it was determined that the 
reversal in selectivity was due to the racemization of benzaldehyde derivatives to the more 
stable anti isomer under the reaction conditions.
37,38 
 
  
Scheme 14. Uemura’s early work in atroposelective cross coupling with chiral planarity 
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     It was observed that the electron deficient Cr(CO)3 must be placed on the aryl halide 
coupling partner to facilitate a more facile oxidative addition by Pd.  The placement of 
Cr(CO)3 onto the aryl boronic acid led to low yields and virtually no atroposelectivity.
36
  
 
     The same researchers have also developed conditions for isomerization of the aryl-aryl 
bond of benzaldehyde derivatives to the desired anti isomer via heating in an aromatic 
(toluene) solvent, leading to the more thermodynamically stable isomer.
37,38
 This 
isomerization towards the more stable atropisomer was utilized again by Uemura et. al. for 
the total synthesis of korupensamines A (10) and B (11). The same late stage intermediate 
20 was used for both natural products, as shown in Scheme 15, where 20 was thermally 
isomerized to the appropriate atropisomer after oxidation of the benzyl alcohol functionality. 
The most obvious advantage to the use of chiral metal complexes is that both atropisomers 
can be produced from a single chiral planar precursor, as the work shown in Scheme 15 
elegantly displays. 
 
Scheme 15. Uemura’s atroposelective divergent synthesis of 10 and 11 
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4.4 Prior Work in Total Synthesis of korupensamine D 
     Korupensamine D is unique in the fact that, (1) of all the korupensamines it is the only 
one containing both methyl substituents of the tetrahydroisoquinoline ring in a 1, 3- cis  
equatorial relationship, and (2) features a methylated amine (Figure 8).  The promising 
initial anti-HIV properties of michellamine B and recently discovered anti-malarial features 
of the korupensamines have provided a desire for access to korupensamine D, along with its 
dimerization to michellamine analogs for biological screenings has fostered need its 
synthesis. The preparation of authentic korupensamine D has yet to be seen due to its 
conformation about the tetrahydroisoquinoline ring. The conformation of having both 
hydrogens in the 1, 3 axial positions has been proven unstable, the easily accessible axial 
hydrogen is prone to oxidation with atmospheric oxygen as the free base, mild acid-base 
catalyzed epimerization, Hoffmann rearrangement, and retro-Mannich ring opening 
epimerization events (vide infra) to relive stress at the ‘1’ position forming the trans isomer 
discovered from related works of cis-1, 3 dimethyl- tetrahydroisoquinoline ring systems.  
 
4.4.1 Hoye’s 1st Attempted Synthesis of korupensamine D 
     After korupensamine D (13) had been isolated and identified,
12
 the laboratory of Hoye et 
al. pursued the total synthesis of 13 (Schemes 16-18) in enantiopure form in 1996.
39
  They 
presented a new synthetic scheme (Scheme 16) to access the asymmetric 
tetrahydroisoquinoline from the chiral aziridine 21 readily obtained from D or L valine in 
three steps
40
 allowing access to both R and S isomers at the C3 center.  Asymmetric ring 
opening via Grignard addition followed by detoslylation formed the enantiopure primary 
amine 22, confirmed by Mosher amide analysis. This method of stereo assignment was 
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developed by Bringmann et al. in a number of his nonracemic tetrahydroisoquinoline 
syntheses.
41
 After formation of the amide, Bischler-Napieralski cyclization led to cyclic 
imine 23. Although the known reduction with NaBH4 had been established, they decided to 
subject 23 to traditional hydrogenation conditions to give the cis configured compound 24 as 
the only diastereomer (via 
1
H NMR).  Exchange of the methoxy groups for benzyloxy was 
performed to avoid the late stage use of harsh BBr3 demethylation procedures, followed by 
carboamination with concurrent reduction using LiAlH4 afforded the N-methylated cis 
configured tetrahydroisoquinoline compound 25.  Simple iodination with I2 and Ag2SO4 
gave the ready to use coupling partner 26, (Scheme 16) although the enantiomer of the 
tetrahydroisoquinoline portion of 13. They had placed both methyl groups in the axial 
positions unlike the natural product 13 with both methyl groups in equatorial positions very 
well likely due to its known instability vide infra as had later confirmed with our work in 
tetrahydroisoquinoline ring synthesis. 
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Scheme 16. Hoye’s original tetrahydroisoquinoline synthesis en route toward 
korupensamine D 13 
 
 
 
     They obtained their naphthylene coupling partner in a short four step route previously 
utilized for the synthesis of michellamines A-C, 4-6.
42
 (Scheme 17)  The MOM protected 
dibromide 27 was easily prepared from 2,4-dibromophenol.  They had hypothesized that 29 
was formed from the benzyne intermediate of 27, formed with lithium 
cyclohexylisopropylamide and N,N-diethylseneciamide that underwent a Diels Alder 
transformation with the enolate of 28.  Although only a 20% yield of 29 was achieved, the 
procedure is very reproducible with similar overall yields compared to previous naphthylene 
syntheses.   Facile O-methylation followed by borylation affords their naphthylene partner 
30. 
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Scheme 17. Hoye’s general naphthylene synthesis for korupensamines and michellamines 
 
     With both coupling partners now in hand they carried out a routine Suzuki coupling 
(Scheme 18) to obtain korupensamine analogs 31 and 32 in a combined 73% yield, although 
with essentially no atroposelectivity (4:5).  Both analogs were subjected to hydrolysis of the 
MOM ether and hydrogenation of the benzyl groups which provided the two atropisomers 
13-ent and 13-dst. Researchers determined compound 13-dst to be the diastereomer, and  
while 13-ent had identical 
1
H NMR to 13 the specific rotation had the opposite sign but 
same magnitude confirming it as an enantiomer.   Nevertheless, their work can be applied to 
the synthesis of structural and analogs of the korupensamines and their respective dimeric 
michellamines. 
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Scheme 18. Hoye’s first attempt to synthesize kourpenamine D 13 
 
4.4.2 Hoye’s 2nd Attempt: Synthesis of korupensamine D 
     Since Hoye’s first attempt of the total synthesis of korupensamine D39 which yielded its 
enantiomer 13-ent and its diastereomer 13-dst, they have reinvestigated the synthesis in 
efforts of a more efficient tetrahydroisoquinoline synthesis.
13
 Instead of utilizing the 
previously used chiral aziridine 21, they employed a chiral reductive amination as developed 
by Bringmann et al.
43
 on the phenyl-2-propanone (P2P) derivative 33 (Scheme 19) with R-1-
phenylethyl amine to yield the C3 chiral intermediate 34. Upon hydrogenation with 
ammonium formate the chiral amine 22 was obtained.  Compound 22 underwent further 
manipulation as shown in Scheme 16 to yield the same tetrahydroisoquinoline coupling 
partner 26.  I find it odd that Hoye would synthesize the same intermediate 26 knowing that 
is was indeed a cis relationship but the unnatural isomer, other than the novelty of a more 
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efficient synthesis to arrive at 26 over their previous publication,
39
 and leads to the 
enantiomer (13-ent) of korupensamine D (13). 
 
 
Scheme 19. Hoye’s modified tetrahydroisoquinoline synthesis in route toward 
korupensamine D 13 
 
 
     This new naphthylene coupling partner strategy (Scheme 20) was more efficient over the 
first in the sense that compounds prepared were crystalline and could be purified via 
recrystallization allowing for preparation at larger scales where column chromatography is 
prohibitive.
44
 Compound 35 was prepared after a simple MOM protection of the starting 
tolulylol with NBS in the presence of a 100W tungsten incandescent bulb, which they had 
noted without the intense irradiation multiple bromination would occur making purification 
a daunting task.  Displacement of the benzylic bromide with sodium phenylsulfinite yielded 
36 that in turn formed the sulfone. Deprotonation with LDA and addition of methyl 
crotonate formed an adduct which following saponification, was cyclized to ketosulfone 37.  
Aromatization of 37 via elimination of the sulfone with tBuOK efficiently afforded 29. 
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Subjection of 29 to the conditions outlined in Scheme 17 arrive at the naphthylene coupling 
partner 30. 
 
 
Scheme 20. Hoye’s modified naphthylene synthesis for korupensamines and michellamines 
 
          Again, with both coupling partners they performed a Suzuki coupling (Scheme 18) to 
obtain korupensamine analogs 31 and 32 in the same 73% yield that they had previously 
obtained. They then transformed both into the unprotected korupensamine D analogs in the 
same fashion displayed in Scheme 18.  The selectivity was the same as previously seen, with 
little selectivity with respects to the aryl-aryl bond of 4:5 for 31:32.  The same compounds 
13-ent and 13-dst were obtained from their second approach, being the enantiomer and 
diastereomer of korupensamine D 13.   
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4.5 Results and Discussion 
     Inducing atroposelective biaryl bond formation has been described above, along with the 
two racemic syntheses of korupensamine D 13 having been outlined.  Previously, we have 
pursued atroposelective cross coupling of an analog of korupensamine A (10, Scheme 9) and 
korupensamine B (11, Scheme 8) with atroposelectivities of 99:1 and 9:1, respectively, via 
chiral directing groups.  
     Firstly, in efforts to further our methodology of atroposelective biaryl bond formation, we 
have pursued improvement of key literature cross couplings to korupensamine D 13, or an 
analog and, secondly, transforming the biaryl product to authentic 13 with the known 
unstable tetrahydroisoquinoline ring.  We have invoked a similar strategy (Scheme 21) to 
that previously employed by our research group
21
 for synthesis of 11. That is, we utilized a 
π-stacking phenomenon to block one face of the tetrahydroisoquinoline coupling partner to 
force the ‘long’ side of the naphthylene partner away from the π-stacking unit, as well the 
bulky silyl ether of 38 that further encourages the direction of coupling to avoid a steric 
clash with the π-stacking unit, as shown in intermediate 40.  These features should aid in the 
formation of the P isomer of 41 which could be further manipulated to korupensamine D 13 
(Scheme 21). 
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Scheme 21. Proposed pi-stacking phenomena for atroposelective formation of 41 
 
4.5.1 Synthesis of the cis-tetrahydroisoquinoline coupling partner 
     Synthesis of the tetrahydroisoquinoline coupling partner is loosely related to the work 
performed by Keith in his atroposelective cross coupling towards korupensamine A 10 
analog 16.
45
 We have chosen to work with the benzyl protected analog to avoid the late 
stage use of BBr3 to access the free phenols of 13.  Starting with commercially available 3,5-
difluorobromobenzene 42, we performed a double nucleophilic aromatic substitution with 
benzyl alcohol to provide the benzylated aryl bromide derivative 43 (Scheme 22). The TIPS 
protected R-glycidol 44 was formed from routine silylation chemistry to give the TIPS 
protected alcohol in nearly quantitative yield; assignment of stereochemistry matches that of 
previously synthesized material.
46
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Scheme 22. Tetrahydoisoquinoline coupling partner synthesis 
 
     The known
47
 regioselective copper catalyzed epoxide ring opening was performed 
initially with CuBr·SMe2 yielding 45 in a disappointing 22% yield, with the remaining mass 
being homocoupled Grignard starting material. From careful re-inspection of the literature 
we found that CuI is better suited with our aryl bromide 43. With the new catalyst we were 
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able to readily achieve yields in excess of 85%. Transformation of the free alcohol of 45 to 
the phthalimide derivative 46 with inversion of stereochemistry was carried out by 
Mitsunobu conversion,
48
 followed by hyrdrazinolysis to afford primary amine 47.  
Acetimidation was performed with acetic anhydride to give 48. This route was chosen as we 
have found from previous work that installation of the chiral methyl group in a cis 
relationship post-cyclization proved to be difficult.  From acetamide 48 ring closure was 
performed via a Bischler-Napieralski reaction
21,49
 forming imine 49 in excellent yield.  
 
     It is important to note that formation of 49 requires care with respect to reaction time, 
temperature, and work-up.  If the reaction is allowed to continue reflux after completion (~3 
h), the yield was generally depressed due to degradation from in situ phosphoric acid 
formation. The issue becomes much worse at elevated temperatures.  Also, the work-up 
must be completed quickly by pouring the reaction mixture into a mixture of cold 1:1 ethers 
: triethylamine and stirred immediately, followed by basic work-up and purification. 
 
     With imine 49 in hand it was decided to carry out a diastereoselective sodium 
borohydride reduction to 50, as previously used by Bringmann for similar cis selective 
reductions of 1,3 dimethyltetrahydroisoquinolines.
41
 This route was chosen over the widely 
used hydrogenation on Pd/C, which would lead to concurrent debenzylation. This unwanted 
deprotection could give material that might prove too difficult to solely methylate or 
reprotect the phenols vs the amine. 
 
Although this procedure proved selective to obtain 50, 
our initial attempt led to a disappointing 3:1 cis:trans (entry 1) selectivity at 5 °C (Table 1).  
Further optimization led to the current condition (entry 5) providing a 13:1 cis:trans 
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selectivity.  Although superior selectivities (entries 3 and 4) were achieved at colder 
temperatures, reaction rates dropped precipitously along with yields. 
 
Table 1. Optimization for the formation of the cis secondary amine 50 
 
 
     Proton and carbon NMR assignments were made at the two stereogenic centers, C1 and 
C3 of 50 with the use of HMQC, 
1
H, and 
13
C NMR (Figure 9). These assignments were 
necessary as the diastereotopic methylene protons tend to be quite misleading if one were to 
only rely on simple proton NMR. Using this information we observed a strong nOe effect 
between the 1-3, and 4eq-8 hydrogens of 50 with 2-D NOSEY NMR experiments, this 
assignment confirms the cis relationship as originally reported when korupensamine D 13 
was first isolated.
12 
Importantly, there is an absence of an nOe between hydrogens 5-3 which 
would be present in the trans isomer. 
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Figure 9. Stereochemical assignment of 50 from key nOe interactions 
 
     Special care must be taken from this point on in the synthesis, as 1,3-cis-dimethyl 
tetrahydroisoquinolines with axial hydrogens are known to epimerize to the more stable 
trans isomer under both mildly basic and acidic conditions (Scheme 23). They have also 
been found to rapidly oxidize at room temperature in the presence of atmospheric oxygen 
furthering the need for cautious handling.
41
 This epimerization was used by Bringmann to 
convert their unwanted cis byproducts 50a from a Pictect-Spengler reaction with 
ammonia/EtOH (pH 8), as shown in Scheme 23 (Path A) in nearly quantitative yield to the 
trans isomer 50b.
41
 While Bringmann was able to use this epimerization to his advantage, 
Amat et al.
50
 were not so fortunate.  They had set out to synthesize the 
tetrahydroisoquinoline portion of 13, and unexpectedly realized this epimerization when 
performing a N-Boc deprotection with TFA (Scheme 23, Path B) which was overcome by 
using TMSOTf and 2,6-lutidine. A proposed mechanism is drawn (Scheme 23, bottom) for 
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the plausible retro-Michael ring opening and closure. With this insight the utmost attention 
must be paid throughout the remainder of the synthesis as to avoid this potential dead end. 
 
 
Scheme 23. Pathways for the known epimerization of cis configured compounds like 50 a 
 
     Formation of N-methylated amine 52 initially proved difficult as we wished to use 
traditional single step methylation procedures over the known two step methods, from 
carbamate installation followed by reduction as used by Hoye et al.
51
 We soon discovered 
why… 
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     From screening of the electrophilic methyl sources; methyl iodide (MeI), Meerweins salt 
(Me3O
+ -
BF4), and dimethyl sulfate (Me2SO4).  Shown in Table 2, use of MeI at room 
temperature (entry 1) led to no reaction after being left overnight. When the reaction was 
heated (entry 2) three products were obtained: N-methyl 52 (cis)/52’ (trans), amine salt 52a, 
similar to the Hoffmann rearrangement products of the natural product gentrymine B 
synthesized by Bringmann et. al.
52
  (Scheme 24), and epimerized starting material. 
      
Table 2. Screening for N-methylation of 50 to 52 
 
 
     Meerwiens salt (entry 3, Table 2) afforded the N-methylated product 52 in the correct 
stereochemistry, although in a rather poor yield of 51%.  Dimethyl sulfate gave incomplete 
reaction with a 12% yield (entry 4). We chose not to further pursue the use of Me3O
+ -
BF4 or 
Me2SO4 from our lesson learned with unwanted byproduct formation with heating 
electrophilic MeI (Scheme 24).   
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Scheme 24. Formation of unwanted gentrymine B analog 52 a 
 
     Efforts using reductive amination with formaldehyde and formic acid led solely to the 
trans isomer 52’, which could be formed from presumably two pathways shown in Scheme 
25. Either the preferred product may be formed which then undergoes acid catalyzed 
epimerization (Scheme 23), or the reactive imine my lower the pKa of the benzylic proton 
such that formate can serve as a base at 60 °C, resulting in a new imine with the C1 position 
sp
2
 hybridized center available for hydride delivery to form the more stable product 52’. 
 
 
Scheme 25. Formation of 52’ from reductive amination of 50 
 
     After quickly realizing we were exhausting precious cis dimethyl amine 50 we resorted 
to using the two step procedure by first formation of a ethyl carbamate 51 (Scheme 22) 
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followed by reduction using LiAlH4 in dry refluxing ether, which afforded the N-methyl 
amine 52 in 70% overall yield. Its stereochemistry was assigned again with 
1
H, 
13
C, HMQC 
and Noesy NMR as shown in Figure 10. Key nOe correlations observed were the hydrogen 
signals of 1-3, 4eq-8, 3-4eq, and again the lack of 5-3.  
 
. 
Figure 10. Stereochemical assignment of 52 from key nOe interactions 
 
     Now with a reliable means to produce N-methylated 52 in a diastereomericly pure 
fashion we moved on to installation of the halogen for cross coupling.  Iodination of 52 with 
I2 and Ag2SO4 in ethanol proceeded smoothly affording aryl iodide 53 in 66% yield. 
Although exposure to UV light should be avoided, an impromptu stability sample was 
placed in an NMR tube and left on the window sill in direct sunlight for ~8 h a day. 
Impressively after two weeks the sample had retained ~80% of the iodide. The 
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regiochemistry of the iodine atom and the stereochemistry of the C1 and C3 hydrogens were 
determined via 2D Noesy assigned again from HMQC, 
1
H, and 
13
C as shown in Figure 11. 
The observed nOe’s of proton 7 with both benzylic protons and the loss of the 4eq-8 nOe 
determined the regiochemistry of the iodine, if the iodine were in the 7 position only one of 
the benzyls would show an nOe.  The stereochemistry of 53 was found from the nOe of 1-3, 
and proton 3 was assigned from its nOe with the 4eq proton. It appears there may be a small 
nOe of 3-5 although only a single diastereomer is resolved with the 
1
H NMR, and the 
following desilylation to 54 did not contain a nOe for 3-5, only 1-3 and 3-4eq hydrogens 
suggesting that we still have the labile cis configuration. 
 
  
Figure 11. Regio and stereochemical assignment of 53 from key nOe interactions 
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     Desilylation of 53 proceeded uneventfuly giving 87% yield of alcohol 54, 2D NMR 
suggests that the cis configuration is still in place from the nOe correlations of 1-3, 3-4eq 
hydrogens, and noting the lack of the trans 5-3 hydrogens nOe. (See SI)  Alcohol 54 was 
carried into a DCC coupling with 1-naphthoic acid to cleanly produce the 
tetrahydroisoquinoline coupling partner 55 (Scheme 22). Structural assignment shown in 
Figure 12 of 55 was performed with 
1
H, 
13
C, HMBC, HMQC, and NOESY NMR. The 
observed nOe for the cis compound was found for 1-3, 3-4eq, and 5-4ax as well the 
1
H 
NMR indicated there to be only a single diastereomer. 
 
 
Figure 12. Regio and stereochemical assignment of 55 from key nOe interactions 
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4.5.2 Synthesis of the naphthylene coupling partner 
     Synthesis of the naphthylene coupling partner (Scheme 26) was far more straightforward 
as most of the details and pitfalls had been previously worked through by Keith,
45
 
Petersen,
53
 and utilized by Bringmann
23 
for his work with michelleamines A-C. 
     Commercially available 3-hydroxybenzaldehyde 56 was benzylated in 97% yield to 
afford 57, which was subjected to bromination conditions with NBS and sodium acetate 
giving the brominated aldehyde derivative 58.  Preparation of 59 resulted from t-butyl 
bromoacetate and diethylphosphonate ethyl ester in 97% yield,
54
 which was and used in the 
Horner-Wadsworth-Emmons reaction forming 60. We typically see much higher yields, 
although it was noted after addition that the THF still had become contaminated with water: 
product 60 was obtained in 38% yield. The t-butyl ester was cleaved under acid hydrolysis 
conditions to give 61 that was cyclized using acetic anhydride, and then aromatized with 
sodium ethoxide furnishing 62 in 71% overall yield. Methylation followed by ester 
reduction gave the alcohol 64.  At this point we could have removed the alcohol via 
mesylation and reduction, but decided to silylate the free alcohol to the TIPS ether 
increasing the steric bulk on the ‘long’ side of the naphthylene ring of 65. Typical borylation 
chemistry gave the final product 66 in 81% yield. 
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Scheme 26. Naphthylene coupling partner synthesis 
 
4.5.3 Atroposelective cross-coupling en route towards korupensamine D 
     With successful completion of both coupling partners 55 and 66 we were able to carry 
out the much anticipated atroposelective cross coupling towards korupensamine D analog 67 
(Scheme 27). We accomplished the selective formation of 67 in a yield of 89% with 
excellent selectivity of 9.8:1 (67:67’) for the P:M  diastereomers by 1H NMR, better than the 
related cross coupling reactions in prior art towards 13.
13,39
 Identification of the P and M 
diastereomers was performed in the same fashion using the diastereotopic protons appended 
to the naphthylene unit, and 4ax/4eq positions of the tetrahydroisoquinoline ring as 
previously reported in work towards related korupensamine analogs discussed below.
13,54,56
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Scheme 27. Atroposelective cross coupling of korupensamine D 13 analog 67 
 
     Further structural information was gathered through extensive 
1
H, 
13
C, HMQC, and 
Noesy NMR studies with comparison to related cis korupensamines. They key nOe 
hydrogen correlations leading to an assignment of axial chirality for 67, were 1-3, 4eq-1’, 
4ax-4’, 6’-1’, and the lack of 3-5, these correlations were also observed by Hallock et al.10,12 
and shown in Figure 13.  The specific rotation was also positive like that of 13, thus 
providing further evidence of the P isomer. 
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Figure 13. Key nOe correlations for the assignment of 67 
 
     Our choice of atropisomer induction via the π-stacking unit had been previously 
developed by Petersen
21,54
and Huang.
21,56
 From their optimization studies (Table 3) that 
involved varying sterics, hydrogen bonding, and levels of conjugation, 1-naphthoate ester 
68g proved best giving atroposelectivity of 9:1 for 69g in nBuOH as measured by the 
diastereotopic protons via 
1
H NMR as confirmed by HPLC.
21
 The effect of π-stacking was 
confirmed with substrate 68i bearing a simple methyl ester, lacking the aryl π-stacking 
interactions leading to cross coupled product 69i in a 1:1 ratio. 
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     Although they had worked towards the M isomer, our modeling would suggest that the P 
isomer selectivity should be similar if not higher than previous efforts. This was suggested 
given that the naphthylene unit is in closer proximity to the aryl ring of the 
tetrahydroisoquinoline ring when placed in the equatorial position, such as in 55. By contrast 
68g contains both, a large sterically crowding N-tosyl protecting group and the π-unit in the 
axial-like positions. 
Table 3. Effect of the pi-stacking unit for the atroposelectivity of 69 a-i by Petersen and 
Huang 
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     With the optimal π-stacking unit selected; their efforts to further increase 
atroposelectivity moved towards solvent selection
45
 in hopes of increasing the stability of 
intermediate 40 (Scheme 21).  As shown in Table 4, from work by Petersen,
54
 toluene 
displayed a modest selectivity due to its aromaticity, which perturbs the desired π-stacking 
of 40.  More polar solvents were investigated in order to induce the π-stacking effect and, as 
shown, n-butanol led to an impressive 9:1 atropisomer selectivity. 
 
Table 4. The effect of solvent for the atroposelectivity of 69 g by Petersen 
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4.5.4 Auxiliary and protecting group removal towards korupensamine D 
     Accomplishing the first project goal of expanding our groups’ capabilities towards 
atroposelective bond formations with the formation of 67 in 9.8:1 selectivity, an analog of 
the natural product 13 had been achieved.  Previous work suggested that we could easily 
transform korupensamine D analog 67 to 13 in relatively high yields, as performed by 
Huang,
56
 to complete the synthesis of extremely labile cis configured 13 that has been 
shown to epimerize under mild conditions (vide infra). Saponification of the naphthyl unit 
with sodium hydroxide in dry MeOH:THF gave compound 70 in 97% yield (Scheme 28).  
Stereochemical assignments for 70 proved to be inconclusive due to overlapping proton 
signals for the expected nOe correlation of 1-3 hydrogens. In contrast, it is important to note 
that the trans isomer was not observed, indicated by the lack of a nOe correlation for signal 
3-5 (See SI). The known facile base-catalyzed isomerization described above (Scheme 23) 
was not observed, although desilyated 70 (71) was produced after extended reaction times.   
 
 
Scheme 28. Works toward natural product 13 from analog 67 
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   The routine desilylation of 70 proceeded without incedent to afford 71 in 97% yield. 
Stereochemical assignments for 71 were again found to be difficult due to the overlap of the 
N-methyl, position 3, and position 4ax protons, thus the conclusive assignment is not 
certain.  An alternative method that may be employed, involves ruthenium catalyzed 
degradation to the respective chiral amino acids as previously performed for structure 
elucidation.
7,8
  
  The transformation of 71 to 13 using Appel-like reaction conditions followed by LiAlH4 
reduction then global debenzylation was used in the known analogous synthesis of 
korupensamine B 11.
21
  In our hands, despite our best attempts to reproduce the literature 
procedure, we could not obtain 13, but did make 72 in a 3% yield (entry 1, Table 5) with a 
large amount of dimerization, as shown in Figure 12.  The dimerization event occurs from 
the highly electrophilic benzylic alcohol intermediate being transformed into its derived 
halide or mesylate, and then being displaced in an SN2 fashion by the more nucleophilic 
aliphatic alcohol. 
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Table 5. Screening of deoxygenation methods for the formation of 72 
 
 
 
     In search of other means of halogen installation followed by reduction we had turned to 
the tried and true Appel reaction
57
 (entry 2), but this route led largely to dimerized starting 
material, presumably due to the more reactive iodo intermediate (Figure 14).  Disappointed 
that neither the previous deoxygenation conditions nor the Appel reaction had provided the 
desired product 72, we turned to PBr3, well known for its ability to exchange oxygen for 
bromine that could then be removed with LiAlH4.  Several attempts with PBr3 (entry 3) 
through varying the addition rate and temperature routinely led to the degradation products 
BnBr and 71-PO4H as detected by GC-MS by the reaction of the benzylic oxygen and PBr3.   
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Figure 14. Plausible route for the dimerization of 71 
 
     Reviewing the literature for alternative methods en route to 72, the traditional method of 
mesylation followed by mild reduction using LiEt3BH (super hydride) of aliphatic alcohols 
seemed plausible.
58,59
 With this new procedure we set out to obtain a sample of 72 (entry 4) 
although our first attempt led only to dimerized starting material with a viscous white 
precipitate hypothesized to be polymerized THF.  The use of THF for the installation of the 
mesylate should be avoided, with efforts to perform the reduction in the same pot as we had 
done. Literature methods called for initial mesylation in DCM, filtration, and solvent 
evaporation then running the reduction in THF with superhydride. We followed the 
literature procedure closely using DCM and then THF (entries 5 and 6) at 0.1 and 0.05 
molarities, respectively, and the exchange of LiAlH4 for LiEt3BH.  The reaction ran at 20 
fold less concentration (entry 6) afforded 72 in only 14% yield, the 
1
H NMR was nearly 
identical to an intermediate of 13-ent  by the works  Hoye,
13
 and was quickly moved to the 
next step due to its known stability issues.   
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     From 72, the last transformation!, debenzylation with H2 over Pd/C catalyst in EtOH led 
disappointingly not to 13, but to a new product 13-epi in 42% yield which is the product we 
had feared would surface from the unstable cis conformation of the 1,3-dimethyl’s of 13. 
The product was assigned from the characteristic relationship of the C1 and C3 protons for 
the cis vs trans configurations of the korupensamine series.
12
 Chemical shift values for the 
cis C1 and C3 protons are always are at 3.8-3.7 and 2.4-2.3 ppm, respectively, whereas the 
trans position of the C1 and C3 protons are also all within a close range for the entire 
korupensamine series at 4.5-4.3 and 3.3-2.9 ppm, respectively. As the new compound 
obtained 13-epi has the characteristic chemical shifts of the trans isomer of 4.26 and 2.88 
ppm for C1 and C3, respectively, versus the relative shifts of cis 13.
12
 The accurate atomic 
mass measurement indicated a mass precisely like that of compound 13 giving further 
evidence that 13-epi was produced 
 
     In conclusion, the epimerization event as outlined in Scheme 23 very likely occurred at 
some point during the last few transformations of saponification (basic), or deoxygenation 
(in situ acid formation), although the exact timing could not be confirmed due to 
inconclusive 2D NMR analysis. In order to circumvent this issue in the future one could 
perform the previously mentioned ruthenium catalyzed oxidative degradation of the 
tetrahydroisoquinoline ring to its respective chiral alanine and 3-aminobutyric acid residues 
as performed for prior structure elucidation of closely related structures.
7,8
  
 
     Noted from previous total syntheses of cis-naphthyl-tetrahydroisoquinoline alkaloids 
bearing both hydrogens in the axial positions, the last step is almost always a facile, mild 
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cross coupling, global debenzylation, or N-methylation reaction providing the desired 
material albeit, generally in racemic form, thus limiting the exposure of the unstable cis 
isomer to additional reaction sequences.
13,60-61 
  Our use of the chiral pi-stacking unit and 
silyl ether with their need to removal followed by deoxygenation may not be amenable to 
the synthesis of 13 due to its inherent instability (vide supra). 
 
      An alternative strategy to access authentic 13 would be to deoxygenate the naphthylic 
oxygen prior to coupling, thus enabling a much more facile deoxygenation of the 
tetrahydroisoquinoline ring by preventing the observed dimerization. A potential drawback 
of this alternative could be decreased atroposelectivity, but would still enable the 
investigation of our π-stacking atroposelective cross coupling methodology. While the 
option of deoxygenating in a step wise fashion may increase yields, the end result might still 
depend on instability issues as we had discovered. Thus these cis compounds are amenable 
to our methodology, as evidenced by the high atroposelectivity of 9:8:1, yet are plagued by 
their intrinsic unstable configuration as still preventing the total synthesis of natural 
korupensamine D 13. 
 
 
 
 
 
  178 
4.6 Experimental and Compound Data 
General Information 
All reactions were carried out under an argon atmosphere with dry solvents using 
anhydrous conditions unless otherwise stated. THF, diethyl ether, and DCM were all 
purified via Innovative Technologies Pure-Sol SPS-400-5 purification system. Et3N, POCl3, 
MeCN, 2,6 Ltd was distilled prior to use. MeOH, EtOH, acetone, and n-BuOH were 
purchased in anhydrous form purged with argon for ~30 min. and stored over activated 4Å 
molecular sieves. 
Reagents were purchased and used without further purification. Thin layer 
chromatography was performed using EM Science 60-F254 (250 nm) silica gel precoated 
plates; EM Science cat. No. 5714-3. Flash chromatography was performed using 200–425 
mesh silica gel (Type 60A Grade 633) available from Fisher Scientific. HRMS spectra were 
recorded at the UCSB mass spectrometry facility by Dr. James Pavlovich using a Micromass 
VG 70e magnetic sector by standard methods on a PE Sciex Qstar quadrapole/time-of-flight 
tandem mass spectrometer. NMR spectra were recorded using Varian Inova spectrometers 
either at 500, or 600 MHz for 1H, and 125, or 150 MHz for 13C and 2-D experiments in 
CDCl3 or CD3OD. Chemical shifts are referenced to chloroform solvent residual peaks (1H 
= 7.26 ppm, 13C = 77.23 ppm). Optical rotations were measured on a Perkin Elmer model 
341 polarimeter 
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(S)-triisopropyl(oxiran-2-ylmethoxy)silane (44, JF-004-155) To a dry 500 mL round 
bottom flask charged with magnetic a stir bar and argon, added (R)-gycidol (11.11 g, 9.92 
mL, 150 mmol, 1 equiv.), and DCM (200 mL, 0.75M) then cooled to -5°C. Added DMAP 
(21.99 g, 180 mmol, 1.20 equiv.) and ImH (11.23 g, 165 mmol, 1.10 equiv.) in one portion, 
followed by dropwise addition of TIPS-Cl (34.70 g, 38.52 mL, 180 mmol, 1.20 equiv.) via 
syringe at -5°C. The reaction was allowed to stir and warm to RT overnight (14h). Solid 
residue was removed via filtration then diluted with DCM (200 mL) and washed with sat. 
NH4Cl (2 x 100 mL), brine (1 x 100 mL), dried over Na2SO4 and concentrated in vacuuo.  
Crude product was purified via flash chromatography with silica gel (50 x 150 mm) eluted 
with 5:95 EtOAc:Hex (Rf = 0.43, 1:9 EtOAc:Hex, developed with KMnO4) to yield 26.26 g, 
76 % 44 a clear oil. 
1
H NMR (500 MHz, CDCl3) δ 3.91 (dd, J = 11.6, 3.2 Hz, 1H), 3.75 (dd, 
J = 11.7, 4.7 Hz, 1H), 3.11 (m, 1H), 2.77 (dd, J = 5.1, 4.2 Hz, 1H), 2.66 (dd, J = 5.2, 2.7 Hz, 
1H), and 1.07 (m, 21H). 
13
C NMR (125 MHz, CDCl3) δ 63.92, 52.55, 44.43, 17.89, and 
11.94. [α]23D=-3.62° ; CHCl3. HREIMS calc’d for C12H26O2Si: 230.1702, Found: 187.1154 
[M–C3H7]
+
. Compound data matches that of previously reported.
47 
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(((5-bromo-1,3-phenylene)bis(oxy))bis(methylene))dibenzene (43, JF-004-156) To a dry 
250 mL three neck round bottom flask fitted with water condenser was charged with 
magnetic stir bar and argon, added NaH (50 wt. %, 3.92 g, 81.6 mmol, 2.33 equiv.), and 
suspended in NMP (44 mL, 1.85M) then cooled to 0°C (Note: formed pink suspension). 
Added a solution of BnOH (8.71 g, 8.34 mL, 80.5 mmol, 2.30 equiv.) in NMP (27mL, 
3.0M) drop wise at 0°C then removed the ice bath and stirred at RT for 1 h (Note: reaction 
turned dark purple) Cooled to 0°C and added a solution of 42 (6.75 g, 4.03 mL, 35 mmol, 
1.00 eqiuv.) in NMP (17 mL, 2.0M) drop wise at 0°C then removed the ice bath and heated 
to 100°C for 2 h (Note: reaction now dark green). Once cooled to room temperature the 
reaction was partitioned into 1:1 Et2O:H2O (250 mL) and separated. Extracted with Et2O (5 
x 100 mL), the combined organic extracts were washed with 10 wt% KOH:H2O (2 x 200 
mL), brine (1 x 100 mL), dried over MgSO4, and concentrated invacuuo to afford a yellow 
solid. Crude product was purified via flash chromatography with silica gel (50 x 175 mm) 
eluted with 3:97 EtOAc:Hex (Rf = 0.33, 3:97 EtOAc:Hex) to yield 12.27 g, 95 %  43 a white 
crystalline solid. 
1
H NMR (500 MHz, CDCl3) δ 7.43-7.32 (m, 10H), 6.78 (d, J = 2.1 Hz, 
2H), 6.55 (t, J = 2.1 Hz, 1H), and 5.01 (s, 4H). 
13
C NMR (125 MHz, CDCl3) δ 160.37, 
136.31, 128.64, 128.16, 127.52, 122.93, 111.06, 101.36, and 70.30. HREIMS calc’d for 
C20H17O2Br: 368.0412, Found: 368.0408 
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(S)-1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-ol (45, JF-004-167) 
To a dry 500 mL three neck round bottom flask fitted with water condenser was charged 
with a magnetic stir bar and argon, added Mg turnings (18.23 g, 750 mmol, 7.50 equiv) then 
flamed dried under high vac and backfilled with argon thrice. Dissolved 43 (55.39 g, 150 
mmol, 1.50 equiv.) in THF (200 mL, 0.75M) and added approximately 10 % of the solution 
to the Mg turnings via addition funnel followed by ethylene bromide (1.30 mL, 2.82 g, 15 
mmol, 0.02 equiv.) (Note solution began to reflux without applied heat) then the rest of the 
aryl bromide solution was added dropwise at a rate (~30 min.) to maintain reflux with 
additional heat. Upon complete addition of the aryl bromide the solution was heated to 
reflux for 1.5 h then cooled to room temperature. To a second flask, a 1 L mL round bottom 
flask charged with magnetic stir bar and argon suspended CuI (2.38 g, 12.5 mmol, 0.13 
equiv.) in THF (30 mL) at -40°C then added the Grignard solution and allowed to stir for 
approximately 15 min followed by dropwise addition of 44 in THF (60 mL). The reaction 
was stirred at -40°C until complete as judged by TLC (2.25 h). Diluted the reaction with 
Et2O (250 mL) and washed with sat. NH4Cl (3 x 200 mL) then extracted the aqueous with 
Et2O (2 x 100 mL). The combined organics were washed with sat. NaHCO3 (2 x 150 mL) 
and brine (2 x 100mL), dried over MgSO4 and concentrated in vaccuo to afford a yellow oil.  
The crude product was purified via flash chromatography with silica gel (75 x 250 mm) 
eluted with 0 to 20% Et2O:Hex (Rf = 0.16, 1:9 Et2O:Hex) to yield 47.16 g, 91 % 45 a clear 
oil. 
1
H NMR (500 MHz, CDCl3) δ 7.44-7.37 (m, 8H). 7.35-7.31 (m, 2H), 6.52 (s, 2H), 6.51 
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(d, J = 1.7 Hz, 1H), 5.03 (s, 4H), 3.94-3.88 (m, 1H), 3.71 (dd, J = 9.8, 4.0 Hz, 1H), 3.62 (dd, 
J = 9.8, 6.6 Hz, 1H), 2.75 (s, 1H), 2.74 (s, 1H), 2.36 (br s, 1H), and 1.16-1.03 (m, 21H) 
13
C 
NMR (125 MHz, CDCl3) δ 159.98, 140.70, 136.95, 128.55, 127.94, 127.52, 108.49, 100.11, 
72.76, 70.02, 66.64, 39.98, 17.99, and 11.94. [α]20D=+1.67° ; CHCl3. HREIMS calc’d for 
C32H44O4Si: 520.3009, Found: 520.3016 
 
 
(R)-2-(1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-yl)isoindoline-
1,3-dione (46, JF-004-169) To a dry 2 L round bottom flask charged with magnetic stir bar 
and argon, dissolved PPh3 (25.97 g, 99 mmol, 1.50 equiv.) and phthalimide (12.14 g, 82.5 
mmol, 1.25 equiv.) in THF (660 mL, 0.1M) and cooled to 0°C. Added DIAD (19.49 mL, 
20.02 g, 99mmol, 1.50 equiv.) dropwise and stirred for 15 min (Note: formed a bright 
yellow suspension) then added 45 (34.37 g, 66 mmol, 1.0 equiv.) in THF (100 mL) and 
allowed to warm to room temperature and stir overnight until complete at judged by TLC 
(10.5 h). Added 1:1 celite:silica gel (75 g) and removed solvent invaccuo. Crude product 
was purified via flash chromatography with silica gel (75 x 250 mm) eluted with 5:95 to 1:9 
EtOAc:Hex (Rf = 0.22, 1:9 EtOAc:Hex developed with 2,4 dinitrophenyl hydrazine) to yield 
30.52 g, 71 %, 46 a faint yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.78 (dd, J = 5.3, 3.2 Hz, 
2H), 7.67 (dd, J =, 5.5, 3.0 Hz, 2H), 7.37-7.28 (m, 10H), 6.46 (d, J = 2.0 Hz, 2H), 6.40 (t, J 
= 2.1 Hz, 1H), 4.93 (d, J = 11.6 Hz, 2H), 4.89 (d, J = 11.6 Hz, 2H) 4.73-4.68 (m, 1H) 4.19 
(dd, J = 9.7, 8.7 Hz, 1H), 4.01 (dd, J = 9.8, 6.2 Hz, 1H), 3.28 (dd, J = 14.0, 10.5 Hz, 1H), 
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3.11 (dd, J = 14.1, 5.6 Hz, 1H), and 1.06-0.93 (m, 21H). 
13
C NMR (125 MHz, CDCl3) δ 
168.55, 159.92, 140.28, 136.90, 133.72, 131.91, 128.49, 127.87, 127.48, 123.00, 107.94, 
100.61, 69.97, 62.98, 54.79, 34.76, 17.85, and 11.86. [α]20D=+67.50°; CHCl3.HREIMS 
calc’d for C40H47NO5Si: 649.3224, Found:  649.3218 
 
 
(R)-1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-amine (47, JF-004-
170) To a 1 L round bottom flask fitted with reflux condenser and charged with a magnetic 
stir bar dissolved 46 (30.06 g, 46.25 mmol, 1.0 equiv.) in EtOH (460 mL, 0.1M) followed by 
hydrazine hydrate (115.74 g, 112.48 mL, 2.31 mol, 50 equiv.) and heated to reflux until 
complete as judged by TLC (1 h, Rf = 0.06, 1:9 EtOAc:Hex). Cooled to ~ 0°C and filtered 
the crystallized phenylhydrazide then concentrated in vacuo.  Dissolved the resulting oil in 
Et2O (250 mL), added water (200 mL) and extracted with Et2O (5 x 250 mL). Washed 
combined organics with 2N NaOH (2 x 400 mL), brine (2 x 150 mL), dried over MgSO4 and 
concentrated in vacuo to afford a yellow oil. The crude oil was passed over a pad of silica 
gel (75 x 75mm) and eluted with 1:1 EtOAc:Hex to yield 27.24 g, 95%, 47 a faint yellow 
oil. 
1
H NMR (500 MHz, CDCl3) δ 7.44-7.36 (m, 8H), 7.35-7.31 (m, 2H), 6.51-6.49 (m, 1H), 
6.49 (d, J = 1.9 Hz, 2H), 5.02 (s, 4H), 3.69 (dd, J = 9.6, 4.6 Hz, 1H), 3.58 (dd, 9.6, 6.5 Hz, 
1H), 3.17-3.11 (m, 1H), 2.79 (dd, J = 13.3, 5.2 Hz, 1H), 2.51 (dd, J = 13.2, 8.5 Hz, 1H), 1.81 
(br s, 2H), and 1.16-1.01 (m, 21H) 
13
C NMR (125 MHz, CDCl3) δ 159.99, 141.51, 136.94, 
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128.55, 127.93, 127.50, 108.48, 100.09, 70.03, 67.67, 54.53, 40.56, 33.02, 18.045and 11.98. 
[α]20D=+1.90°;  HREIMS calc’d for C32H45NO3Si: 519.3169, Found:  476.2617 [M–C3H7]
+
. 
 
 
 
(R)-N-(1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-yl)acetamide 
(48, JF-004-172) To a 500 mL round bottom flask charged with argon and a magnetic stir 
bar dissolved 47 (22.35 g, 43 mmol, 1.0 equiv.) in DCM (287 mL, 0.15M) followed by Et3N 
(27.19 g, 37.61 mL, 269 mmol, 6.25 equiv.), DMAP (0.534 g, 4.3 mmol, 0.10 equiv.), and 
~1 g 4Å molecular sieves and stirred for ~ 15 min.  Then added Ac2O (43.90 g, 40.65 mL, 
430 mmol, 10 equiv.) dropwise and allowed to stir at room temperature until complete as 
judged by TLC (66 h). Diluted with water (100 mL) and separated, extracted with Et2O (3 x 
100 mL) to the combined organic extracts wshed with sat. NH4Cl (1 x 100 mL), sat. 
NaHCO3 (2 x 100 mL), brine (100 mL), dried MgSO4 and concentrated in vacuo.  Passed 
over a pad of silica (50 50 mm) eluted with 1:1 EtOAc:Hex (Rf = 0.19, 2:8 EtOAc:Hex) to 
yield 23.02 g, 95%, 48 a faint yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.43-7.36 (m, 8H), 
7.34-7.30 (m, 2H), 6.51 (d, J = 2.1 Hz, 2H), 6.49 (t, J = 2.1 Hz, 1H), 5.76 (d, J = 8.3 Hz, 
1H), 5.01 (s, 4H), 4.26-4.19 (m, 1H), 3.66 (dd, J = 10.2, 3.2 Hz, 1H), 3.64 (dd, J = 10.2, 4.3 
Hz, 1H,  2.86 (dd, J = 13.4, 6.3 Hz, 1H), 2.82 (dd, J = 13.4, 8.3 Hz, 1H), 1.95 (s, 3H), and 
1.15-1.03 (m, 21H). 
13
C NMR (125 MHz, CDCl3) δ 169.36, 159.98, 140.43, 136.93, 128.53, 
127.91, 127.47, 108.51, 100.34, 69.98, 63.04, 51.54, 37.26, 23.45, 18.02, and 11.95. 
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[α]20D=+17.45°, CHCl3. HREIMS calc’d for C34H47NO4Si: 561.3274, Found:  518.2728 [M–
C3H7]
+
. 
 
 
 
(R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-di- 
hydroisoquinoline (49, JF-004-180) To a 500 mL three neck round bottom flask charged 
with argon, magnetic stir bar and water condensor dissolved 48 (11.24 g, 20 mmol, 1.0 
equiv.) in MeCN (200 mL, 1.0M) followed by 2, 6-lutidine (5.36 g, 5.79 mL, 50 mmol, 2.5 
equiv.), and drop wise addition of freshly distilled POCl3 (6.13 g, 3.73 mL, 40 mmol, 2.0 
equiv.), and heated at 80°C until complete as judged by TLC (2.75 h). Cooled to room 
temperature then poured into a seperatory funnel with Et2O (250 mL), water (50 mL), and 
Et3N (25 mL) then quickly shook and separated. Quickly extracted the aqueous with Et2O (2 
x 100 mL), to the combined organics washed with 1N NaOH (2 x 100 mL) and brine (1 x 
100 mL),  dried MgSO4 and concentrated in vacuo to afford a dark orange oil.  Crude 
product was purified via flash chromatography with silica gel (90 x 225 mm) eluted with 
20:80:1 EtOAc:Hex:Et3N, (Rf = 0.08, 2:8 EtOAc:Hex, Product appears blue with long wave 
UV) to yield 9.54 g, 88 %, 49 a viscous yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.45-7.34 
(m, 10H), 6.52 (d, J = 2.2 Hz, 1H), 6.50 (d, J = 2.1 Hz, 1H), 5.08 (d, J = 3.9 Hz, 2H), 5.07 
(d, J = 2.6 Hz, 2H), 4.19 (dd, J = 9.6, 4.6 Hz, 1H), 3.73 (t, J = 9.8 Hz, 1H), 3.38 (m, 1H), 
2.93 (dd, J = 15.7, 4.4 Hz, 1H), 2.43 (s, 3H), 2.39 (d, J = 14.4 Hz, 1H), and 1.10-1.02 (m, 
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21H). 
13
C NMR (125 MHz, CDCl3) δ 142.36, 136.41, 136.23, 128.67, 128.63, 128.20, 
128.16, 127.65, 127.55, 105.84, 103.73, 99.18, 70.77, 70.17, 67.58, 57.96, 31.07, 27.79, 
18.05, and 11.96. [α]20D=-1.63°; CHCl3. HREIMS calc’d for C34H45NO3Si: 543.3169, 
Found:  543.3145. 
 
(R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-di- 
hydroisoquinoline (49b, JF-004-188) Followed the procedure for formation of 49. Used 48 
(10.11 g, 18 mmol, 1.0 equiv.), MeCN (180 mL, 1.0M) followed by 2, 6-lutidine (4.82g, 
5.21 mL, 45 mmol, 2.5 equiv.), and POCl3 (5.52 g, 3.36 mL, 36 mmol, 2.0 equiv.) to yield 
an additional 9.06 g, 93%, 49 labeled as 49b a viscous yellow oil. 
1
H NMR (500 MHz, 
CDCl3) δ 7.45-7.34 (m, 10H), 6.52 (d, J = 2.2 Hz, 1H), 6.50 (d, J = 2.1 Hz, 1H), 5.08 (d, J = 
3.9 Hz, 2H), 5.07 (d, J = 2.6 Hz, 2H), 4.19 (dd, J = 9.6, 4.6 Hz, 1H), 3.73 (t, J = 9.8 Hz, 1H), 
3.38 (m, 1H), 2.93 (dd, J = 15.7, 4.4 Hz, 1H), 2.43 (s, 3H), 2.39 (d, J = 14.4 Hz, 1H), and 
1.10-1.02 (m, 21H). 
13
C NMR (500 MHz, CDCl3) δ 142.36, 136.41, 136.23, 128.67, 128.63, 
128.20, 128.16, 127.65, 127.55, 105.84, 103.73, 99.18, 70.77, 70.17, 67.58, 57.96, 31.07, 
27.79, 18.05, and 11.96. [α]20D=-1.44°; CHCl3. Compound data matched that of previously 
synthesized. 
 
 
(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline (50, JF-004-185) To a 1L round bottom flask charged with a stir 
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bar, dissolved 49 (8.16 g, 15 mmol, 1.0 equiv.) in MeOH (500 mL, 0.03M) and cooled to -
15 °C.  Added NaBH4 (1.13 g, 30 mmol, 2.0 equiv.) in one portion and allowed to stir at -
15°C until complete as judged by TLC (2 h). Added basic Al2O3 (~20 g ) and removed 
solvent in vacuuo. Crude product was purified via flash chromatography with silica gel (90 x 
250 mm) eluted with 10:90:1 EtOAc:Hex:Et3N, (Rf = 0.39, 2:8 EtOAc:Hex) to yield 7.68 g, 
94 %, 50 labeled as 50a 13:1 cis:trans, of a faint viscous yellow oil. 
1
H NMR (500 MHz, 
CDCl3) δ 7.45-7.37 (m, 8H), 7.35-7.31 (m, 2H), 6.48 (d, J = 2.2 Hz, 1H), 6.38 (d, J = 2.1 
Hz, 1H), 5.04 (d, J = 7.3 Hz, 2H), 5.03 (d, J = 7.0 Hz, 2H), 4.37 (q, J = 6.1 Hz, 1H), 3.85 
(dd, J = 9.6, 4.4 Hz, 1H), 3.79 (dd, J = 9.6, 5.5 Hz, 1H), 2.96-2.91 (m, 1H), 2.72 (dd, J = 
15.2, 2.5 Hz, 1H) 2.58 (dd, J = 15.2, 11.2 Hz, 1H), 1.95 (br s, 1H), 1.51 (d, 6.27 Hz), and 
1.20-1.06 (m, 21H). 
13
C NMR (500 MHz, CDCl3) δ 157.64, 157.05, 137.99, 137.11, 137.08, 
128.58, 128.53, 127.95, 127.77, 127.57, 127.13, 127.00, 106.15, 98.62, 70.10, 69.94, 67.11, 
54.36, 49.03, 33.95, 23.20, 18.05, and 11.98. 
 
(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline (50b, JF-004-190) Followed the procedure for 50. Used 49b (8.97 
g, 16.5 mmol, 1.0 equiv.), MeOH (550 mL, 0.03M), and NaBH4 (1.25 g, 33 mmol, 2.0 
equiv) to yield an additional 7.83 g, 87 %, 50 labeled as 50b 13:1 cis:trans, of a faint 
viscous yellow oil. Compound data matches that of previously synthesized 50a. 
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 (1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline (50, JF-004-191) Combined 50a and 50b (15.51 g) in effort to 
increase purity via flash chromatography with silica gel (90 x 250 mm) eluted with 5:95:1 
EtOAc:Hex:Et3N, (Rf = 0.39, 2:8 EtOAc:Hex) to recover 12.193 g, 79 %, of 50 in a 14:1 
cis:trans, of a faint viscous yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.45-7.37 (m, 8H), 
7.35-7.31 (m, 2H), 6.48 (d, J = 2.2 Hz, 1H), 6.38 (d, J = 2.1 Hz, 1H), 5.04 (d, J = 7.2 Hz, 
2H), 5.03 (d, J = 7.0Hz, 2H), 4.37 (q, J = 6.1 Hz, 1H), 3.85 (dd, J = 9.6, 4.4 Hz, 1H), 3.79 
(dd, J = 9.6, 5.5 Hz, 1H), 2.96-2.91 (m, 1H), 2.72 (dd, J = 15.2, 2.5 Hz, 1H) 2.58 (dd, J = 
15.2, 11.2 Hz, 1H), 1.95 (br s, 1H), 1.51 (d, 6.3 Hz, 3H), and 1.20-1.06 (m, 21H). 
13
C NMR 
(125 MHz, CDCl3) δ 157.64, 157.05, 137.99, 137.11, 137.08, 128.58, 128.53, 127.95, 
127.77, 127.57, 127.13, 127.00, 106.15, 98.62, 70.10, 69.94, 67.11, 54.36, 49.03, 33.95, 
23.20, 18.05, and 11.98. [α]20D= +45.24°; CHCl3. HRCIMS calc’d for C34H47NO3Si: 
545.3325, Found: 546.405 [M+H]
+
. THIQ stereochemistry determined by 
1
H, 
13
C, HMQC, 
and 2-D Noesy analysis. 
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Key nOe interactions of 50 
 
 
 
 
Ethyl-(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-
dihydroisoquinoline-2 (1H)-carboxylate (51, JF-004-192) To a 500 mL round bottom 
flask charged with argon and magnetic stir bar dissolved 50 (11.05 g, 20.25 mmol, 1.0 
equiv.) in DCM (203 mL, 0.1M) followed by Et3N (8.81 g, 12.14 mL, 87 mmol, 4.3 equiv.), 
then cooled to 0°C followed by drop wise addition of ethyl chloroformate (4.18 g, 3.68 mL, 
38.5 mmol, 1.9 equiv.), removed ice bath and stirred at room temperature until complete as 
judged by TLC (2.25 h). Washed with H2O (1 x 50 mL) and brine (1 x 50 mL),  dried over 
Na2SO4 and concentrated in vacuo to afford a yellow oil.  Crude product was purified via 
  190 
flash chromatography with silica gel (70 x 225 mm) eluted with 4:95:1 EtOAc:Hex:Et3N, 
(Rf = 0.41, 1:9 EtOAc:Hex) to yield 9.883 g, 79 %, 51 a clear viscous oil. 
1
H NMR (500 
MHz, CDCl3) δ 7.44-7.37 (m, 8H), 7.36-7.32 (m, 2H), 6.48 (d, J = 2.2 Hz, 1H), 6.43 (s, 1H), 
5.62 (d, J = 49 Hz, 1H),  5.07 (s , 2H), 5.03 (s, 2H), 4.32 (br s, 1H), 4.18 (dd, J = 15.8, 8.9 
Hz, 2H), 3.88 (s, 1H), 3.77 (s, 1H), 3.12 (d, J = 4.8 Hz, 1H), 2.99 (dd, J = 18.3, 14.1 Hz, 
1H), 1.43 (d, J = 6.8 Hz, 3H), 1.29 (t, J = 6.5, 3H), and 1.15-1.06 (m, 21H). 
13
C NMR (125 
MHz, CDCl3) δ 158.36, 155.94, 155.37, 137.01, 135.41, 134.70, 128.60, 128.00, 127.79, 
127.55, 127.03, 120.82, 105.67, 98.56, 70.17, 69.98, 65.81, 64.60, 61.21, 52.64, 45.74, 
30.25, 22.08, 18.05, 14.73, and 12.00. [α]20D= +12.26°; CHCl3. HREIMS calc’d for 
C37H51NO5Si: 617.3537, Found:  574.2998 [M–C3H7]
+
.  
 
 
(1R,3R)-6,8-bis(benzyloxy)-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline (52, JF-004-193) To a 1 L round bottom flask charged with argon, 
magnetic stir bar, and reflux condenser, suspended LiAlH4 (2.35 g, 62 mmol, 5.1 equiv.) in 
Et2O (150 mL) then dissolved 51 (7.49 g, 12 mmol, 1.0 equiv.) in Et2O (150 mL), 0.04M 
global concentration and heated to relfux until complete as judged by TLC (5.25 h). Cooled 
to 0°C and slowly quenched with H2O (6 mL), 15 wt% NaOH:H2O (8 mL), then additional 
H2O (100 mL), filtered off salts, washed with brine (50 mL), dried over MgSO4, absorbed 
onto basic Al2O3 (~20 g) and concentrated in vacuo. Crude product was purified via flash 
chromatography with silica gel (90 x 200 mm) eluted with 5:95:1 EtOAc:Hex:Et3N, (Rf = 
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0.18, 1:9 EtOAc:Hex) to yield 6.03 g, 88 %, 52 a clear viscous oil. 
1
H NMR (500 MHz, 
CDCl3) δ 7.46-7.37 (m, 8H), 7.36-7.31 (m, 2H), 6.48 (d, J = 1.7 Hz, 1H), 6.43 (d, J = 1.3 
Hz, 1H), 5.04 (m, 4H), 4.00 (dd, J = 5.7, 3.3 Hz, 1H), 3.91 (dd, J = 6.0, 6.4 Hz, 1H), 3.60 (t, 
J = 8.3 Hz, 1H), 2.94 (dd, 12.2, 3.2 Hz, 1H), 2.67 (dd, J = 12.3, 3.8 Hz, 1H), 2.61 (br s / m, 
1H), 2.50 (s, 3H), 1.35 (d, J = 5.8 Hz, 3H), and 1.18-1.03 (m, 21H). 
13
C NMR (125 MHz, 
CDCl3) δ 157.85, 155.94. 137.18, 137.12, 128.56, 128.54, 127.95, 127.79, 127.63, 127.16, 
105.42, 98.37, 70.14, 69.93, 67.01, 62.21, 55.36, 43.43, 32.53, 22.70, 18.06, and 11.98. 
[α]20D= +27.34°; CHCl3. HREIMS calc’d for C35H49NO3Si: 559.3482, Found:  516.2944 
[M–C3H7]
+
. THIQ stereochemistry determined by 
1
H, 
13
C, HMQC, and 2-D Noesy analysis. 
Key nOe interactions of 52 
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(1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-
1,2,3,4-tetrahydroisoquinoline (53, JF-004-196) To a 150 mL round bottom flask charged 
with a stir bar added I2 (3.02 g, 11.90 mmol, 6.60 equiv.) and Ag2SO4 (3.62 g, 11.61 mmol, 
6.45 equiv.), dissolved in EtOH (18 mL) then wrapped in Al foil. Added 52 in EtOH (18 
mL), 0.05M global concentration dropwise, stirred at room temperature until complete as 
judged by TLC (4.75h). Filtered to remove salts, absorbed onto basic Al2O3 (~10 g) and 
concentrated in vacuo. Crude product was purified via flash chromatography with silica gel 
(40 x 150 mm) eluted with 1:9:1 EtOAc:Hex:Et3N, (Rf = 0.41, 1:9 EtOAc:Hex) to yield 2.43 
g, 66 %, 53 a foamy white solid. 
1
H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.5 Hz, 2H), 
7.41-7.32 (m, 8H), 6.43 (s, 1H), 5.09 (s, 2H), 5.03 (d, J = 3.7 Hz, 2H), 4.01 (d, J = 7.7 Hz, 
1H), 3.91 (d, J = 6.3 Hz, 1H), 3.62 (t, J = 7.3 Hz, 1H), 3.31 (dd, 12.2, 2.4 Hz, 1H), 2.60 (d, J 
= 7.9 Hz, 1H), 2.55 (br s / m, 1H), 2.48 (s, 3H), 1.31 (d, J = 5.9 Hz, 3H), and 1.17-1.08 (m, 
21H). 
13
C NMR (125 MHz, CDCl3) δ
 155.95, 155.84, 140.13, 136.80, 136.76, 128.64, 
128.53, 127.98, 127.83, 127.11, 127.07, 97.27, 83.41, 71.35, 70.26, 66.82, 62.58, 55.59, 
43.24, 37.68, 22.70, 18.10, and 12.01. [α]20D= +33.01°; CHCl3. HRCIMS calc’d for 
C35H48NO3SiI: 685.2448, Found:  686.2522 [M+H]
+
. THIQ regio and stereochemistry 
determined by 
1
H, 
13
C, HMQC, and 2-D Noesy analysis. 
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Key nOe interactions of 53 
 
 
 
 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-
yl)methanol (54, JF-004-198) To a 25 mL round bottom flask charged with a stir bar 
dissolved 53 (1.71 g, 2.50 mmol, 1.0 equiv.) in THF (7.5 mL, 0.2M), cooled to 0°C, the 
added TBAF (0.91 g, 3.25 mmol, 1.30 equiv.)  in THF (3.25 mL, 1.0M) and stirred at room 
temperature until complete as judged by TLC (3 h). Diluted with EtOAc (150 mL), washed 
with sat. NaHCO3 (2 x 25 mL) and brine (1 x 25 mL). Dried over MgSO4, absorbed onto 
basic Al2O3 (~5 g) and concentrated in vacuo. Crude product was purified via flash 
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chromatography with silica gel (70 x 200 mm) eluted with 2 to 5% MeOH:DCM with 1% 
Et3N (Rf = 0.09, 2:98 MeOH:DCM) to yield 1.16 g, 87 %, 54 a foamy white solid. 
1
H NMR 
(500 MHz, CDCl3) δ 7.49 (d, J = 7.5 Hz, 2H), 7.42-7.31 (m, 8H), 6.45 (s, 1H), 5.09 (s, 2H), 
5.04 (s, 2H), 4.04 (q, J = 6.8 Hz, 1H), 3.78 (dd, J = 10.6, 4.2 Hz, 1H), 3.50 (dd, J = 10.7, 3.2 
Hz, 1H), 3.05 (dd, J =  16.2, 4.5 Hz, 1H), 2.81 (dd, J = 16.2, 10.7 Hz, 1H), 2.59 (m, 2), 2.59 
(m OH),  2.44 (s, 3H), and 1.31 (d, J = 6.8 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 156.11, 
155.72, 139.97, 136.68, 136.64, 128.68, 128.57, 128.07, 127.90, 127.14, 127.07, 123.33, 
97.29, 82.98, 71.36, 70.31, 62.95, 61.21, 54.87, 43.49, 36.40, and 23.77. [α]20D= +33.01°; 
CHCl3. HRCIMS calc’d for C26H28NO3I: 529.1114, Found:  530.1194 [M+H]
+
. THIQ regio 
and stereochemistry determined by 
1
H, 
13
C, HMQC, and 2-D Noesy analysis. 
Key nOe interactions of 54 
 
. 
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((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-
yl)methyl 1-naphthoate (55, JF-004-200) To a 50 mL round bottom flask charged with 
argon and magnetic stir bar, dissolved 54 (635 mg, 1.2 mmol, 1.0 equiv.), DCC (322 mg, 
1.56 mmol, 1.3 equiv.), DMAP (29 mg, 0.24 mmol, 0.2 equiv.), and 1-naphthoic acid (413 
mg, 2.4 mmol, 2.0 equiv.) in DCM (16 mL, 0.08M) then stirred at room temperature until 
complete as judged by TLC (15 h). Diluted with DCM (50 mL), washed with sat. NaHCO3 
(25 mL), brine (25 mL), dried over MgSO4, absorbed onto basic Al2O3 (~5 g) and 
concentrated in vacuo. Crude product was purified via flash chromatography with silica gel 
(25 x 150 mm) eluted with 1:9 EtOAc:Hex with 1% Et3N, (Rf = 0.15, 1:9 EtOAc:Hex) to 
yield 731 mg, 89 %, 55 a white foamy solid. 
1
H NMR (500 MHz, CDCl3) δ 8.99 (d, J = 8.6 
Hz, 1H), 8.27 (dd, J = 7.3, 1.3 Hz, 1H), 8.03 (d, J = 8.2 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 
7.63 (ddd, J = 8.6, 6.8, 1.4 Hz, 1H), 7.56-7.47 (m, 4H), 7.41-7.31 (m, 8H), 6.45 (s, 1H), 5.09 
(s, 2H), 5.05 (d, J = 3.6 Hz, 2H), 4.64 (dd, J = 11.1, 4.1 Hz, 1H), 4.48 (dd, J = 11.1, 6.3 Hz, 
1H), 4.00 (q, J = 6.6 Hz, 1H), 3.29 (dd, J = 15.4, 3.6 Hz, 1H), 2.96-2.88 (m, 1H), 2.84 (dd, J 
= 15.4, 9.8 Hz, 1H), 2.58 (s, 3H), and 1.37 (d, J = 6.6 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) 
δ 167.52, 156.05, 155.90, 139.17, 136.65, 133.37, 130.36, 128.67, 128.55, 128.50, 128.04, 
127.88, 127.80, 127.12, 127.08, 126.17, 125.99, 124.54, 97.47, 83.16, 71.38, 70.30, 67.33, 
59.24, 55.39, 43.05, 38.04, and 22.73. [α]20D= +37.19°; CHCl3. HREIMS calc’d for 
C37H34NO4I: 683.1533, Found:  684.1631 [M + H]
+
. THIQ regio and stereochemistry 
determined by 
1
H, 
13
C, HMQC, and 2-D Noesy analysis. 
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Key nOe interactions of 55 
 
 
 
 
 
3-benzyloxy benzaldehyde (57, JF-004-153) To a 250mL round bottom flask charged with 
a magnetic stir bar, 3-hydroxybenzaldehyde 56 (30.53 g, 250 mmol, 1.0 equiv.), K2CO3 
(41.46 g, 300 mmol, 1.20 equiv.) and dissolved in acetone (100 mL, 2.5M). Cooled to ~0°C 
and added via syringe benzyl bromide (49.17 g, 34.15 mL, 287.5 mmol, 1.15 equiv.). The 
reaction was allowed to stir and warm to RT overnight (16 h). Solid residue was removed 
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via vacuum filtration and filtrate was concentrated in vacuuo. The resulting oil was 
dissolved in Et2O (500 mL) and washed with 1N NaOH (2 x 200 mL), brine (1 x 100 mL), 
dried over MgSO4, and concentrated. The crude product was purified via recrystallization 
from hot Et2O and cold n-Pentane, the filtrate was concentrated in vacuuo and subjected to 
flash chromatography with silica gel (50 x 150 cm) eluted with 1:9 EtOAc:Hex (Rf = 0.34, 
1:9 EtOAc:Hex) Combined yield from recrystallization and flash chromatography was 51.23 
g, 97 %, 57 a white crystalline solid. 
1
H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H), 7.47 (m, 
5H), 7.40 (m, 2H), 7.35 (m, 1H), 7.26 (m, 1H), and 5.13 (s, 2H). 
13
C NMR (125 MHz, 
CDCl3) δ 192.01, 159.32, 137.84, 136.31, 130.11, 128.67, 128.19, 127.53, 123.65, 122.17, 
113.31, and 70.24. HREIMS calc’d for C14H12O2: 212.0837, Found: 212.0838 
 
 
 
5-(benzyloxy)-2-bromobenzaldehyde (58, JF-004-171) To a 2 L three neck round bottom 
flask charged with a magnetic stir bar, argon, and addition funnel, dissolved 57 (49.88 g, 
235 mmol, 1.0 equiv) in DCM (712 mL, 0.33M) followed by NaOAc (131.08 g, 1.6 mol, 
6.80 equiv.) then cooled to ~0°C. Added Br2 (187.8 g, 60.2 mL, 1.18 mol, 5.0 equiv.) via 
addition funnel over ~ 45 min, then removed ice bath and allowed to stir at room 
temperature for until complete as judged by TLC (5.25 h).  Quenched with ice (~ 0.5 kg) and 
water (0.5 L), added sodium thiosulfate (250 g) and stirred until the bromine color had faded 
then separated. Extracted with DCM (4 x 250 mL), washed with sat. NaHCO3 (2 x 250 mL) 
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and brine (2 x 250 mL), dried over MgSO4 and removed solvent in vaccuo to afford a 
yellow solid. The crude produict was purified via flash chromatography with silica gel (90 x 
225 cm) eluted with 3:97 EtOAc:Hex (Rf = 0.33, 5:95 EtOAc:Hex) to yield 59.26 g, 87 %, 
58 as a white crystalline solid. 
1
H NMR (500 MHz, CDCl3) δ 10.31 (s, 1H), 7.53 (d, J = 8.8 
Hz, 1H), 7.51 (d, J = 3.2 Hz, 1H), 7.44-7.33 (m, 5H), 7.10 (dd, J = 8.8, 3.2 Hz, 1H), and 
5.10 (s, 2H). 
13
C NMR (125 MHz, CDCl3) δ 191.65, 158.37, 135.90, 134.63, 134.01, 
128.69, 128.30, 127.54, 123.69, 118.15, 113.88, and 70.46. HREIMS calc’d for C14H11BrO2: 
289.9942, Found: 289.9944 
 
 
4-(t-butyl) 1-ethyl 2-(diethoxyphosphoryl)succinate (59, JF-004-163) To a dry 1 L round 
bottom flask charged with a stir bar and argon, suspended NaH (55 wt%, 13.2 g, 275 mmol, 
1.10 equiv.) in THF (111 mL) and cooled to 0°C. To a dry 500 mL round bottom flask 
charged with argon, dissolved ethyl 2-(diethoxyphosphoryl)acetate (56.05 g, 49.60 mL, 250 
mmol, 1.00 equiv.) in THF (222 mL) and transferred via cannula to the NaH suspension 
over 30 min then stirred for 1 h at 0°C. To a dry 250 mL round botton flask charged with 
argon dissolved t-butyl bromoacetate (52.42 g, 39.68 mL, 267.5 mmol, 1.07 equiv.) in THF 
(167 mL, 1.6M) and transferred via cannula over 30 min, allowed to stir and warm to room 
temperature until complete as judged by TLC (13 h) (Note: reaction turned cloudy white 
suspension). Quenched reaction with ice / H2O (150 mL) then extracted with EtOAc (5 x 
100 mL), washed with brine (2 x 100 mL), dried over MgSO4 and concentrated in vaccuo to 
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afford a pale yellow oil. Crude product was purified via flash chromatography with silica gel 
(75 x 250 mm) eluted with 1:1 EtOAc:Hex (Rf = 0.22, 1:1 EtOAc:Hex, developed with 
KMnO4) to yield 81.79 g, 97 %, 59 as a clear oil. 
1
H NMR (500 MHz, CDCl3) δ 4.37-3.98 
(m, 6H), 3.37 (ddd, J = 24.0, 11.6, 3.4 Hz, 1H), 2.96 (ddd, J = 17.5, 11.6, 7.1 Hz, 1H), 2.70 
(ddd, J = 17.4, 9.1, 3.4 Hz, 1H), 1.40 (s, 9H), and 1.35-1.22 (m, 9H). 
13
C NMR (125 MHz, 
CDCl3) δ 16.27 (d, JCP = 6.05 Hz), 16.36 (d, JCP = 6.25 Hz), 32.50 (d, JCP = 2.64 Hz), 41.41 
(d, JCP = 131.13 Hz), 61.57, 62.84 (d, JCP = 6.94 Hz), 63.27 (d, JCP = 7.17 Hz), 168.26 (d, 
JCP = 5.52 Hz), and 170.07 (d, JCP = 19.43 Hz). HREIMS calc’d for C14H27O7P: 338.1494, 
Compound data matches that of previously reported.
54 
 
 
4-(t-butyl) 1-ethyl (E)-2-(5-(benzyloxy)-2-bromobenzylidene)succinate (60, JF-004-174) 
To a dry 1 L round bottom flask charged with a stir bar and argon, suspended NaH (50 wt%, 
9.76 g, 203 mmol, 1.07 equiv.) in THF (50 mL) and cooled to 0°C. To a dry 500 mL round 
bottom flask charged with argon, dissolved 59 (68.78 g, 203 mmol, 1.07 equiv.) in THF 
(200 mL, 1M) and transferred via cannula to the NaH suspension over 30 min at 0°C then 
stirred for 6 h at room temperature. (Note: solution turned dark yellow). Recooled to 0°C 
and to a dry 250 mL round bottom flask charged with argon dissolved 58 (55.32 g, 190 
mmol, 1.0 equiv.) in THF (190 mL, 1M) and transferred via cannula over 30 min, allowed to 
stir and warm to room temperature until complete as judged by TLC (13 h) (Note: reaction 
turned dark brown). Reduced reaction volume by ~50% in vacuuo before diluting with Et2O 
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(200 mL), water (300 mL) and separated. Extracted with Et2O (4 x 250 mL), washed with 
sat NaHCO3 (2 x 200 mL), and brine (2 x 200 mL).  Dried over MgSO4 and removed 
solvent in vaccuo to afford a dark brown oil. Crude product was purified via flash 
chromatography with silica gel (90 x 250 mm) eluted with 5:95 EtOAc:Hex (Rf = 0.24, 1:9 
EtOAc:Hex, developed with KMnO4) to yield 33.93 g, 38 %, 60 as a faint yellow oil. 
1
H 
NMR (500 MHz, CDCl3) δ 7.81 (s,1H), 7.48 (d, J = 8.8 Hz, 1H), 7.41-7.34 (m, 5H), 7.04 (d, 
J = 3.0 Hz, 1H), 6.84 (dd, J = 8.8, 3.0 Hz, 1H), 5.01 (s, 2H), 4.30 (q, J = 7.1 Hz, 2H), 3.32 
(s, 2H), 1.46 (s, 9H), and 1.35 (t, J = 7.1 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 170.17, 
166.86, 157.84, 140.53, 136.42, 136.26, 133.40, 128.61, 128.41, 128.15, 127.44, 117.39, 
116.08, 114.63, 81.10, 70.25, 61.18, 35.13, 28.00, and 14.23. HREIMS calc’d for 
C24H27O5Br: 474.1042, Found: 474.1034 
 
 
(E)-4-(5-(benzyloxy)-2-bromophenyl)-3-(ethoxycarbonyl)but-3-enoic acid (61, JF-004-
176) To a 250 mL round bottom flask charged with a stir bar dissolved 60 (33.28 g, 70 
mmol, 1.0 equiv.) in trifluoroacetic acid (106 g, 71 mL, 928 mmol, 13.25 equiv.) then added 
water (7.7 mL,427 mmol, 6.10 equiv.) and stirred at room temperature open to the 
atmosphere until complete as judged by TLC (3h). Removed TFA invaccuo and dissolved 
the resulting oil in DCM (500 mL), washed with H2O (3 x 150 mL) and brine (2 x 150 mL). 
Dried over MgSO4 and concentrated in vaccuo to afford a yellow solid. Crude product was 
purified via flash chromatography with silica gel (90 x 175 mm) eluted with 25:75:1 
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EtOAc:Hex:AcOH (Rf = 0.13, 1:3 EtOAc:Hex) to yield 20.79 g, 71 %, 61 as a white solid. 
1
H NMR (500 MHz, CDCl3) δ 7.85 (s,1H), 7.48 (d, J = 8.8 Hz, 1H), 7.38-7.28 (m, 5H), 6.95 
(d, J = 3.0 Hz, 1H), 6.87 (dd, J =  8.8, 3.0 Hz, 1H), 5.04 (s, 2H), 4.29 (q, J = 7.2 Hz, 2H), 
3.36 (s, 2H), and 1.33 (t, J = 7.1 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 176.46, 166.80, 
157.83, 141.63, 136.19, 135.91, 133.58, 128.65, 128.10, 127.21, 127.13, 117.81, 115.93, 
114.49, 70.18, 61.55, 33.69, and 14.12. HREIMS calc’d for C20H19O5Br: 418.0416, Found: 
418.0412. 
 
 
 
ethyl 5-(benzyloxy)-8-bromo-4-hydroxy-2-naphthoate (62, JF-004-182) To a dry 1 L 
round bottom flask charged with argon, stir bar, and a water condenser dissolved 61 (20.54 
g, 49 mmol, 1.0 equiv.) in acetic anhydride (490 mL, 0.1M) then added KOAc (5.39 g, 54.9 
mmol, 1.12 equiv.).  Heated to and maintained reflux until complete as judged by TLC ( ~15 
min.) (Rf = 0.38, 1:3 EtOAc:Hex). Poured reaction over ice with K2CO3 (200 g) and stirred. 
Extracted with DCM (4 x 250 mL), washed with brine (250 mL) and dried over Na2SO4. 
Removed solvent invaccuo and azeotoped the remaining acetic acid with toluene (4 x 150 
mL) to afford a brown solid. To a dry 2 L round bottom flask charged with argon and a stir 
bar dissolved Na° (19.26 g, 17.1 equiv.) in EtOH (700 mL, 0.07M) followed by slow 
addition of  the intermediate dissolved in EtOH (50 mL) allowed reaction to stir at room 
temperature until complete as judged by TLC (14 h).  The reaction was acidified with 2N 
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HCl (400 mL) and extracted with EtOAc (5 x 250 mL), washed with 2N HCl (2 x 250 mL) 
and brine (250 mL), dried over MgSO4 and concentrated in vacuuo to afford a brown solid. 
Crude product was purified via flash chromatography with silica gel (90 x 225 mm) eluted 
with 15:85 EtOAc:Hex:AcOH (Rf = 0.46, 1:3 EtOAc:Hex) to yield 14.15 g, 71 %, 62 as an 
off white solid. 
1
H NMR (500 MHz, CDCl3) δ 9.50 (s, 1H), 8.44 (d, J = 1.5 Hz, 1H), 7.66 (d, 
J = 8.3 Hz, 1H), 7.51-7.40 (m, 6H), 6.83 (d, J = 8.4 Hz, 1H), 5.28 (s, 2H), 4.44 (q, J = 7.1 
Hz, 2H), and 1.44 (t, J = 7.1 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 166.17, 15.08, 154.90, 
134.45, 133.96, 130.83, 130.18, 129.1, 128.03, 120.89, 118.26, 116.52, 111.19, 107.71, 
72.17, 61.33, and 14.33. HREIMS calc’d for C20H17O4Br 400.0310, Found: 400.0286 
 
 
 
ethyl 5-(benzyloxy)-8-bromo-4-methoxy-2-naphthoate (63, JF-004-189) To a 500 mL 
round bottom flask charged with a stir bar and reflux condenser dissolved 62 (14.04 g, 35 
mmol, 1.0 equiv.) in acetone (233 mL, 0.15M) followed by addition of K2CO3 (12.58 g, 91 
mmol, 2.60 equiv.) and  Me2SO4 (12.58 g, 9.46 mL, 99.8 mmol, 2.85 equiv.) at room 
temperature. Heated to reflux until complete as judged by TLC (14 h). Diluted with EtOAC 
(200 mL) and reduced volume by 50% , repeated thrice times.  Diluted with EtOAc (250 
mL) and washed with sat NaHCO3 (2 x 150 mL), brine (1 x 150 mL), dried over MgSO4 and 
concentrated to afford a white solid.  Crude product was passed over a bed of silica gel (75 x 
75mm) eluted with 1:9 EtOAc:Hex (Rf = 0.33, 1:9 EtOAc:Hex) to yield 14.29 g, 98 %, 63 as 
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a white solid. 
1
H NMR (500 MHz, CDCl3) δ 8.56 (s, 1H), 7.70 (d, J = 8.3 Hz, 1H), 7.56 (d, J 
= 7.6 Hz, 1H), 7.48 (s, 1H), 7.41 (t, J = 7.6 Hz, 2H), 7.33 (t, J = 7.4 Hz, 1H), 6.86 (d, J = 8.4 
Hz, 1H),  5.14 (s, 2H), 4.45 (q, J = 7.1 Hz, 2H), 4.00 (s, 3H), and 1.45 (t, J = 7.1 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 166.43, 157.74, 155.95, 136.87, 134.27, 131.09, 129.43, 
128.43, 127.75, 126.91, 122.52, 121.25, 115.32, 110.81, 105.69, 71.58, 61.38, 56.39, and 
14.38. HREIMS calc’d for C21H19O4Br 414.0467, Found: 414.0451. 
 
 
 
(5-(benzyloxy)-8-bromo-4-methoxynaphthalen-2-yl)methanol (64, JF-004-195) To a dry 
500 mL round bottom flask charged with argon and a stir bar suspended LiAlH4 (1.92 g, 
50.63 mmol, 1.5 equiv.) in THF (85 mL) then cooled to 0°C. Added 63 (14.02  g, 34 mmol, 
1.0 equiv.) in THF (85 mL) drop wise then stirred and allowed to warm to room temperature 
until complete as judged by TLC (14 h, Rf = 0.12, 1:4 EtOAc:Hex). Cooled o 0°C and 
slowly quenched with MeOH (~25 mL), diluted with EtOAc (300 mL) and washed with 10 
wt% KF:H2O (2 x 200 mL), brine (1 x 100 mL), dried over MgSO4 and concentrated to 
afford an off white solid (4:1 brominated:debrominated by GCMS) Recrystallized form 
EtOH to yield 9.67 g, 77 %, 64 as a white crystalline solid. 
1
H NMR (500 MHz, CDCl3) δ 
7.75 (s, 1H), 7.64 (d, J = 8.3 Hz, 1H), 7.57 (d, J = 7.1 Hz, 2H), 7.42 (t, J = 7.6 Hz, 2H), 7.34 
(t, J = 7.4Hz, 1H), 6.93 (s, 1H), 6.76 (d, J = 8.4 Hz, 1H), 5.17 (s, 2H), 4.83 (s, 2H), 3.95 (s, 
3H), and 1.86 (br s, 1H). 
13
C NMR (125 MHz, CDCl3) δ 157.84, 156.04, 140.63, 137.15, 
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134.78, 130.67, 128.40, 127.68, 126.95, 118.64, 117.27, 114.16, 108.88, 105.66, 71.54, 
65.45, and 56.32. HREIMS calc’d for C19H17O3Br 372.0361, Found: 372.0352. 
 
 
 
((5-(benzyloxy)-8-bromo-4-methoxynaphthalen-2-yl)methoxy)triisopropylsilane (65, 
JF-004-197) To a dry 250 mL round bottom flask charged with argon and a stir bar 
dissolved 64 (9.33 g, 25 mmol, 1.0 equiv.), DMAP (0.31 g, 2.5 mmol, 0.1 equiv.) and Et3N 
(2.78g, 3.83 mL, 27.5 mmol, 1.1 equiv.) in DCM (50 mL, 0.5M) and cooled to 0°C.  Added 
TIPSCl (7.23 g, 8.02 mL, 37.5 mmol, 1.5 equiv.) drop wise, stirred and allowed to warm to 
room temperature until complete as judged by TLC (15.5h). Partioned into sat NaHCO3 (100 
mL) and separated, extracted with DCM (4 x 50 mL), washed with brine (50 mL), dried over 
MgSO4 and concentrated to afford an off white solid. Rf = 0.12, 1:4 EtOAc:Hex). Cooled o 
0°C and slowly quenched with MeOH (~25 mL), diluted with EtOAc (300 mL) and washed 
with 10 wt% KF:H2O (2 x 200 mL), brine (1 x 100 mL), dried over MgSO4 and 
concentrated to afford an off white solid Crude product was purified via flash 
chromatography with silica gel (90 x 250 mm) eluted with 5:95 EtOAc:Hex, (Rf = 0.47, 1:9 
EtOAc:Hex) to yield 12.14 g, 92 %, 65 as a white solid.. 
1
H NMR (500 MHz, CDCl3) δ 7.83 
(s, 1H), 7.64 (d, J = 8.3 Hz, 1H), 7.59 (d, J = 7.6 Hz, 2H), 7.42 (t, J = 7.6 Hz, 2H), 7.34 (t, J 
= 7.7Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H), 5.18 (s, 2H), 5.02 (s, 2H), 3.96 (s, 3H), 1.29-1.20 (m, 
3H), and 1.17-1.12 (m, 18H). 
13
C NMR (125 MHz, CDCl3) δ 157.50, 156.06, 141.63, 
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137.28, 134.87, 130.39, 128.38, 127.61, 126.95, 118.32, 116.03, 114.29, 108.44, 105.03, 
71.54, 65.01, 56.26, 18.09, and 12.11. HREIMS calc’d for C28H37O3BrSi 528.1695, Found: 
528.1700. 
 
 
 
(4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy)methyl)naphthalen-1-yl)boronic 
acid (66, JF-004-199) To a dry 500 mL round bottom flask charged with argon and a stir 
bar dissolved 65 (8.21 g, 15.5 mmol, 1.0 equiv.), in THF (155 mL, 0.1M) and cooled to -
78°C.  Added nBuLi (1.09 g, 7.93 mL, 17.05 mmol, 1.1 equiv., 2.15M) drop wise and 
allowed to stir for ~ 15 min. at -78°C. (Note: formed yellow solution) then added B(OMe)3 
(8.05 g, 8.64 mL, 77.5 mmol, 5.0 equiv.) quickly (Note: reaction turned clear) stirred and 
allowed to warm to room temperature overnight.  Diluted with EtOAc (300 mL), washed 
with sat. NaHCO3 (3 x 150 mL) and brine (2 x 100 mL). Dried over MgSO4 and removed 
solvent in vacuuo to afford a pink solid.  Recrystallized from PhMe and nPent to yield 6.23 
g, 81%, 66 as a white crystalline solid. 
1
H NMR (500 MHz, CDCl3) δ 8.81 (d, J = 1.1 1H), 
8.58 (d, J = 7.9 Hz, 1H), 7.67 (d, J = 7.1 Hz, 2H), 7.46 (t, J = 7.6 Hz, 2H), 7.36 (t, J = 7.4 
Hz, 1H), 7.20 (d, J = 1.0 Hz, 1H), 7.02 (d, J = 8.1 Hz, 1H),  5.31 (s, 2H), 5.02 (s, 2H), 4.01 
(s, 3H), 1.21-1.12 (m, 3H), and 1.10-1.05 (d, J = 6.6 Hz, 18H). 
13
C NMR (125 MHz, CDCl3) 
δ 160.30, 157.90, 141.75, 140.82, 139.21, 137.26, 128.41, 127.61, 126.85, 117.35, 117.04, 
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106.17, 104.93, 70.65, 65.72, 56.08, 18.09, and 12.08. CIMS calc’d for C28H39O5BSi 
494.2660, Found: 451.28 [M–C3H7]
+
. 
 
 
 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl) naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl1-
naphthoate  (67 and 67’, JF-004-202) To a dry 25 mL round bottom flask charged with 
argon and magnetic stir bar, added 55 (273 mg, 0.4 mmol, 1.0 equiv.), 66 (297 mg, 0.6 
mmol, 1.5 equiv.), Pd(OAc)2 (3.6 mg, 0.016 mmol, 0.04 equiv.), SPhos (13 mg, 0.032 
mmol, 0.08 equiv.), and K3PO4 (272 mg, 1.3 mmol, 3.2 equiv.) then evacuated and 
backfilled with argon thrice times. Added nBuOH (11.4 mL, 0.04M), wrapped in Al foil 
then stirred at room temperature until complete as judged by TLC (21 h). Diluted with brine 
(25 mL) and extracted with DCM (4 x 25 mL), washed combined organics with sat. 
NaHCO3 (2 x 25 mL) and brine (1 x 25 mL), dried over MgSO4, absorbed onto basic Al2O3 
(~5 g) and concentrated in vacuo. Crude product was purified via flash chromatography with 
silica gel (50 x 150 mm) eluted with 2:8 EtOAc:Hex with 1% Et3N, (Rf = 0.24, 2:8 
EtOAc:Hex) to yield 357 mg, 89 %, 67/67’ as a white foamy solid, (9.8:1 P/M) as 
inseparable isomers. Data for P atropisomer 67: 
1
H NMR (500 MHz, CDCl3) δ 8.79 (d, J = 
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8.1 Hz, 1H), 7.91 (d, J = 8.1 Hz, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.74 (d, J = 6.2 Hz, 1H), 7.67 
(d, J = 7.18 Hz, 2H), 7.53-7.34 (m, 13H), 7.17 (dd, J = 1.2 Hz, 1H), 7.16 (d, J = 1.2 Hz, 1H), 
7.15 (d, J = 1.2 Hz, 1H), 7.10 (s, 1H), 6.97-6.94 (m, 2H), 6.83 (d, J = 9.0 Hz, 1H), 6.60 (s, 
1H), 5.19-5.09 (m, 4H), 4.90-4.83 (m, 2H), 4.82-4.76 (m, 2H), 4.54 (dd, J = 10.7, 3.7 Hz, 
1H), 4.12 (dd, J = 12.8, 6.2 Hz, 1H), 4.08 (dd, J = 10.2, 7.9 Hz, 1H), 3.95 (s, 3H), 2.82 (m, 
1H), 2.67 (dd, J = 15.8, 3.6 Hz, 1H), 2.59 (s, 3H), 2.34 (dd, J = 15.6, 9.9 Hz, 1H), 1.46 (d, J 
= 6.2 Hz, 3H), 1.10-1.01 (m, 3H), and 0.99-0.95 (m, 18H). 
13
C NMR (125 MHz, CDCl3) δ 
167.16, 157.41, 155.67, 155.51, 154.95, 139.90, 137.97, 137.49, 137.30, 136.79, 136.06, 
133.69, 133.02, 131.28, 130.11, 128.63, 128.51, 128.33, 128.19, 127.91, 127.59, 127.57, 
127.42, 127.28, 127.26, 126.92, 126.67, 126.06, 125.83, 124.49, 122.02, 121.91, 117.30, 
114.66, 107.76, 104.22, 97.67, 71.32, 70.96, 70.18, 67.53, 65.04, 59.07, 56.13, 55.22, 43.61, 
29.41, 23.05, 18.03, and 11.99.  [α]20D= +8.45°; CHCl3. [M + H]
+
. Key nOe were observed 
in agreement with literature observed nOe shown below, assignments made by use of 
1
H, 
13
C, HMQC, HMBC, COSY and NOESY NMR.  Data for M atropisomer 67’: 1H NMR (500 
MHz, CDCl3) δ 8.86 (d, J = 7.7 Hz, 1H), 8.22 (d, J = 7.2 Hz, 1H), 8.04 (d, J = 8.2 Hz, 1H), 
7.86 (d, J = 7.1Hz, 1H), 7.77 (d, J = 6.9 Hz, 1H), 7.57 (d, J = 7.2 Hz, 2H), 7.53-7.49 (m, 
12H), 7.22 (d, J = 4.5 Hz, 1H), 7.03-7.00 (m, 2H), 6.92 (d, J = 4.3 Hz, 2H), 6.78 (s, 1H), 
6.57 (s, 1H), 6.49 (s, 1H), 6.41 (s, 1H), 5.17 (m, 2H), 5.03 (m, 2H), 4.75 (m, 2H), 4.65, (m, 
2H), 4.41 (dd, J = 11.0, 4.2 Hz, 1H), 4.20 (d, J = 7.1 Hz, 1H), 4.18 (d, J = 7.2 Hz, 1H), 3.98 
(s, 3H), 2.90 (m, 1H), 2.61 (s, 3H), 2.48 (m,  2H), 1.40 (d, J = 6.6 Hz, 3H), 1.10-1.01 (m, 
3H), and 0.99-0.95 (m, 18H)  
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Key nOe interactions of 67 
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((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methanol (70, 
JF-004-206) To a dry 100 mL round bottom flask charged argon, ~0.2 g 4Å molecular 
sieves, and  a magnetic stir bar, added dissolved 67 (302 mg, 0.3 mmol, 1.0 equiv.) in dry 
THF:MeOH (30 mL, 0.01M) followed by NaOH (600 mg, 15 mmol, 50 equiv.) then stirred 
at room temperature until complete as judged by TLC (4 h). Note: aide in absorbing any 
residual moisture, prevent the aq. Base catalyzed epimerization, and may not be left in 
solution once complete) Diluted with Et2O (50 mL) and washed with sat. NaHCO3 (1 x 25 
mL), extracted aqueous with Et2O (3 x 25 mL), washed combined organics with brine (1 x 
25 mL), dried over MgSO4, absorbed onto basic Al2O3 (~1 g) and concentrated in vacuo. 
Crude product was purified via flash chromatography with silica gel (50 x 150 mm) eluted 
with 5:95 MeOH:DCM with 1% Et3N, (Rf = 0.28, 7:93 MeOH:DCM) to yield 248 mg, 97 
%, 70 as a white foamy solid. 
1
H NMR (600 MHz, CDCl3) δ 7.64 (d, J = 7.4 Hz, 2H), 7.45 – 
7.40 (m, 6H), 7.35 (dt, J = 15.0, 9.6 Hz, 3H), 7.16 (d, J = 7.9 Hz, 1H), 7.15-7.13 (m, 3H), 
7.00 (s, 1H), 6.96 (d, J = 7.9 Hz, 1H), 6.93 (dd, J = 6.2, 3.0 Hz, 2H), 6.85 (s, 1H), 6.56 (s, 
1H), 5.25 (s, 2H), 5.07 (q, J = 11.8 Hz, 2H), 4.84 (d, J = 12.4 Hz, 2H), 4.79 (dd, J = 13.0, 
6.1 Hz, 2H), 4.15 (dd, J = 13.4, 6.7 Hz, 1H), 3.97 (s, 3H), 3.55 (dd, J = 10.5, 3.8 Hz, 1H), 
3.14 (d, J = 9.2 Hz, 1H), 2.65 (br s,  1H), 2.46 (dd, J = 10.8, 3.4 Hz, 1H), 2.43 (s, 3H), 2.33 
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(dd, J = 15.8, 11.0 Hz, 1H), 2.24 (dd, J = 15.9, 4.5 Hz, 1H), 1.39 (d, J = 6.6 Hz, 3H), 1.08-
1.05 (m, 3H), and 0.98 (d, J = 6.2 Hz, 18H). 
13
C NMR (125 MHz, CDCl3) δ 
13
C NMR (126 
MHz, CDCl3) δ 157.40, 155.79, 155.54, 154.79, 139.91, 137.91, 137.47, 137.26, 136.84, 
128.63, 128.38, 128.33, 128.20, 128.17, 127.94, 127.65, 127.44, 127.29, 127.27, 127.01, 
126.65, 126.55, 122.04, 117.36, 114.66, 107.96, 104.28, 97.48, 71.54, 70.98, 70.17, 65.09, 
62.83, 56.21, 54.80, 46.16, 43.87, 27.95, 23.89, 18.04, and 12.01. [α]20D= +18.93°; CHCl3. 
HRCIMS calc’d for C54H65NO6Si: 854.4581, Found:  852.4647 [M + H]
+
. 
 
Key nOe correlations for 70 
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 ((P)-5-(benzyloxy)-8-((1R,3R)-6,8-bis(benzyloxy)-3-(hydroxymethyl)-1,2-dimethyl-
1,2,3,4-tetrahydroisoquinolin-5-yl)-4-methoxynaphthalen-2-yl)methanol (71, JF-004-
209) To a dry 10 mL round bottom flask charged a magnetic stir bar,  dissolved 70 (234 mg, 
0.28 mmol, 1.0 equiv.) in THF (3 mL, 0.1M) followed by dropwise addition of TBAF (85 
mg, 0.3 mmol, 1.1 equiv.) then stirred at room temperature until complete as judged by TLC 
(30 min). Diluted with Et2O (25 mL) and washed with sat. NaHCO3 ( 1 x 10 mL), extracted 
aqueous with Et2O (3 x 10 mL), washed combined organics with brine (1 x 10 mL), dried 
over MgSO4, absorbed onto basic Al2O3 (~1 g) and concentrated in vacuo. Crude product 
was purified via flash chromatography with silica gel (50 x 150 mm) eluted with 7:93 
MeOH:DCM with 1% Et3N, (Rf = 0.19, 7:93 MeOH:DCM) to yield 186 mg, 97 %, 71 as a 
white foamy solid. Cis by 2-D Noesy. 
1
H NMR (500 MHz, CDCl3) δ 
1
H NMR (500 MHz, 
CDCl3) δ 7.65 (d, J = 7.9 Hz, 2H), 7.47 – 7.41 (m, 6H), 7.37 (ddd, J = 19.1, 10.1, 4.6 Hz, 
2H), 7.23 (d, J = 7.9 Hz, 1H), 7.18 – 7.16 (m, 3H), 7.00 (d, J = 7.9 Hz, 1H), 6.97 (dd, J = 
6.1, 2.5 Hz, 1H), 6.93 (s, 1H), 6.89 (s, 1H), 6.60 (s, 1H), 5.26 (s, 2H), 5.10 (q, J = 11.8 Hz, 
2H), 4.85 (dd, J = 31.9, 12.5 Hz, 2H), 4.63 (s, 2H), 4.17 (dd, J = 13.2, 6.5 Hz, 1H), 3.99 (s, 
3H), 3.57 (dd, J = 10.8, 3.1 Hz, 1H), 3.18 (d, J = 10.3 Hz, 1H), 2.78 (br s, 1H), 2.51 – 2.46 
(m, 1H), 2.45 (s, 3H), 2.41 (d, J = 10.8 Hz, 1H), 2.19 (d, J = 12.2 Hz, 1H), 1.42 (d, J = 6.7 
Hz, 3H), and 1.16 (br s, 1H). 
13
C NMR (125MHz, CDCl3) δ 
13
C NMR (126 MHz, CDCl3) δ 
  212 
13
C NMR (126 MHz, CDCl3) δ 157.93, 155.68, 155.60, 154.81, 139.22, 137.77, 137.34, 
137.10, 136.82, 136.59, 128.98, 128.65, 128.36, 128.23, 128.22, 127.99, 127.50, 127.41, 
127.30, 126.99, 126.72, 126.60, 121.79, 117.74, 116.18, 108.37, 105.09, 97.73, 71.55, 
70.97, 70.23, 65.68, 62.53, 56.26, 54.97, 43.48, 28.29, and 23.75.  [α]20D= +24.23°; CHCl3. 
HCIMS calc’d for C45H45NO6: 695.3247, Found:  696.3352 [M + H]
+
. 
 
 
(3S)-6,8-bis(benzyloxy)-5-((S)-4-(benzyloxy)-5-methoxy-7-methylnaphthalen-1-yl)-
1,2,3-trimethyl-1,2,3,4-tetrahydroisoquinoline (72, JF-004-211) To a dry 25 mL round 
bottom flask charged with argon and a stir bar dissolved 71 (44 mg, 0.07 mmol, 1.0 equiv.), 
in DCM (7 mL, 0.01M), followed by Et3N (50 uL, 36 mg, 0.35 mmol, 5.0 equiv.) then 
cooled to 0 °C and stirred (~ 15 min).  Added MsCl (32 mg, 21 uL, 0.28 mmol, 4.0 equiv.) 
in DCM (0.3 mL, 1 M) allowed to stir at ~0 °C for 15 min. then removed ice bath and stirred 
at rt until complete as judged by TLC (3 h) (Rf = 0.85, 7:93 MeOH:DCM; deactivated TLC 
plate with Et3N) Note: the mesylate intermediate will decompose on silica gel)  Diluted with 
DCM (25 mL) and quickly washed with sat. NH4Cl (1 x 10 mL), and brine (1 x 10 mL), 
dried over MgSO4, concentrated in vaccuo to afford an orange oil. To the mesylate 
intermediate in a 25 mL RBF with stir bar dissolved in dry THF (7 mL, 0.01M) followed by 
4Å molecular sieves (10 beads) then cooled to 0 °C and stirred (~ 15 min).  Added LiEt3BH 
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(111 mg, 1.1 mL, 1.1 mmol, 15 equiv.) in THF (1 M) allowed to stir at 0 °C for 15 min. then 
removed ice bath and stirred at rt. Reaction was incomplete as judged by TLC (7 h) with 
little product formed and still mainly mesylate intermediate, recooled to  0 °C. Added 
additional LiEt3BH (111 mg, 1.1 mL, 1.1 mmol, 15 equiv.) in THF (1 M) allowed to stir at 0 
°C for 15 min. then removed ice bath and stirred at rt until complete as judged by TLC (12 
h). Cooled to 0 °C and slowly quenched with sat. NH4Cl (10 mL) then extracted with Et2O 
(3 x 10 mL), washed with brine (1 x 10 mL), dried over MgSO4, and concentrated in vaccuo. 
Crude product was purified via prep-TLC, developed withh 7:93 MeOH:DCM with 1% 
Et3N, (Rf = 0.34, 7:93 MeOH:DCM) to yield 6.4 mg, 14 %, 72 as a tan solid.
 58,59
 
1
H NMR 
(500 MHz, CDCl3) δ 7.65 (d, J = 7.2 Hz, 2H), 7.43 (dd, J = 8.0, 4.8 Hz, 6H), 7.36 (m, 2H), 
7.19 – 7.17 (m, 3H), 7.15 (d, J = 7.8 Hz, 1H), 7.01 – 6.97 (m, 2H), 6.95 (d, J = 7.9 Hz, 1H), 
6.81 (s, 1H), 6.70 (s, 1H), 6.61 (d, J = 5.3 Hz, 1H), 5.26 (s, 2H), 5.08 (dd, J = 26.0, 11.7 Hz, 
2H), 4.84 (dd, J = 29.6, 12.4 Hz, 2H), 4.06 (dd, J = 12.4, 8.0 Hz, 1H), 3.97 (s, 3H), 3.65 – 
3.58 (m, 1H), 2.58 (dd, J = 14.3, 7.1 Hz, 1H), 2.51 (s, 3H), 2.34 (s, 3H), 2.27 (dd, J = 14.2, 
9.6 Hz, 1H), 1.61 (d, J = 6.1 Hz, 3H), and 1.09 (d, J = 5.8 Hz, 3H). [α]20D= +13.04°; CHCl3. 
HREIMS calc’d for C45H45NO4: 663.3497, Found:  664.3409 [M + H]
+
. 
 
 
. 
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(1S,3S)-5-((P)-4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-1,2,3-trimethyl-1,2,3,4-
tetrahydroisoquinoline-6,8-diol (13-epi, JF-004-213) and (1R,3S)-5-((P)-4-hydroxy-5-
methoxy-7-methylnaphthalen-1-yl)-1,2,3-trimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-
diol (13, JF-004-213) To a 25 mL round bottom flask charged with a stir bar, dissolved 72  
(6.4 mg, 0.01mmol, 1.0 equiv.) in MeOH:DCM, 2:1 (5 mL, 2 mM), added Pd/C (10 wt%, 33 
mg, 0.03 mmol, 3.0 equiv.), then fixed an H2 balloon and stirred at rt until complete as 
judged by TLC (8 h). Filtered reaction through a pad of celite and concentrated filtrate in 
vaccuo  Crude product was purified via prep-TLC, developed withh 1:9 MeOH:DCM with 
1% Et3N, (Rf = 0.16, 1:9 MeOH:DCM) to yield 2.4 mg, 62 %, 13-epi as a tan solid.
 1
H NMR 
(500 MHz, CD3OD) δ 7.07 (d, J = 7.8 Hz, 1H), 6.76 (d, J = 7.4 Hz, 3H), 6.42 (s, 1H), 4.25 
(d, J = 5.1 Hz, 1H), 4.06 (s, 3H), 3.06 (dd, J = 14.5, 7.3 Hz, 1H), 2.87 (s, 1H), 2.74 (s, 3H), 
2.31 (s, 3H), 2.27 (d, J = 2.7 Hz, 1H), 2.17 (dd, J = 16.8, 10.3 Hz, 1H), 1.67 (d, J = 6.4 Hz, 
3H), and 1.14 (d, J = 6.3 Hz, 3H). HREIMS calc’d for C24H28NO4: 393.2018, Found:  
394.2032 [M + H]
+
. 
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4.7 Spectral Data 
(S)-triisopropyl(oxiran-2-ylmethoxy)silane 44; Proton NMR, CDCl3 
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(S)-triisopropyl(oxiran-2-ylmethoxy)silane 44; Carbon NMR, CDCl3 
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(((5-bromo-1,3-phenylene)bis(oxy))bis(methylene))dibenzene 43; Proton NMR,  
CDCl3 
 
 
  218 
(((5-bromo-1,3-phenylene)bis(oxy))bis(methylene))dibenzene 43; Carbon NMR,  
CDCl3 
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(S)-1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-ol 45; Proton NMR,  
CDCl3 
 
 
  220 
(S)-1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-ol 45; Carbon NMR,  
CDCl3 
 
 
  221 
(R)-2-(1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-yl)isoindoline-1,3-
dione 46; Proton NMR, CDCl3 
 
 
  222 
(R)-2-(1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-yl)isoindoline-1,3-
dione 46; Carbon NMR, CDCl3 
 
 
  223 
(R)-1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-amine 47; Proton 
NMR, CDCl3
 
 
  224 
(R)-1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-amine 47; Carbon 
NMR, CDCl3
 
 
  225 
(R)-N-(1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-yl)acetamide 48; 
Proton NMR, CDCl3
 
 
  226 
(R)-N-(1-(3,5-bis(benzyloxy)phenyl)-3-((triisopropylsilyl)oxy)propan-2-yl)acetamide 48; 
Carbon NMR, CDCl3
 
 
  227 
(R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-di- 
hydroisoquinoline 49; Proton NMR, CDCl3 
 
 
  228 
(R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-di- 
hydroisoquinoline 49; Carbon NMR, CDCl3 
 
  229 
(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 50; Proton NMR, CDCl3  
 
 
  230 
(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 50; Carbon NMR, CDCl3 
 
 
  231 
(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 50; HMQC NMR, CDCl3
 
 
 
 
 
 
 
 
 
 
 
 
  232 
(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 50; Noesy NMR, CDCl3
  
 
 
 
 
 
 
 
  233 
Ethyl-(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-
dihydroisoquinoline-2 (1H)-carboxylate 51; Proton NMR, CDCl3 
 
  234 
Ethyl-(1R,3R)-6,8-bis(benzyloxy)-1-methyl-3-(((triisopropylsilyl)oxy)methyl)-3,4-
dihydroisoquinoline-2 (1H)-carboxylate 51; Carbon NMR, CDCl3  
 
 
  235 
(1R,3R)-6,8-bis(benzyloxy)-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 52; Proton NMR, CDCl3 
 
 
  236 
(1R,3R)-6,8-bis(benzyloxy)-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 52; Carbon NMR, CDCl3 
 
 
  237 
(1R,3R)-6,8-bis(benzyloxy)-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 52; HMQC NMR, CDCl3 
 
 
 
 
 
 
 
 
 
 
  238 
(1R,3R)-6,8-bis(benzyloxy)-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 52; 2D Noesy NMR, CDCl3 
 
 
 
 
 
 
 
  239 
(1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 53; Proton NMR, CDCl3 
 
 
  240 
(1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 53; Carbon NMR, CDCl3 
 
 
  241 
(1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 53; HMQC NMR, CDCl3 
 
 
 
 
 
 
 
 
 
  242 
(1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-3-(((triisopropylsilyl)oxy)methyl)-1,2,3,4-
tetrahydroisoquinoline 53; 2D Noesy NMR, CDCl3 
 
 
 
 
 
 
  243 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-
yl)methanol 54; Proton NMR, CDCl3 
 
  244 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-
yl)methanol 54; Carbon NMR, CDCl3 
 
 
  245 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-
yl)methanol 54; HMQC NMR, CDCl3 
 
 
 
 
 
 
 
 
 
 
  246 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-
yl)methanol 54; 2D Noesy NMR, CDCl3 
 
 
 
 
 
 
  247 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl 
1-naphthoate 55; Proton NMR, CDCl3 
  
 
  248 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl 
1-naphthoate 55; Carbon NMR, CDCl3 
 
 
  249 
((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl 
1-naphthoate 55; HMQC NMR, CDCl3 
 
 
 
 
 
 
 
 
 
 
  250 
 ((1R,3R)-6,8-bis(benzyloxy)-5-iodo-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl 
1-naphthoate 55; 2D Noesy NMR, CDCl3 
 
 
 
 
 
 
 
  251 
3-benzyloxy benzaldehyde 57; Proton NMR, CDCl3 
 
 
 
  252 
3-benzyloxy benzaldehyde 57; Carbon NMR, CDCl3 
 
 
 
  253 
5-(benzyloxy)-2-bromobenzaldehyde 58; Proton NMR, CDCl3
 
 
 
  254 
5-(benzyloxy)-2-bromobenzaldehyde 58; Carbon NMR, CDCl3 
 
 
 
  255 
4-(t-butyl) 1-ethyl 2-(diethoxyphosphoryl)succinate 59; Proton NMR, CDCl3
 
 
 
  256 
4-(t-butyl) 1-ethyl 2-(diethoxyphosphoryl)succinate 59; Carbon NMR, CDCl3 
 
 
 
  257 
4-(t-butyl) 1-ethyl (E)-2-(5-(benzyloxy)-2-bromobenzylidene)succinate 60; Proton NMR, 
CDCl3)  
 
 
  258 
4-(t-butyl) 1-ethyl (E)-2-(5-(benzyloxy)-2-bromobenzylidene)succinate 60; Carbon NMR, 
CDCl3 
 
 
  259 
(E)-4-(5-(benzyloxy)-2-bromophenyl)-3-(ethoxycarbonyl)but-3-enoic acid 61; Proton NMR, 
CDCl3 
 
 
  260 
(E)-4-(5-(benzyloxy)-2-bromophenyl)-3-(ethoxycarbonyl)but-3-enoic acid 61; Carbon 
NMR, CDCl3 
 
 
  261 
Ethyl 5-(benzyloxy)-8-bromo-4-hydroxy-2-naphthoate 62; Proton NMR, CDCl3
 
 
 
  262 
Ethyl 5-(benzyloxy)-8-bromo-4-hydroxy-2-naphthoate 62; Carbon NMR, CDCl3 
 
 
 
  263 
Ethyl 5-(benzyloxy)-8-bromo-4-methoxy-2-naphthoate 63; Proton NMR, CDCl3 
 
 
  264 
Ethyl 5-(benzyloxy)-8-bromo-4-methoxy-2-naphthoate 63; Carbon NMR, CDCl3
 
 
 
  265 
(5-(benzyloxy)-8-bromo-4-methoxynaphthalen-2-yl)methanol 64; Proton NMR, CDCl3 
 
 
 
  266 
(5-(benzyloxy)-8-bromo-4-methoxynaphthalen-2-yl)methanol 64; Carbon NMR, CDCl3 
 
 
 
  267 
((5-(benzyloxy)-8-bromo-4-methoxynaphthalen-2-yl)methoxy)triisopropylsilane 65; Proton 
NMR, CDCl3
 
 
  268 
((5-(benzyloxy)-8-bromo-4-methoxynaphthalen-2-yl)methoxy)triisopropylsilane 65; Carbon 
NMR, CDCl3
 
 
  269 
(4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy)methyl)naphthalen-1-yl)boronic acid 
66; Proton NMR, CDCl3 
 
 
  270 
(4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy)methyl)naphthalen-1-yl)boronic acid 
66; Carbon NMR, CDCl3 
 
  271 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl) naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl1-
naphthoate  67 and 67’; Proton NMR, CDCl3 
 
  272 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl) naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl1-
naphthoate  67 and 67’; Carbon NMR, CDCl3 
 
  273 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl) naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl1-
naphthoate  67; HMQC NMR, CDCl3 
 
 
 
 
 
 
 
 
  274 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl) naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl1-
naphthoate  67; 2D Noesy NMR, CDCl3 
 
 
 
 
  275 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methanol 70; 
Proton NMR, CDCl3
 
  276 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methanol 70; 
Carbon NMR, CDCl3
 
  277 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methanol 70; 
HMQC NMR, CDCl3 
 
  
 
 
 
 
 
  278 
((1R,3R)-6,8-bis(benzyloxy)-5-((P)-4-(benzyloxy)-5-methoxy-7-(((triisopropylsilyl)oxy) 
methyl naphthalen-1-yl)-1,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-3-yl)methanol 70; 2D 
Noesy NMR, CDCl3 
 
 
 
 
 
  279 
((P)-5-(benzyloxy)-8-((1R,3R)-6,8-bis(benzyloxy)-3-(hydroxymethyl)-1,2-dimethyl-1,2,3,4-
tetrahydroisoquinolin-5-yl)-4-methoxynaphthalen-2-yl)methanol 71; Proton NMR, CDCl3
 
  280 
((P)-5-(benzyloxy)-8-((1R,3R)-6,8-bis(benzyloxy)-3-(hydroxymethyl)-1,2-dimethyl-1,2,3,4-
tetrahydroisoquinolin-5-yl)-4-methoxynaphthalen-2-yl)methanol 71; Carbon NMR, CDCl3
 
  281 
((P)-5-(benzyloxy)-8-((1R,3R)-6,8-bis(benzyloxy)-3-(hydroxymethyl)-1,2-dimethyl-1,2,3,4-
tetrahydroisoquinolin-5-yl)-4-methoxynaphthalen-2-yl)methanol 71; 2D Noesy NMR, 
CDCl3 
 
 
 
 
 
 
 
  282 
 ((P)-5-(benzyloxy)-8-((1R,3R)-6,8-bis(benzyloxy)-3-(hydroxymethyl)-1,2-dimethyl-
1,2,3,4-tetrahydroisoquinolin-5-yl)-4-methoxynaphthalen-2-yl)methanol 71; 2D Noesy 
NMR, CDCl3 
 
 
 
  283 
(3S)-6,8-bis(benzyloxy)-5-((S)-4-(benzyloxy)-5-methoxy-7-methylnaphthalen-1-yl)-1,2,3-
trimethyl-1,2,3,4-tetrahydroisoquinoline 72; Proton NMR, CDCl3 
.  
  
  284 
(1S,3S)-5-((P)-4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-1,2,3-trimethyl-1,2,3,4-
tetrahydroisoquinoline-6,8-diol 13-epi; Proton NMR, CDCl3 
  
 
 
 
 
  285 
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